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Abstract 
The direct functionalisation of C–H bonds has emerged in recent years as an efficient and 
atom-economic alternative to the traditional cross coupling reaction. One of the challenges 
towards this goal is the selective transformation of a particular C–H bond amongst many 
other C–H bonds. This thesis describes studies on the use of CO2 as a traceless promoter for 
controlling meta-regioselective arylation of phenols and a separate investigation into an 
enantioselective arylation of pre-chiral η6-arene tricarbonyl chromium complexes. 
The introduction provides a general review of recent advances in the use of coordinating 
moieties as directing groups for selective activation of aromatic C–H bonds. The challenge of 
meta-selective C–H activation and the direct functionalisation of phenols is assessed and 
discussed. To overcome the scarce methods for accessing meta-arylated phenols, our 
objective was to develop an efficient methodology for the meta-arylation of phenols. Our 
strategy includes an ortho-carboxylation of the phenol followed by ortho-arylation of the 
salicylic acids and the subsequent protodecarboxylation to afford meta-arylphenols is 
proposed. 
A step-wise approach towards our aim is applied. First, a convenient and efficient method 
for the carboxylation of phenols is presented in Chapter 2. Then, a tandem 
arylation/decarboxylation reaction of salicylic acids is described in Chapter 3. Last, an 
efficient methodology for the meta-arylation of phenols via carboxylation/arylation/ 
decarboxylation processes in one-pot is presented in the following section in Chapter 3. To 
demonstrate the utility of this powerful methodology, an efficient synthesis of ϒ-secretase 
inhibitor and the further transformation of the meta-arylphenols are shown. Furthermore, 
an alternative method is described for the synthesis of meta-arylphenols via a tandem 
oxidation/arylation/decarboxylation reaction of salicylaldehydes. 
In Chapter 4, an approach towards the development of enantioselective C–H arylation 
leading to planar chirality is stated. Preliminary results are presented for this ongoing 
project. 
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Chapter 1 Background and Objectives 
1.1 Meta-selective C–H activation 
1.1.1 Introduction 
Aryl–aryl bond formation is of great interest in organic synthesis as the biaryl motif is widely 
found in a variety of natural products as well as pharmaceuticals, agrochemicals and 
advanced materials. Aromatic rings are also relevant constituents of many ligands, being 
particularly interesting the axial chiral biaryls used in enantioselective catalysis. Examples of 
these are shown in Scheme 1.1. 
 
Scheme 1.1 Molecules that contain biaryl substructure 
The calcium salt of atorvastatin (1.1), sold under the trade name LIPITOR®, is one of the 
most popular drugs containing the biaryl substructure. As a prescription medicine it is used 
for not only lowering “bad” cholesterol (LDL), but also raising “good” cholesterol (HDL) in 
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blood. It was the most worldwide sold drug in 2009, which generated $16,537 million in 
revenue as reported by Pfizer.1 Amarogentin (1.2) is one of the most bitter natural 
compounds known, it is found in the gentian root which is used for the treatment of 
digestive disorders.2 Fluorescent materials 1.3, frequently based on the biaryl core are 
increasingly important in sensing applications. Boscalid (1.4) is a fungicide widely used to 
control a range of plant pathogens in broadacre and horticultural crops. Chiral ligands are 
vital components in enantioselective transformations and many of them contain the biaryl 
motif, for example the MeO-BIPHEP ligand (1.5). Its applications include Rh(I)-catalysed 
asymmetric isomerizations of allylamines to enamines3 and Pd(0)-mediated cyclizations of 
hydroxy allylic carbonates.4 All of these examples demonstrate that the construction of aryl–
aryl bond constitutes an important tool in organic synthetic chemistry.  
In order to stitch the carbon atoms together, chemists historically had to kick-start the 
reaction between two carbon atoms using reactive reagents. Such methods do work when 
building up simple molecules, but it encounters problems when creating more complex 
molecules due to the undesired by-products. However, particularly in the case of biaryl 
synthesis, palladium catalysed cross couplings has provided a precise and efficient method 
to construct C–C bond. The importance and high impact of this transformation was 
recognized in 2010, when Richard F. Heck, Ei-ichi Negishi and Akira Suzuki received the 
Nobel Prize in Chemistry for their contributions on “Palladium-catalysed cross-couplings in 
organic synthesis”.5 Some specific reactions, named after the chemist who developed each 
particular cross-coupling, are shown in Scheme 1.2. 
 
Scheme 1.2 Traditional cross-coupling transformations 
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The mechanisms of these traditional transformations usually involve the oxidative addition 
of the haloarene to Pd(0) to form the Pd(II) species 1.6, followed by transmetallation from 
the organometallic reagent into species 1.6, forming the diaryl-Pd(II) species 1.7. The biaryl 
product is formed after reductive elimination from species 1.7, simultaneously regenerating 
Pd(0) (Scheme 1.3). 
 
Scheme 1.3 Mechanism of the traditional Pd-catalysed cross coupling 
 
1.1.2 C–H activation 
Even though traditional cross couplings are extensively utilised in the construction of aryl–
aryl bond, they still encounter several intrinsic disadvantages (Scheme 1.4, a). 
1) Usually several synthetic operations are required for the pre-installation of a metal on the 
aromatic ring to form the organometallic reagent, which makes the process less efficient. 
Moreover, it is not atom-economic due to the requirement for stoichiometric amounts of 
metals to form the organometallic reagents. 
2) The heavy metal salts (M-X) formed as waste are in some cases very toxic, such as SnR3X 
waste generated in the Stille cross coupling. 
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Therefore, chemists have sought to develop new and more efficient aryl–aryl bond forming 
methods in the past decades. As a result, catalytic C–H activation shows its potential to fulfil 
this requirement as it allows efficient and economical access to myriad known and yet 
unknown molecules (Scheme 1.4, b). 6 The replacement of the organometallic reagent with 
a simple arene makes the reaction more efficient since pre-functionalisation is obviated for 
this reagent, as well as more environmentally friendly because the waste product is less 
toxic. The ideal scenario is dehydrogenative cross coupling that does not require pre-
functionalisation of either arene, forming aryl–aryl bond in the most efficient way (Scheme 
1.4, c). However, an external oxidant is usually required. 
 
Scheme 1.4 Comparison of tradition cross coupling and C–H activation 
Generally, the main challenge that this type of processes faces is the C–H activation step, 
due to the intrinsically low reactivity of C–H bonds and the difficulties of controlling the 
selectivity when many of them are present. There are four major kinds of mechanisms for 
the transition metal mediated C–H activation (Scheme 1.5): 7 
a) Traditional electrophilic aromatic substitution, which usually involves a rate-limiting 
metalation of the arene to form an unstable Wheland intermediate, followed by a rapid 
deprotonation step with re-aromatisation to form the metal-aryl intermediate (Scheme 1.5, 
a).8 
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b) Oxidative addition, usually takes place with low-oxidation state, electron-rich transition 
metals to form metal hydride species by the addition of the C–H bond into the metal centre 
(Scheme 1.5, b).9 
c) σ-Bond metathesis, typically through a four-membered cyclic transition state, forming 
metal-aryl intermediate by the loss of HX (Scheme 1.5, c).10 
d) Concerted-metalation-deprotonation (CMD) mechanism which requires the assistance of 
a carboxylate or carbonate. A six-membered cyclic transition state involving the metal 
carboxylate (or carbonate) and arene, results in simultaneous cleavage of the C–H bond and 
formation of a metal-aryl intermediate (Scheme 1.5, d).11 
 
Scheme 1.5 General mechanism for transition metal catalysis C–H activation 
It is obvious that C–H activation could drastically shorten the synthetic route as there is no 
requirement for pre-functionalisation of the arene starting materials. The abundance of C–H 
bonds in nature provides precedent for developing methodologies that enable the 
conversion of C–H bonds into valuable functionalised organic molecules. However, there are 
still significant hurdles to be overcome: 
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1) Harsh conditions are usually required due to the intrinsic low reactivity of C–H bond 
(aromatic C(sp2)–H bond energies are generally in the order of 100 kcal/mol), 
consequently, resulting in low substituted toleration. 
2) Poor chemoselectivity, as most of functional groups present in the molecule may be 
more reactive than the targeted C–H bond. Thus, undesired products may be 
generated during the C–H activation. 
3) Poor regioselectivity, due to the ubiquitous nature of C–H bonds in organic 
molecules.  
In this thesis, we will focus on the third point in particular for the regioslective 
functionalisation of aromatic compounds. In this approach, it is obviously necessary to 
control the regioselectivity while dealing with molecules containing more than one C–H 
bond. However, to obtain high regioselectivity in the direct arylation of substituted arenes is 
a big challenge, especially when a requirement for overcoming their ‘natural’ reactivity 
controlled by the electronic properties of their substituents is demanded. 
The most common strategy for inducing regioselectivity relies on the use of directing groups 
(DGs) which coordinate the transition-metal catalyst, forced to activate the proximal C–H 
bond, consequently achieving the selectivity in both intramolecular and intermolecular 
direct arylation (Scheme 1.6). 
 
Scheme 1.6 C–H activation in the presence of DGs 
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1.1.3 Meta-selective functionalisation  
Even though the use of DGs for regioselectivity-controlling groups can direct site-selective 
C–H activation because of its σ-chelating coordination ability, the DGs direct the transition 
metal into close proximity to the C–H bond to be activated. Moreover, a conformationally 
rigid five- or six-membered cyclic pre-transition state is usually formed, thus ortho-selective 
C–H activation takes place in most of the cases. Therefore, a great many methods have been 
reported for ortho-selective functionalisation by the use of DGs,12 whereas meta- and para-
selective functionalisation methods are still significantly underdeveloped (Scheme 1.7).13 
 
Scheme 1.7 Regioselectivity in C–H functionalisation in the presence of DGs 
To date, only a handful of methodologies for the meta C–H functionalisation have been 
reported. Pioneering reports by Gaunt and co-workers described the use of acetanilide and 
acetamide as DGs for meta-selective direct arylation under Cu catalysis conditions.14 The 
authors proposed an oxy-cupration across the 2,3-positions of the aromatic ring with 
participation of the carbonyl oxygen. Later on, however, a theoretical study by Wu’s group 
suggested a Heck-like four-membered-ring transition state involving a Cu(III)-Ph 
intermediate (1.10)15 even though the exact mechanism of the reaction remains unclear. 
However, the method is limited exclusively to the use of 2-oxo-substituted directing groups, 
and the non-commercially available Ar2IOTf species as the coupling partner (Scheme 1.8). 
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Scheme 1.8 Cu-catalysed meta-selective arylation 
Instead, Yu and co-workers demonstrated a method for meta-olefination and arylation 
assisted by an end-on template (Scheme 1.9, b).16  An innovatively designed moiety 
containing a strategically positioned nitrile group that is able to coordinate a Pd catalyst is 
installed and therefore directs the functionalisation in the meta-position (Scheme 1.9, a). 
This strategy was then applied in many other substrates such as phenyl amines 1.1917, 
indolines 1.2018 and phenyl acetic acids 1.2119, by introducing different precisely designed 
templates that control the C–H functionalisation at meta-position (Scheme 1.9, c).  
However, this method is limited due to the requirement of a covalently attached complex 
template, which makes the process less atom- and step-economic. The need for a particular 
template matching each substrate also limits its application. 
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Scheme 1.9 Template assisted meta-selective functionalisation 
Our group published a method for accessing the meta-substituted biaryls by the use of 
carboxylic acid as a removable ortho-directing group. Direct arylation catalysed by Pd in the 
ortho-position of the carboxylic acid group takes place with a subsequent in situ 
protodecarboxylation, forming a meta-substituted biaryl (Scheme 1.10, a).20 Unlike the 
previous methods reported by Gaunt’s and Yu’s groups, where particular directing groups 
are required, in this method,  biaryls with a variety of meta-substituents such as -Me, -OMe, 
-Cl, -F, -NO2, -CF3  can be transformed from the corresponding ortho-substituted benzoic 
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acids, owing to the loss of the real directing group. Su and co-workers used the same 
strategy, with Rh(III) catalysed C–H/C–H cross coupling reaction, achieving meta-arylation 
via a tandem arylation/decarboxylation process (Scheme 1.10, b).21 
 
Scheme 1.10 CO2 as a traceless directing group for accessing the meta-substituted biaryls 
Very recently, Yu’s group has developed a strategy via a Catellani-like process22 (Scheme 
1.11).23 The process starts with an ortho C–H activation of 1.29, giving palladacycle 1.31, 
followed by the insertion of norbornene to give place to complex 1.32 which contains the Pd 
centre in the appropriable position for C–H activation of the original meta C–H bond. The 
meta-functionalised product 1.30 is therefore generated via a stepwise process involving 
meta C–H activation, oxidative addition, reductive elimination and β-carbon elimination of 
norbornene. The Pd catalyst was regenerated by protodemetallation. It is an attractive 
method for meta-selective functionalisation without any introduction of other 
regioselectivity-controlling groups by the use of a transient norbornene. However, the 
reaction scope is currently extremely limited in the iodoarenes coupling partner as is the 
case in most Catellani-type processes. Later on, Dong and co-workers also reported a 
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method using Pd/norbornene catalysis, which allows meta-selective C−H arylation of simple 
dimethylaniline.24 
 
Scheme 1.11 Norbornene as a transient mediator for meta-functionalisation 
In 2011, Frost et al. reported a meta-sulfonation taking advantage of the para-directing 
effect of Ru on an electrophilic aromatic substitution (SEAr) on ruthenacycle 1.37 (Scheme 
1.12, left).25 Afterwards, Hofmann and Ackermann applied this method for meta-alkylation 
of 2-phenylpyridines (Scheme 1.12, right).26 
 
Scheme 1.12 Ru-catalysed meta C–H functionalisation  
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Beyond directing groups, methodologies for meta-selective borylation and one-pot 
borylation/functionalisation of 1,3-disubstituted arenes at C5 position have been reported 
by Hartwig, Miyaura et al. and Smith et al.27 Regioselectivity was shown to be dictated by a 
minimisation of the steric hindrance around the catalyst (Scheme 1.13). 
 
Scheme 1.13 Ir-catalysed borylation of 1,3-disubstituted arene at C5 position 
A template base, [Na4Mg2(TMP)6(
nBu)2], directed ortho-meta’ and meta-meta’ dimetalation 
(DomM, DmmM) depending on the directing groups was developed by O’Hara’s group 
(Scheme 1.14). The regioselectivity is controlled by the interaction between the template 
base cage and the directing group (Figure 1.1).28  
 
Scheme 1.14 Directed meta-meta’ metalation and subsequent electrophilic addition 
                  
                                Figure 1.1 Molecular structures: DomM (left) and DmmM (right) 
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1.1.4 Conclusions 
In conclusion, catalytic C–H functionalisation has received great attention due to its simple, 
and efficient access to myriad known and yet unknown molecules. Over the last decades, an 
array of methodologies for ortho C–H functionalisation compatible with a variety of 
directing groups have been reported, but there is still a lack of directing groups that can lead 
to meta-selective C–H activation, with the only examples reported by Gaunt and co-workers 
for Cu-catalysed meta-selective arylation of acetanilide and acetamide and Yu and co-
workers who developed a series of nitrile containing U-shaped templates that are able to 
coordinate with Pd catalyst thus control the functionalisation of  C–H bond at the meta-
position. An alternative efficient strategy that allows access to a variety of meta-substituted 
biaryls by the use of a removable directing group was developed by our group. Su and co-
workers applied it in a Rh(III) catalysed C–H/C–H cross coupling system. Very recently, Yu’s 
and Dong’s groups have developed an efficient methodology for meta-functionalisation by 
the use of norbornene as a transient mediator via a Catellani-like process. Beyond directing 
groups, the work reported by Hartwig and Smith that used Ir-catalysed meta-borylation of 
1,3-disubstited arenes and O’Hara’s work on the template base directed ortho-meta’ and 
meta-meta’ dimetalation constitute powerful alternatives. However, they are extremely 
limited to particular substrates. 
On the other hand, the low availability of meta C–H functionalisation methodologies is 
striking when compared with the number of meta-substituted motifs in pharmaceuticals, 
biologically active molecules and materials, thus, developing more general meta-selective 
C–H functionalisation methods is highly desired. 
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1.2 Functionalisation of phenols 
1.2.1 Importance of phenols 
In this thesis, we targeted the direct functionalisation of phenols as they are important 
central motifs that are abundant in many natural products, pharmaceuticals and 
agrochemicals, they are also found in catalysis ligands and polymers. Moreover, the high 
reactivity of phenol derivatives makes them versatile building blocks for organic synthesis.29 
 
Scheme 1.15 Phenol-containing molecules 
For example, Estradiol (1.43), is well-known to drive the development of secondary sex 
characteristics in women. It is not only essential for the development and maintenance of 
female reproductive tissues, but also vital for keeping men’s joints and brains healthy.30 
Another example, Quercetin (1.45) is widely distributed in nature, it has been found in many 
fruits, vegetables and grains,31 and it is used as a health care product as its powerful 
antioxidant properties can help protect the body against harmful free radicals. Polymers 
such as phenol formaldehyde resin and polycarbonate can be used in a variety of areas 
involving electronic applications, automotives, aircrafts, fiberglass, sound walls and so on, 
and both are made from the corresponding phenolic precursor.32 
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1.2.2 Site-selective functionalisation of phenols 
The functionalisation of phenols is of great interest and many efforts have been made in the 
past generally taking advantage of their nucleophilic character. Due to the well-known 
electron-donating nature of the hydroxyl group, electrophilic substitution on phenols is 
highly favoured at the ortho- and para-positions, as a result, many methodologies for site-
selective ortho- and para-functionalisation of phenols have been reported and commonly 
exploited. On the other hand, there is no example that could lead to meta-functionalised 
phenols merely by a single synthetic operation from parent phenols to date (Scheme 1.16).  
Scheme 1.16 Direct functionalisation of phenols is favoured at ortho- and para-positions 
Ortho-functionalisation of phenols 
Methodologies for ortho-selective functionalisation of phenols are generally based upon an 
active role of the hydroxyl group, by means of hydrogen bonding or coordination. For 
example, the selective ortho-formylation of phenol was achieved by the assistance of 
magnesium, which acts as a Lewis acid coordinating both the phenol and the formaldehyde, 
directing it to the ortho-position to form species 1.50 via a transition state 1.49. Re-
aromatisation then forms hydroxymethylated phenol magnesium salt (species 1.51), which 
is oxidised to aldehyde by hydrogen transfer with a second equivalent of formaldehyde 
(Scheme 1.17).33  Thus, the coordinating ability of the hydroxyl group with magnesium is 
essential for this reaction to proceed selectively at the ortho-position. 
 
 
23 
 
 
Scheme 1.17 Magnesium-mediated ortho-formylation of phenol 
A large amount of work based upon transition metal catalysed ortho-functionalisation of 
phenols has been reported in the past decade. In this area, the participation of the hydroxyl 
group is also essential for the reaction with regard to both reactivity and regioselectivity.  
Pioneering work was reported by Toste and Trost who synthesised coumarins by Pd(0)-
catalysed direct ortho-olefination of phenols from alkynes in formic acid, followed by 
nucleophilic attack for cyclisation.34 From the proposed mechanism in Scheme 1.18, the 
coordination between Pd and the hydroxyl group in the assistance of formic acid is 
necessary, with the formation of species 1.52. The insertion of an alkyne leads to 1.53 which 
followed by reductive elimination to afford ortho-olefin phenols 1.54. Finally, isomerisation 
cyclisation of 1.54 gives place to coumarin 1.55. 
 
Scheme 1.18 Pd(0)-catalysed direct synthesis of coumarins 
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Afterwards, Fujiwara and co-workers used Pd(II) catalysis to efficiently activate the ortho C–
H bond of phenol by the use of TFA.35 More recently, Malti and Shi’s research groups 
realised that base could accelerate Pd(II)-catalysed  ortho-couplings of phenol with olefins.36 
In this process, intermediate 1.56 forms by coordinating phenoxide with palladium catalyst 
in the presence of base, and then Pd 1,3-migration to generate intermediate 1.58 via 1.57,  
Alkene insertion and β-H elimination releases the alkenylated product (Scheme 1.19). Pt37, 
Ru 38 , Cu39 , Au40  have also been found to catalyse or mediate ortho-alkylation and 
alkenylation in different manners. 
 
Scheme 1.19 Pd(II)-catalysed direct synthesis of coumarins 
However, the ability of the hydroxyl group to act as a directing group is limited, due to 
unfavourable four-membered metallacycle. As an alternative, the strategy of pre-
functionalisation of the hydroxyl group can be used in order to form more stable five- or six-
membered metallacycles. For instance, Gevorgyan’s group strategically installed a silanol 
group which could easily coordinate Pd to form a six-membered palladacycle, thus leading 
to ortho-alkenylation, oxygenation and carboxylation of phenol (Scheme 1.20).41 
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Scheme 1.20 Pd-catalysed silanol directed ortho-alkenylation, oxygenation and 
carboxylation of phenol 
This strategy was also used by Dong et al. 42  and Liu et al. 43  in ortho-arylation of 
phenylcarbamates and phenol esters as well (Scheme 1.21). In both cases, a carbonyl motif 
is contained so that palladium is able to coordinate with the protecting groups, forming a 
six-membered palladacycle which leads to ortho-arylated products. 
 
Scheme 1.21 Ortho-arylation of phenol derivatives 
Bedford and co-workers reported the used of a catalytic phosphinite that can transesterify 
with the substrate phenols in situ, then an ortho-metalation can occur to give less-strained, 
five-membered metallacyles (Scheme 1.22).44 The limitation of the reaction is that a bulky 
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group such as tert-butyl is required in the ortho-position. No activity is observed with simple 
phenol. 
 
Scheme 1.22 Catalytic arylation of phenols 
 
Para-functionalisation of phenols 
In terms of the functionalisation of phenols at its para-position, there are few examples that 
have been applied in transition metal-catalysed systems. However, it is also possible to 
recognise the slightly higher reactivity to achieve high para-selectivity in the presence of 
transition metals. Gaunt and co-workers reported the selective para-arylation of phenol, 
anisole and aniline derivatives in the presence of Cu catalyst (Scheme 1.23, a). Although the 
mechanism is unclear, the authors proposed a Cu-catalysed Friedel-Crafts arylation.45 In 
2013, Zhou’s group reported a Pd-catalysed para-selective arylation of phenols under quite 
mild and green conditions (Scheme 1.23, b).46 The mechanism might involve an electrophilic 
metalation of the C–H bond of phenol at the para-position, followed by oxidative addition of 
aryl iodide, and reductive elimination affords the desired product. More recently, the group 
of Zhang used diazo compounds in the presence of a gold complex for highly para-selective 
direct C–H bond functionalisation of phenols (Scheme 1.23, c). The reaction probably 
proceeds through an electrophilic addition of the gold-carbene complex, followed by rapid 
1,2-hydride migration.47 
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Scheme 1.23 Para-selective functionalisation of phenol in the presence of transition metal 
However, para-selective direct functionalisation of phenols can be achieved via Friedel-
Crafts processes. Although it is hard to discriminate between the ortho- and para-positions 
by minor differences in the electron density, the para-position is less hindered compared to 
the ortho-position, so it is still possible to achieve the single para-selective functionalised 
phenol regioisomer. Selected examples of those highly selective para-functionalisations of 
phenol are listed below (Scheme 1.24):48 
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Scheme 1.24 Selected examples of para-functionalisation of phenol 
 
Meta-functionalisation of phenols 
Meta-functionalisation of phenols, on the other hand, is a big challenge due to the well-
known ortho/para directing ability of the electron-donating hydroxyl group. Ground-
breaking work was reported by Yu’s group via the strategy discussed in Chapter 1.1.3 
(Scheme 1.9). Meta- olefination49 and arylation16 could be achieved by the assistance of the 
U-shaped template, which can remotely control the meta-selective C–H activation via a 
macrometallacycle, (Scheme 1.25). However, the requirement of a covalently attached 
complex template is a substantial drawback for synthetic applications, as it introduces 
several additional steps. 
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Scheme 1.25 Template assisted meta-functionalisation of phenol 
There are no other examples of direct meta-functionalisation of phenols existing to date. 
However, several indirect methodologies have been developed over the past decade. A nice 
strategy was reported by Stahl and co-workers, who used cyclohexenone as a phenol 
precursor, through an aerobic oxidative Heck/dehydrogenation process, achieving meta-
arylated phenols (Scheme 1.26).50  Nevertheless cyclohexenone substitutions 1.83 are 
extremely limited compared with the variety of readily available phenols.  
 
Scheme 1.26 One-pot oxidative Heck/dehydrogenation 
Another approach for the synthesis of meta-functionalised phenols is the late-stage 
installation of hydroxyl group from the corresponding aryl iodide, aryl bromide or aryl 
boronic acid.51 However, in this approach, to achieve the meta-substituted phenols, the 
corresponding meta-substituted aryl bromide or aryl boronic acid, which are not easily 
prepared, are required. 
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1.3 Conclusions and objectives of this thesis 
In conclusion, there are a great variety of methodologies for catalytic ortho- 
functionalisation of phenols. Despite a lack of transition metal catalysed para- 
functionalisation of phenols, there are easily accessible via Friedel-Crafts processes so that 
further functionalisation can be continued. However, there are many areas in which the 
methodologies could still be improved. For instance, in the catalytic ortho-functionalisation 
of phenols, pre-functionalisation of the hydroxyl group is frequently required, which results 
in extra independent synthetic operations/purifications including removal of the protecting 
group to release free phenol. Therefore, the direct functionalisation of free phenols is more 
attractive.  
On the other hand, methodologies for the meta-functionalisation of phenols are scarce, so 
the development of this method is highly desirable. We aimed to develop an efficient 
methodology for meta-arylation of phenols from the wide availability of cheap phenol 
starting materials. Ideally, such methodology would proceed in one step and be highly 
functional group tolerant, under mild conditions and scalable. 
To date, the most common way to achieve the desired meta-arylphenols so far employs 
Suzuki coupling, in which eight to ten synthetic steps are required, involving the protection 
of the hydroxyl group, installation of a strong ortho-directing functionality, such as an 
amide, in the para-position with reference to the hydroxyl group (1.87), followed by 
arylation, removal of the amide and deprotection. Overall, such a synthetic route would 
need nine steps involving stoichiometric reagents which are not incorporated into the final 
product (Scheme 1.27, bottom route). 
We hypothesised that, instead of transforming the hydroxyl group into a meta-directing 
group, a removable directing group (RDG) could be installed at the ortho-position of phenols 
so that the meta-arylphenols could be accessible with the cleavage of the directing group 
after the arylation at ortho-position referred to RDG (meta-position referred to -OH group). 
Recently, carboxylic acids have been shown to be useful in transition metal catalysed ortho-
arylation.52 In addition, decarboxylation of benzoic acids can also occur in the presence of 
transition metals.53 Finally, a variety of methods allow the installation of carboxylic acid in 
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the ortho-position of phenols, such as Kolbe-Schmitt carboxylation, 54  carbonylation/ 
oxidation,55 and ortho-lithiation of suitable O-substituted phenols, followed by reaction with 
CO2.
56 Based on this work, CO2H would be an ideal traceless directing group candidate for 
testing our hypothesis (Scheme 1.27, top route). 
 
Scheme 1.27 Our hypothesis route and traditional route to access meta-arylated phenol 
A step-wise approach towards our aim will be applied (Scheme 1.28): 
Firstly, we aimed to develop a novel method for carboxylation of phenols that would offer a 
broad scope of salicylic acids under mild reaction conditions. As CO2 is a green carbon 
source, highly abundant in the atmosphere and non-toxic, the utility of CO2 as C1 source for 
the carboxylation of phenols would be of high interest (Scheme 1.28, Objective 1).  
Secondly, our efforts were directed towards a Pd-catalysed tandem arylation/ 
protodecarboxylation of salicylic acid in the reaction with aryl iodide coupling parther, to 
afford the corresponding meta-arylated phenol product (Scheme 1.28, Objective 2).  
Finally, we wondered if the combination of these two transformations above could lead to 
the development of a one-pot process carboxylation/arylation/decarboxylation, achieving 
meta-arylated phenols. If that would be the case, the methodology would provide an 
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efficient alternavtive to meta-arylphenol derivatives from the corresponding phenols 
(Scheme 1.28, Objective 3). 
 
Scheme 1.28 Objectives of the project 
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Chapter 2 
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Chapter 2 Carboxylation of phenolsi 
2.1 Transition metal-catalysed carboxylation 
2.1.1 Introduction 
CO2 is a green carbon source, highly abundant in the atmosphere, as well as non-toxic and 
recyclable. What is more, steadily increasing levels of CO2 in the atmosphere due to the 
human activities are associated with ‘global warming’. Thus, it is highly attractive to develop 
methodologies that use CO2 as a building block in organic synthesis. Of particular interest is 
the synthesis of carboxylic acids by fixation of CO2. However, due to the thermodynamic 
stability and high oxidation state of CO2, to couple with CO2, energy-rich substrates such as 
epoxides, aziridines and amines are always required. As a result, the construction of C–O 
and C–N bonds by the use of CO2 is widely explored in past decades.
57 The formation of C–C 
bond by coupling with CO2, on the other hand, still remains a challenge. The most common 
strategy applied for the creation of C–C bond by coupling with CO2 is to use the highly 
reactive organolithium or Grignard reagents to react with CO2.
58  However, the low 
compatibility of functional groups with organolithium or Grignard reagents limits their 
applications. Therefore, efforts have focused on transition metal-catalysed C–C versions of 
this process. In this part, state of the art transition metal-catalysed carboxylation, 
particularly the carboxylation of aromatic compounds, will be presented. 
2.1.2 Carboxylation of organometallic reagents 
Organotin reagents 
As described above, although the fixation of CO2 into valuable carboxylic acids and their 
derivatives by the use of highly reactive organolithium or Grignard reagents are well studied 
                                                     
i
 This work was carried out in collaboration with Dr Sara Preciado, the contributions where included will be 
highlighted in the text. 
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and developed, the low compatibility of functional groups with organolithium or Grignard 
reagents limits their applications. Thus, many other less reactive organometallic reagents, 
such as organoboron, organozinc, have been developed. Pioneering work was reported by 
Nicholas and co-workers in 1997 who inserted CO2 into Sn–C bond in the presence of a 
palladium catalyst.59 The use of high loading catalyst and toxic Sn limit the utility (Scheme 
2.1).  
 
Scheme 2.1 Pd-catalysed insertion of CO2 into Sn–C bond 
Organoboron reagents 
The use of organoboron compounds as nucleophiles has also been explored for the 
conversion CO2 into useful molecules. An example is shown in Scheme 2.2 reported by Hou 
and co-workers.60 A variety of functional groups such as cyanide and aldehyde substituted 
arylboronic and alkenylboronic esters can be transformed to carboxylic acids under CO2 
atmosphere catalysed by [(IPr)CuCl].  
 
Scheme 2.2 Cu-catalysed carboxylation of organoboron reagent 
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A plausible mechanism for this transformation was proposed by the authors, [(IPr)Cu(OtBu)] 
(2.7) was initially formed by the ligand exchange between [(IPr)CuCl] (2.6) and KOtBu, and 
subsequently transmetallation with boronic ester (2.4) afforded organocopper complex 
[(IPr)CuR] (2.9). After the insertion of CO2 into the Cu–C bond to form [(IPr)CuCO2R] complex 
(2.10), the carboxylate copper complex undergoes another ligand exchange with KOtBu to 
form potassium salt RCOOK (2.11) with concomitant regeneration of the [(IPr)Cu(OtBu)] 
catalyst (2.7) (Scheme 2.3). CuI and [Rh(OH)(cod)]2 were also explored as catalysts, with 
Iwasawa and co-workers successfully achieving the conversion of boronic ester into 
carboxylate compounds by.61  
 
Scheme 2.3 Proposed catalytic cycle of Cu-catalysed carboxylation of organoboron 
Organozinc reagents 
Organozinc compounds have been found to be efficiently transformed to carboxylic acids by 
Pd and Ni catalysts under mild conditions by Dong and co-workers (Scheme 2.4).62 This work 
was inspired by Aresta’s complex, Ni(η2-CO2)(PCy3)2 (2.14), which was first reported in 
1975.63 However, no method had been developed for the catalytic transformations with CO2 
using Aresta’s complex (2.14). The authors hypothesised that Aresta’s complex (2.14) could 
transmetallate with organozinc compounds 2.12 to afford species 2.15, which followed by 
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reductive elimination, affording a zinc carboxylate 2.16 and Ni(PCy3)2 (2.17). Aresta’s 
complex (2.14) could regenerate by oxidative cycloaddition of 2.17 with CO2 (Scheme 2.4, 
below).  
 
 
Scheme 2.4 Carboxylation of organozinc compounds and proposed mechanism 
2.1.3 Carboxylation of aryl halides 
The transition metal-catalysed carboxylation of aryl halides was first reported by Martin and 
Correa in 2009.64 In this approach, the readily available aryl bromides were converted into 
benzoic acids with CO2 under Pd catalysis in the presence of stoichiometric ZnEt2. A variety 
of substituted aryl bromides bearing electron withdrawing groups (EWGs) and electron 
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donating groups (EDGs) were tested, and smoothly underwent carboxylation to the 
corresponding benzoic acids in moderate to good yields (Scheme 2.5).  
 
 Scheme 2.5 Pd-catalysed carboxylation of aryl bromides 
A proposed mechanism is shown in Scheme 2.6. Firstly, an oxidative addition of aryl 
bromides into the Pd centre occurs, which followed by the insertion of CO2 to generate Pd 
benzoate 2.21. After this, species 2.21 undergoes transmetallation with Et2Zn to produce 
zinc benzoate 2.23 which produces the benzoic acids after work up, on the other hand, Pd 
species 2.22 undergoes reductive elimination to regenerate the Pd(0) species.  
This methodology is more attractive than the catalytic carboxylation of organometallic 
reagents, as the aryl halides are readily available starting materials. However, 2.0 
equivalents of ZnEt2 were still required and the use of pressured CO2 gas resulted in the 
requirement of a special autoclave equipment. 
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Scheme 2.6 Proposed mechanism for Pd-catalysed carboxylation of aryl bromides 
Later on, Tsuji’s research group successfully developed a Ni-catalysed carboxylation of aryl 
and vinyl chlorides at atmospheric pressure CO2 and room temperature (Scheme 2.7).
65  
 
Scheme 2.7 Ni-catalysed carboxylation of aryl and vinyl chlorides 
Ni(I) species was suggested as an active catalyst that plays an important role in the catalytic 
carboxylation by the group, and Mn powder acts as a the reducing reagent. In the proposed 
mechanism, Ni(0)Ln (2.26) is generated via reduction of Ni(II)Ln precatalyst by Mn(0), 
followed by oxidative addition of aryl chloride to give Ar–Ni(II)Cl intermediate (2.27). After 
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this, Ar–Ni(II)Cl (2.27) could be reduced by Mn to Ar–Ni(I) species 2.28 which could then 
react with CO2 to give the carboxylatonickel intermediate 2.29, followed by the reduction by 
Mn(0) to give manganese carboxylate 2.30, and regenerate Ni(0) catalyst 2.26 
simultaneously (Scheme 2.8). 
 
Scheme 2.8 Proposed catalytic cycle for carboxylation of aryl chlorides 
In addition to Ni and Pd complexes that have been developed as catalysts for the reductive 
carboxylation of aryl and vinyl halides, the simple and abundant CuI has also been used as a 
catalyst for carboxylation of aryl iodides with CO2.
66 More recently, the research group of 
Martin reported a methodology that allows benzyl halides to be converted into carboxylic 
acids under a Ni catalytic system.67 
 
2.1.4 Direct carboxylation of C–H bonds  
Similarly to the direct C–H functionalisation described in Chapter 1, the direct carboxylation 
of C–H bonds is of great significance due to the avoidance of substrate pre-functionalisation. 
However, given both the stability of CO2 and C–H bonds, there are few methodologies for 
direct C–H carboxylation existing to date. In 2009, Hou and co-workers reported a 
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methodology for direct C–H carboxylation of aromatic heterocycles using [(IPr)CuCl] catalyst 
(Scheme 2.9). 68  Various benzoxazole derivatives bearing both electron-donating and 
electron-withdrawing groups at the aryl unit could carboxylate in good to high yields. 
 
Scheme 2.9 Cu-catalysed direct C–H carboxylation 
Crucial intermediates 2.33 and 2.34 in Scheme 2.10 were isolated by the authors to 
elucidate the mechanism. Complex 2.34 could be obtained from 2.33 by exposing it to 1 atm 
of CO2 at room temperature. A proposed catalytic cycle is shown in Scheme 2.10. Initially, 
ligand exchange between [(IPr)CuCl] (2.6) and KOtBu affords [(IPr)Cu(OtBu)] (2.7), which 
deprotonates the heterocycle to form 2.33. CO2 insertion of 2.33 takes place to afford 2.34 
which subsequently reacted with tBuOK to regenerate [(IPr)Cu(OtBu)] (2.7), and produces 
the potassium carboxylate 2.35. Further SN2 reaction between 2.35 and alkyl iodide affords 
the ester product 2.32. 
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Scheme 2.10 Proposed mechanism for Cu-catalysed C–H carboxylation 
The group of Hu reported that carboxylation of benzothioazoles could proceed well using 
only Cs2CO3, although the reaction temperature is much higher compared to the previous 
methods already discussed.69 An uphill cleavage of C–H at the C2 position, followed by 
formation of C–C bond with CO2 was proposed (Scheme 2.11). In the case of partial 
conversion, benzothiazole and 2-benzothiazolecarboxylate were detected but not the 2-
benzothiazolyl anion by NMR. Moreover, benzothioazole was not deprotonated by Cs2CO3 in 
the absence of CO2. 
  
Scheme 2.11 C–H carboxylation by the use of a simple base 
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Rh(I)-catalysed direct C–H carboxylation of unactivated aryl C–H bond under ambient 
pressure of CO2 was achieved via chelation-assisted C–H activation.
 70 In this method, 
pyridines and pyrazoles were used and found to be suitable as directing groups. 
Substitutions with electron-donating and electron-withdrawing groups are both tolerated 
(Scheme 2.12). However, the high loading of expensive Rh catalyst limits the application of 
this methodology. 
 
Scheme 2.12 Rh-catalysed C–H carboxylation 
A reasonable catalytic cycle was proposed to consist of C–H activation by oxidative addition 
of Rh(I) species 2.46 with 2-arylpyridine to form Rh(III) species 2.42, which is followed by 
reductive elimination to give Rh (I) species 2.43. Subsequently, nucleophilic carboxylation of 
arylrhodium produces rhodium carboxylate 2.44, which then undergoes transmetallation 
with methylaluminium to afford aluminium carboxylate 2.45, and regenerates 
methylrhodium catalyst 2.46. Further reaction of aluminium carboxylate 2.45 with 
trimethylsilyldiazomethane (TMSCHN2) in methanol affords ester product 2.41 (Scheme 
2.13). 
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Scheme 2.13 Proposed catalytic cycle of Rh-catalysed C–H carboxylation 
2.1.4 Conclusions 
Generally, it is well-known that the reaction between CO2 and energy-rich substrates, such 
as epoxides and aziridines, and the synthesis of polycarbonates/polycarbamates and/or 
cyclic carbonates/carbamates by the use of CO2 have been widely explored during the past 
decades. However, to achieve C–C bond formation by the activation of CO2, highly reactive 
organolithium or Grignard reagents are generally required, which limits the generality of 
this method. Fixation of CO2 into more stable and synthetically useful reagents, on the other 
hand, still remains a big challenge, particularly the carboxylation of aromatic compounds. 
Organometallic reagents, including organotin, organoboron and organozinc reagents have 
been successfully utilised in the transition metal-catalysed carboxylation with CO2. However, 
it is obvious that the stoichiometric use of metals is undesirable for both economical and 
environmental concerns, especially when applying to industrial synthesis.  
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The carboxylation of simple, general and readily available chemicals is extremely limited. 
Methods for the carboxylation of aryl halides were reported by Martin and Tsuji using Pd 
catalyst and Ni complex catalyst, respectively. In terms of the direct C–H carboxylation, 
despite the perfect performance of carbene metal complexes in the CO2 activation, the 
reports have limited substrate scope. Thus, it is highly desirable to develop new 
methodologies for carboxylation to proceed in simple, mild and generally applicable 
conditions using readily available starting materials, so that direct C–H carboxylation can 
meet the requirements for step- and atom-economy. 
2.2 The synthesis of salicylic acids and Kolbe-Schmitt reaction 
Salicylic acid derivatives are important motifs in pharmaceutically and biologically active 
compounds, the high reactivity of salicylic acids makes them versatile building blocks for 
organic synthesis.71 Therefore, efforts have been made in the past generally using the wide 
availability of cheap phenol starting materials. 
Posner and Canella reported that dilithium cation species 2.47 could undergo carboxylation 
by treatment of CO2 to afford salicylic acid in moderate yield (Scheme 2.14).
72 However, the 
use of pyrophoric tert-BuLi limits this application. Moreover, lithiation could be directed by 
many different groups,73 resulting in low functional group tolerance. 
 
Scheme 2.14 Carboxylation of lithium species 
Due to the easy oxidation of salicylaldehydes to the corresponding salicylic acids,74 as well as 
the various methodologies for ortho-formylation of phenols,75 the salicylic acid derivatives 
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are accessible by an ortho-formylation of phenols with a subsequent oxidation (Scheme 
2.15). 
 
Scheme 2.15 Synthesis of salicylic acid by ortho-formation with subsequent oxidation 
More recently, Gevorgyan and co-workers have developed a Pd-catalysed silanol-directed 
carboxylation by the use of CO.41 In this approach, a silanol group was firstly installed on the 
hydroxyl group, then the silanol protected phenol 1.59 could facilitate a Pd-catalysed ortho 
C–H carboxylation in the presence of CO gas (Scheme 2.16). However, the high loading of Pd 
catalyst and the use of 3.0 equivalents of Ag-salts as an oxidant limit the utility.  
 
Scheme 2.16 Pd-catalysed silanol-directed carboxylation using CO 
Kolbe-Schmitt Carboxylation 
The strategy of direct C–H carboxylation of phenols, on the other hand, provides an efficient 
alternative to the salicylic acid derivatives. The first example of C–H carboxylation of 
phenols, Kolbe-Schmitt carboxylation, was developed in the 1860s, and it is still widely used 
in industry today.54 The process begins with the preparation of the phenoxide, classically 
sodium phenoxide (2.47). Then, a nucleophilic addition to CO2 that coordinates with Na
+, 
gives a non-aromatic cyclohexadienonecarboxylate intermediate 2.50 which is followed by 
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tautomerisation to afford salicylate 2.51. Simple acidic work up of 2.51 leads to salicylic acid 
(2) (Scheme 2.17).  
 
Scheme 2.17 Kolbe-Schmitt carboxylation process 
Some typical phenol substrates that have been carboxylated are presented in Table 2.1.76 As 
we can see, both electron-donating and electron-withdrawing groups at ortho-, meta- and 
para-positions can undergo carboxylation, affording moderate to good yields. However, the 
carboxylation of phenols with electron-withdrawing substituents is less efficient than with 
electron donating substituents.  When very strongly electron-withdrawing groups, such as a 
-NO2 group, are present on the phenol ring, no carboxylated product was obtained. The 
sterically hindered substrate 3,5-dimethylphenol, could also be carboxylated, leading to 30% 
of carboxylated product.  
Table 2.1 Kolbe-Schmitt carboxylation 
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phenols 
Conditions 
Products 
Yield 
(%) CO2 (atm) T (°C) t (h) 
 
40 200 6 
 
70 
 
100 125 8 
 
70 
 
40 200 4 
 
85 
 
100 150 8 
 
61 
 
100 175 8 
 
68 
 
100 175 8 
 
69 
 
40 200 6 
 
30 
 
40 210 4 
 
0 
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The Kolbe-Schmitt process is widely used for the synthesis of acetylsalicylic acid, known as 
Aspirin, which is one of the most widely used medicines in the world, with an estimated 
40,000 tonnes being consumed each year. In the synthetic process, salicylic acid was 
prepared using the Kolbe-Schmitt reaction. After this, salicylic acid is simply treated with 
acetic anhydride to afford the acetylsalicylic acid (Scheme 2.18). 
 
Scheme 2.18 Synthesis of Aspirin 
Although a large number of phenol derivatives can be carboxylated using the Kolbe-Schmitt 
reaction, the reaction conditions are very harsh: The process requires pressurised CO2 (40-
100 atm) and high temperatures (125-210 °C). Moreover, the reaction conditions vary over 
a wide range depending on the functional groups on the substrate. The preparation of 
completely dry metal phenoxide is necessary, making the procedure less practical. We 
therefore aimed to develop a method for carboxylation of phenol under milder conditions 
compared to the classic Kolbe-Schmitt procedure. 
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2.3 Aims of the project 
To meet with our hypothetical strategy for meta-arylation of phenols using CO2H as a 
transient directing group described in Chapter 1.2.3, a process of carboxylation of phenols 
to afford salicylic acid derivatives is necessary. Kolbe-Schmitt carboxylation provides an 
efficient method for the synthesis of salicylic acid derivatives from the corresponding 
phenols. However, as described in Chapter 2.2, there are many problems that need to be 
improved. 
At the first stage of our project, we aimed to develop a mild version of the Kolbe-Schmitt 
carboxylation, ideally, this process could proceed under atmospheric CO2 and low 
temperature. Additionally, unlike the conditions of classic Kolbe-Schmitt that vary over a 
wide range depending on the starting alkali metal phenoxide as well as the substituents 
functional groups, we  aimed to achieve the carboxylation of phenols under a simple set of 
unified conditions (Scheme 2.19).  
 
Scheme 2.19 Aim of the project 
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2.4 Previous results 
As described in the introduction, transition metal catalysis plays an important role in CO2 
fixation with many different substrates such as organozinc, organoboron aryl halides, etc. 
Sara Preciado in our group started to explore the possibility of phenol carboxylation using 
Pd catalysis. With an extensive screening of solvents, ligands and bases, a maximum 10% 
yield was obtained when 10 mol % of Pd(OAc)2, 20 mol % of PCy3 and 3.0 equivalents of 
NaOtBu were used in the reaction (Table 2.2, entry 1). An electron-rich phosphine proved 
important to this reaction: replacing of PCy3 with PPh3 resulted in no reactivity (Table 2.2, 
entry 2). The reaction did not work in the absence of Pd and ligand (Table 2.2, entry 3), 
suggesting that the transition metal catalyst together with the phosphine ligand were 
necessary for the carboxylation of phenols. These results demonstrate that it is possible to 
carboxylate phenol with CO2 under mild conditions by the use of a transition metal catalyst. 
However, we still face the challenge to find the optimum conditions.  
Table 2.2 Pd-catalysed carboxylation of phenols 
 
Entry Catalyst (10 mol %) Ligand (20 mol %) Yield of 6 (%) 
1 Pd(OAc)2 PCy3 10 
2 Pd(OAc)2 PPh3 0 
3 - - 0 
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2.5 Modification of Kolbe-Schmitt carboxylation 
2.5.1 Attempts towards Kolbe-Schmitt carboxylation at atmospheric CO2 pressure 
We altered our attention towards the Kolbe-Schmitt carboxylation, aiming to develop a 
method for carboxylation of phenols at low pressure. Initially, we tested the classic Kolbe-
Schmitt carboxylation procedure under atmospheric CO2 pressure (Table 2.3). We were 
pleased to find the alkali metal 2-methylphenolate (7 and 8) underwent carboxylation at 
atmospheric CO2 pressure, affording 2-hydroxy-3-methylbenzoic acid (6) and 4-hydroxy-5-
methylbenzoic acid (9). The higher temperature was found to be necessary to improve the 
reactivity (Table 2.3, entries 1 vs 2 and 3 vs 4). Moreover, the sodium 2-methylphenolate (8) 
was found to be more selective compared to the potassium 2-methylphenolate (9), allowing 
the carboxylation at the ortho-position (Table 2.3, entries 1 vs 3 and 2 vs 4). Although low 
reactivity was obtained when carrying the Kolbe-Schmitt carboxylation at atmospheric CO2 
pressure, it encouraged us to further improve the process.  
Table 2.3 Kolbe-Schmitt carboxylation at atmospheric CO2 pressure
a 
 
entry M T (°C) Yield 6 (%) Yield 9 (%) 
1 K 160 12 9 
2 K 185 11 18 
3 Na 160 16 2 
4 Na 185 24 2 
a 
Unless otherwise noted, all reactions were carried out using 0.25 mmol of 7; Yields were determined by 
1
H 
NMR analysis using 1,3,5-trimethoxybenzene as an internal standard after acidify work up. 
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2.5.2 Screening of bases 
Despite the Kolbe-Schmitt carboxylation proceeding at atmospheric CO2 pressure, we 
wanted to do the carboxylation from simple phenols, avoiding the preparation of 
completely dry metal phenoxide. Therefore, we tried the carboxylation reaction by simply 
mixing o-cresol and KOH, heating at 100 °C for 5 min in order to form the potassium 2-
methylphenolate, and then heating the mixture at 185 °C for 2 h under atmospheric CO2 
pressure. Unfortunately, there was no desired product 6 obtained (Table 2.4, entry 1). The 
use of NaOH resulted in no reactivity either (Table 2.4, entry 2). The formation of water 
during the deprotonation of phenols may quench the reaction, as water has been 
demonstrated to be disastrous for the Kolbe-Schmitt carboxylation.77   
Marasse developed a modification of Kolbe-Schmitt carboxylation, in which the phenols 
could undergo carboxylation in the presence of excess of anhydrous K2CO3 under high 
pressured CO2 (50-100 atm) and elevated temperature.
78 Importantly, the preparation of 
the completely dry metal phenolate is avoided in this method. Thus, the Marasse method 
was tried under atmospheric CO2 pressure, unfortunately, only 1% of desired product 6 was 
obtained (Table 2.4, entry 3). Na2CO3 turned out to lead to no reactivity at all (Table 2.4, 
entry 4). 
NaH is a strong base that is commonly used for deprotonation of phenol derivatives. 
Importantly, unlike KOH or NaOH in which water is formed during the deprotonation of 
phenols, NaH deprotonates phenols to produce easily removed H2. Gratifyingly, 32% of 
ortho-carboxylated product 6 and 2% of para-carboxylated product 8 was obtained when 
1.0 equivalent of NaH was used (Table 2.4, entry 5).  
Increasing the amount of NaH to 2.0 equivalents gave a higher yield of 38% (Table 2.4, entry 
6). However, no improvement in the yield was observed with a further increase in the 
amount of NaH to 3 equivalents (Table 2.4, entry 7). When the reaction time was prolonged 
to 4 h, and still 39% of carboxylated product was obtained (Table 2.4, entry 8), probably 
because the reaction has stopped after 2 h. 
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Table 2.4 Screening of basea 
 
entry Base (equiv) Yield 6 (%) Yield 9 (%) 
1 KOH (1.0) 0 0 
2 NaOH (1.0) 0 0 
3b K2CO3 (1.0) 1 0 
4b Na2CO3 (1.0) 0 0 
5 NaH (1.0) 32 2 
6 NaH (2.0) 38 2 
7 NaH (3.0) 39 3 
8c NaH (2.0) 39 2 
a 
Unless otherwise noted, all reactions were carried out using 0.25 mmol of 5, yields were determined by 
1
H 
NMR analysis using 1,3,5-trimethoxybenzene as an internal standard. 
b 
The reactions were performed at 
elevated temperature from 100 °C to 185 °C. 
c
 The reaction was performed for 4 h.  
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2.5.3 Screening of phenol derivatives as additives 
Given that CO2 could be captured by a metal phenolate through weak coordination between 
the alkali metal and CO2, we speculated that the carboxylation could be promoted by the 
use of an extra phenolate, as more CO2 could be absorbed into the solid phase. However, 
this phenolate should not undergo carboxylation to consume the absorbed CO2. We 
investigated whether 2,4,6-trisubstituted phenolates would be suitable due to having the 
ortho- and para-positions blocked. 
Similar to the formation of sodium 2-methylphenolate (5), the 2,4,6-trisubstituted 
phenolate could be formed in situ by a simple mixture of the corresponding phenol additive 
and NaH. Initially, we tested the effect of the phenolate additive by adding 1 equivalent of 
the corresponding phenol additive and 2 equivalents of NaH respect to the phenol additive. 
Gratifyingly, an improvement in the yield was obtained by the addition of 2,6-di-tert-butyl-
4-methoxyphenol (11), affording 53% of the desired ortho-carboxylated product 6, 5% of 
para-carboxylated product 9 and small amount of dicarboxylated product 10 (Table 2.5, 
entry 2). Encouraged by this, different substituted phenols with tert-butyl at both ortho-
positions 12, 13 were tested but no improvement in the yield was observed (Table 2.5, 
entries 3 and 4).  A substrate with an electron-withdrawing group, 2,4,6-trifluorophenol (14) 
was also tested and afforded a similar result  to the reaction when only NaH was used 
(Table 2.5, entry 5). An aliphatic alcohol, 1-octanol (16), was also tested and no 
improvement in the yield was obtained (Table 2.5, entry 6).  
Finally, 2,4,6-trimethylphenol (15) was found to significantly improve the yield of ortho-
carboxylated product 6 to 84%, as well as para-carboxylated product 9 to 12% (Table 2.5, 
entry 7). Decreasing the use of NaH (15) from 4 equivalents to 3 equivalents gave a lower 
yield 74% (Table 2.5, entry 8), suggesting that an extra 2.0 equivalents of NaH respect to the 
phenol additive were required when the phenol additive was used. Decreasing the amount 
of the phenol additive 15 to 0.5 equivalents was also found to be less efficient in 
comparison with 1.0 equivalent (Table 2.5, entry 9). 
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Table 2.5 Screening of phenol derivatives as additivesa 
 
entry NaH (equiv) Additive (equiv) Yield 6 (%) Yield 9 (%) Yield 10 (%) 
1 2.0 - 38 2 1 
2 4.0 11 (1.0) 53 5 2 
3 4.0 12 (1.0) 37 3 1 
4 4.0 13 (1.0) 36 2 1 
5 4.0 14 (1.0) 40 5 3 
6 4.0 16 (1.0) 40 5 2 
7 4.0 15 (1.0) 84 12 7 
8 3.0 15 (1.0) 74 12 5 
9 3.0 15 (0.5) 76 11 6 
a 
Unless otherwise noted, all reactions were carried out using 0.25 mmol of 5, yields were determined by 
1
H 
NMR analysis using 1,3,5-trimethoxybenzene as an internal standard. 
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2.6 Scope of the phenol carboxylation 
Different phenol substrates were examined to further demonstrate the feasibility of our 
process (Scheme 2.20). Substrates with a small methyl substituent at the ortho-, meta- and 
para-positions were all ortho-carboxylated in good yields (Scheme 2.20, 6, 17 and 18). 
However, in terms of m-cresol, a mixture of C6 and C2 carboxylated products in 85:15 ratio 
was obtained (Scheme 2.20, 17). Dimethyl substituted phenols were found to be compatible 
(Scheme 2.20, 19 and 20), with even the highly hindered 3,5-dimethylphenol affording 37% 
of carboxylated product (Scheme 2.20, 21).  
Different substituents, -Et, -tBu and -OMe were all found to be compatible with this method, 
leading to good yields (Scheme 2.20, 22-24). N-containing phenols, 3-
(dimethylamino)phenol could also be converted into the corresponding salicylic acids in 62% 
yield (Scheme 2.20, 25). 
Cyclic substituted phenols, such as 5,6,7,8-tetrahydro-1-naphthol and sesamol could 
undergo carboxylation to afford the corresponding salicylic acids in 91% and 75% of yields, 
respectively (Scheme 2.20, 26 and 27). Similar to the carboxylation of m-cresol (17), when 5-
indanol was used, a mixture of C6 and C4 carboxylated products in 79:21 ratio were 
obtained, with a 92% of total yields (Scheme 2.20, 28). Simple phenol was also tested and 
carboxylated, affording 64% of salicylic acid which is the precursor of aspirin (Scheme 2.20, 
2).  
For phenols substituted with electron-withdrawing groups, slightly higher CO2 pressure was 
required, and the carboxylation of halophenols satisfyingly afforded the desired products 
when employing 5 atm of CO2 (Scheme 2.20, 29-32). However, a substrate containing the 
strongly electron-withdrawing -NO2 group did not work at all (Scheme 2.20, 33). 
Interestingly, the steroid hormone estrone can be conveniently converted to the 
corresponding ortho-carboxylated product in 51% yield (Scheme 2.20, 34). 
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Yields are of the isolated pure material. 
a
 The product was formed as a 85:15 ratio of regioisomers (C6:C2). 
b
 The product was formed as a 79:21 ratio of regioisomers (C6:C4). 
c
 Reactions were carried out at 5 atm of 
CO2. 
d
 Reactions were  carried out for 12 h. 
Scheme 2.20 Scope of ambient pressure carboxylation of phenols 
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2.7 Conclusions and Future work 
This chapter describes the development of a novel carboxylation methodology, which 
efficiently allows the synthesis of salicylic acids with a range of functionalities, such as alkyl, 
alkoxy, amine, and halogens, under ambient CO2 pressure from the corresponding phenols. 
The trisubstituted phenol additive plays an important role in this ambient pressure 
carboxylation methodology. However, it is still unclear how this trisubstituted phenol 
additive helps the reaction.  
The process proceeds at much lower pressure, representing an important improvement 
compared to the classic Kolbe-Schmitt carboxylation which usually requires high pressures. 
Moreover, the avoidance of phenoxide isolation also improves the current Kolbe-Schmitt 
procedures in terms of operational simplicity.  
Despite the above, there are still some challenges that need to be addressed: 
1) The current method requires high temperatures which should be avoided. The aim of 
these transformations should be to develop a reasonable temperature or room temperature 
C–H carboxylation protocol, which would consequently tolerate a wide range of sensible 
groups. 
2) Developing methodologies for C–H carboxylation of general aromatic compounds. These 
methodologies should be able to carboxylate aromatic compounds with different 
functionalities via C–H cleavage, converting to benzoic acid derivatives. 
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Chapter 3 
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Chapter 3 Meta-selective arylation of phenols 
3.1 Introduction 
As described in Chapter 1, our objective is to develop an efficient methodology for the 
meta-arylation of phenols. We hypothesised that installation of a directing group at the 
ortho-position of phenol would facilitate arylation in the ortho-position to the directing 
group. The meta-arylated phenol could then be obtained via the cleavage of the directing 
group. Our attention has been turned to the carboxylic group which has been widely used as 
the directing group in C–H activation.79 We wondered whether the carboxylated phenol 
could undergo arylation and subsequent decarboxylation to provide the meta-arylated 
phenol. A brief overview of carboxyl directed C–H activation and decarboxylation, based on 
existing literature, will be presented first in this chapter. 
3.1.1 Carboxyl directed C–H functionalisation 
A variety of methodologies for carboxyl group directed C–H functionalisation has been 
developed in the past years.1 Pioneering work was made in 1998 by Miura and co-workers 
who established the protocol for Pd(II)-catalysed ortho-olefination of benzoic acids 3.1 and 
naphthoic acids 3.2 (Scheme 3.1). 80  In this work, phthalide 3.3 was formed exclusively 
when butyl acrylate (3.6) was used via an ortho-vinylation followed by nucleophilic 
cyclisation. The use of styrene 3.7, on the other hand, could afford phthalides 3.5 or 
isocoumarin 3.4 via ortho-vinylation/Wacker-type oxidation depending on the benzoic acid 
used. The authors stated that ortho-substituted benzoic acids or 1-naphthoic acids resulted 
in the formation of phthalides 3.5 potentially due to the low steric hindrance between the 
ortho-substituent and the carbonyl group, while unsubstituted or meta and para substituted 
benzoic acids or 2-naphthoic acids led to isocoumarin 3.4 formation or mixtures of both 
phthalides 3.5 or isocoumarin 3.4.  
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Scheme 3.1 Pd-catalysed ortho-olefination of benzoic acids 
Carboxylic acid directed olefinations in the presence of Pd has been extensively investigated 
by Yu and co-workers who developed an efficient method for ortho-vinylation of 
phenylacetic acids 3.8 using an N-protected amino acid (Scheme 3.2).81 The authors stated 
that the N-protected amino acid not only enhances the reactivity, but also controls the site-
selectivity in C–H activation with two approximately electronically equivalent ortho C–H 
bonds. Besides Pd, Ru82, Ir83 and Rh84 have also been explored as effective catalysts in 
carboxyl directed ortho-olefination. 
 
Scheme 3.2 Pd-catalysed ortho-olefination of phenylacetic acids 
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Beside the carboxyl directed C–H functionalisation with olefins, carboxylic acid directed 
ortho a) halogenation, 85  b) carboxylation, 86  c) arylation 87  d) hydroxylation 88  and e) 
alkylation89 were also explored, as well as ortho-functionalisation with aldehydes and 
subsequent intramolecular cyclisation to afford phthalide derivatives90 (Scheme 3.3).  
 
Scheme 3.3 Carboxyl directed ortho C–H functionalisation 
 
3.1.2 Decarboxylation 
Despite the fact that benzoic acids have been demonstrated to serve as commonly used 
directing groups for a variety of synthetically useful transformations, the application is 
limited when the carboxylic acid group is not needed in the target molecule. Therefore, the 
development of methodologies for the removal of a carboxylic acid is of high interest.  
The first study on the metal-mediated protodecarboxylation of benzoic acids was reported 
by Shepard in 1930 (Scheme 3.4).91 The use of stoichiometric Cu-salts led to decarboxylation 
of furoic acids (3.17) at high temperature. Subsequently, Nilsson92 and Sheppard93 reported 
that benzoic acids could undergo protodecarboxylation under similar conditions.  
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Scheme 3.4 Decarboxylation of furoic acids in the presence of Cu-salts 
However, Cu-catalysed decarboxylation of aromatic carboxylic acids has not been developed 
until 2007, Goossen and co-workers used catalytic Cu2O for decarboxylation of a wide 
variety of aromatic carboxylic acids 3.19 in the presence of 1,10-phenanthroline as a ligand 
(Scheme 3.5). 94 Mechanistic studies suggested that the formation of aryl-Cu species as 
intermediates which upon protonation afford the decarboxylated products 3.20. 
 
Scheme 3.5 Cu-catalysed protodecarboxylation 
Cu is not the only transition metal capable of mediating or catalysing the decarboxylation 
process. A Pd-catalysed decarboxylation of highly electron-rich trimethoxy-substituted 
benzoic acids has also been reported by Myers et al.95 Subsequently, Kozlowski and co-
workers developed a protocol for Pd-catalysed protodecarboxylation of benzoic acids 
(Scheme 3.6). 96 However, this methodology for Pd-catalysed decarboxylation is extremely 
limited as the substrates must contain two or more electron-donating -OMe groups. 
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Scheme 3.6 Pd-catalysed protodecarboxylation of dimethoxy-substituted benzoic acids 
Our group developed a Ag-catalysed protodecarboxylation of a range of ortho-substituted 
benzoic acids,97 and heteroaromatic carboxylic acids in the presence of AcOH (Scheme 
3.7).98 Additionally, selective monoprotodecarboxylation of (hetero)aromatic dicarboxylic 
acids was performed. Mechanistic studies demonstrated that ortho-substituted benzoic 
acids could lead to a much lower activation energy barrier for protodecarboxylation 
compared to their meta- and para-counterparts due to steric and electronic effects.99 At the 
same time, Goossen and co-workers reported a Ag-catalysed decarboxylation of ortho-
substituted (hetero)aromatic carboxylic acid in the presence of K2CO3.
100 However, these 
Ag-catalysed decarboxylation methods are all limited in the substrate scope to ortho-
substituted carboxylic acids. 
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Scheme 3.7 Ag-catalysed protodecarboxylation of (hetero)aromatic carboxylic acids 
The research group of Greaney developed an oxidative radical process to decarboxylate a 
variety of benzoic acids.53 Importantly, this protocol expands the substrate scope, allowing 
not only the ortho-substituted benzoic acids but also the meta- and para-substituted 
benzoic aicds to undergo decarboxylation (Scheme 3.8). 
 
Scheme 3.8 Ag-catalysed oxidative radical decarboxylation of benzoic acids 
 
 
 
67 
 
3.1.3 Carboxyl group as a removable directing group in C–H activation 
Pioneering work in this area was reported by Miura who developed a Pd-catalysed method 
for direct C–H vinylation of indole-3-carboxylic acids 3.24 and indole-2-carboxylic acids 3.26, 
followed by a decarboxylation process to give the corresponding vinylindoles 3.29 and 
3.31.101 This method is also applicable for selective C3-olefination of N-methylpyrrole-2-
carboxylic acid (3.25), benzofuran-2-carboxylic acid (3.27) and benzothiophene-2-carboxylic 
acid (3.28) (Scheme 3.9). 
 
Scheme 3.9 Pd-catalysed olefination/decarboxylation of heteroaromatic carboxylic acids 
In 2010, the same group demonstrated that ortho-substituted benzoic acids 3.34 can be 
transformed to the corresponding meta-vinylated products 3.36 in the presence of Rh 
catalyst via ortho-olefination and decarboxylation step in one-pot (Scheme 3.10).102 
However, the use of the large excess of Ag-salts limited this methodology. 
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Scheme 3.10 Rh-catalysed ortho-olefination/decarboxylation of benzoic acids 
An extension of this work was presented by our group in 2011. We showed that the 
formation of meta-substituted biaryl compounds can be achieved under Pd catalysis via 
arylation of the ortho-substituted benzoic acids 3.34 and subsequent protodecarboxylation 
(Scheme 3.11). A broad range of functionalities at both benzoic acid and iodoarene coupling 
partners were found to be compatible, affording a variety of meta-substituted biaryl 3.38.20 
Unlike Miura’s work, where the vinylation and protodecarboxylation did not occur at the 
same time (Scheme 3.10), in this work, the arylation of benzoic acids and the 
protodecarboxylation of the arylated benzoic acid intermediates occur in a tandem process, 
which makes the method more efficient.  
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Scheme 3.11 Tandem ortho-arylation/decarboxylation process lead to meta-biaryls 
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3.2 Tandem arylation/decarboxylation of salicylic acids 
3.2.1 Objectives 
As described in the introduction, the carboxyl group has been commonly used as an ortho- 
directing group to control site-selective C–H functionalisation. Moreover, the development 
of catalytic decarboxylation of benzoic acids has also been explored. This dual functionality 
of the carboxyl group has been exploited by Miura’s and our group for meta-
functionalisation of substituted aromatic compounds. 
Phenol derivatives are commonly found in many natural products, pharmaceuticals and 
agrochemicals.26 However, due to the high reactivity of phenol derivatives, most of the 
methodologies for carboxyl group-directed C–H functionalisation are not compatible with 
free phenol substrates. Thus, at this stage of our research, we wanted to explore whether 
the salicylic acids could undergo an arylation/protodecarboxylation process to afford meta-
arylphenol derivatives (Scheme 3.12).  
Objective: Tandem arylation/decarboxylation of salicylic acid leads to meta-arylphenol 
 
Scheme 3.12 Aim of the project 
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3.2.2 Optimisation of reaction conditions 
Preliminary optimisation 
With this aim in mind, we started to investigate suitable reaction conditions. Initially, the 
reaction of salicylic acid 2, was submitted into the ‘formal’ meta-arylation conditions 
reported by our group,20 employing 5-iodo-m-xylene 36 as the coupling partner.  
Fortunately, 35% of meta-arylphenol 37 was obtained (Table 3.1, entry 1). On the other 
hand, the non-protodecarboxylated product 38 was not observed in any of the reactions.  
As the solids were not completely soluble in the reaction above, an increased amount of 
AcOH was used, and it turned out to improve the yields (Table 3.1, entries 2 and 3). Due to 
the well-known ability of DMSO to dissolve many salts, as well as its coordinating ability, we 
hoped that the yield could be improved by the use of DMSO in the reaction. However, not 
even a trace of product was obtained when a 1:1 mixture of AcOH and DMSO was used as 
co-solvent (Table 3.1, entry 4). 
The test for the effect of water showed that the reaction was not sensitive to water, with no 
decrease of the yield being observed when 5.0 equivalents of water were added into the 
reaction (Table 3.1, entry 5).  
The increase of temperature from 130 °C to 140 °C gave slightly higher yield (Table 3.1, 
entry 6). On the other hand, we noted that the decrease of temperature resulted in lower 
yields (Table 3.1, entries 7 and 8).  
There was a significant improvement in the yield when the reaction time was prolonged to 
60 h, affording 63% of meta-arylated product 37 (Table 3.1, entry 9). A higher loading of 
Pd(OAc)2 (5 mol %) afforded similar yield to 2 mol % (Table 3.1, entry 10). On the other hand, 
an increased 45% yield was obtained when reducing the amount of Pd(OAc)2 (to 1 mol % 
(Table 3.1, entry 11). Interestingly, no further reaction was obtained when prolonged the 
reaction in the presence of 1 mol % of Pd(OAc)2 to 60 h (Table 3.1, entry 12). This was 
perhaps because the catalyst would deactivate during the long reaction time, consequently, 
a high loading of catalyst was required for further reaction.  
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Table 3.1 Preliminary resultsa 
 
Entry T (°C) t (h) AcOH (equiv) Pd(OAc)2 (mol %) Yield of 37 (%) 
1 130 16 3.5 2 35 
2 130 16 7.0 2 42 
3 130 16 10.5 2 44 
4b 130 16 3.5 2 0 
5c 130 16 3.5 2 28 
6 140 16 7.0 2 50 
7 110 16 3.5 2 32 
8 120 16 3.5 2 35 
9 130 60 3.5 2 63 
10 130 16 3.5 5 36 
11 130 16 3.5 1 45 
12 130 60 3.5 1 45 
a 
Unless otherwise noted, all reactions were carried out using 1.0 equiv of 2, 3.0 equiv of 36 and 1.0 equiv of 
silver carbonate, yields were determined by 
1
H NMR analysis using mesitylene as an internal standard. 
b 
200  L 
of DMSO were also added. 
c
 5.0 equiv of water were also added. 
Screening of Pd sources 
To improve the yield of the tandem arylation/protodecarboxylation of salicylic acid process, 
different Pd sources were tested (Table 3.2). In terms of Pd(0) sources, Pd2(dba)3 and 
Pd(PPh3)4 were found to be compatible with the reaction, affording  51% and 47% yields, 
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respectively (Table 3.2, entries 2 and 3). These yields are slightly higher in comparison with 
Pd(OAc)2 (Table 3.2, entry 1). 
Different Pd(II) sources were also examined (Table 3.2, entries 4-7), and it was found that 
PEPPSI-IPr and PEPPSI-IPent afforded the best results, achieving 57% and 61% yields, 
respectively (Table 3.2, entries 6 and 7). The use of Pd(OAc)2 together with NHC ligands did 
not give as good yield as PEPPSI catalyst (Table 3.2, entries 8 and 9).  
Table 3.2 Palladium catalysts screeninga 
 
Entry [Pd] (2 mol %) Yield of 37 (%) 
1 Pd(OAc)2 42 
2 Pd2(dba)3
b 51 
3 Pd(PPh3)4 46 
4 Pd(TFA)2 42 
5 Pd(MeCN)2Cl2 46 
6 PEPPSI-IPr 57 
7 PEPPSI-IPent 61 
8 Pd(OAc)2
c 45 
9 Pd(OAc)2
d 38 
a 
Unless otherwise noted, all reactions were carried out using 1.0 equiv of 2, 3.0 equiv of 36, 1.0 equiv of silver 
carbonate and 200 µL (7.0 equiv) of AcOH for 16 hours at the temperature of 130 °C, yields were determined 
by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as an internal standard. 
b 
1 mol % of Pd2(dba)3
 
was used. 
c
 2 
mol % of IMesCl were also added. 
d 
2 mol % of IPrCl were also added. 
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Systematic screening using PEPPSI catalyst 
Although PEPPSI-IPent provided the highest yield of the product (61%), PEPPSI-IPr, which 
afforded 57% of product, was selected for the further optimisation on the basis of its much 
lower cost. 
Different amounts of PEPPSI-IPr loading were tested. The reaction in the presence of 1 mol 
% of PEPPSI-IPr gave 51% of meta-arylated product 37 (Table 3.3, entry 1). Increased the 
catalyst to 2 mol % gave a slightly higher yield 57% (Table 3.3, entry 2), which seemed to be 
optimal for the reaction as the reactions in the presence of 3 mol % and 4 mol % of catalysts 
led to the similar yields (Table 3.3, entries 3 and 4). 
Temperature screening was also carried out and it was found that decreasing the 
temperature from 130 °C to 120 °C led to a lower yield 48% (Table 3.3, entry 5). On the 
other hand, an improvement in yield was obtained when increasing the temperature (Table 
3.3, entries 6-9), and it was found that 150 °C seemed to be most suitable for this method, 
affording 70% meta-arylated product 37  (Table 3.3, entry 7). The yield was reduced to 49% 
upon further heating to 180 °C (Table 3.3, entry 9). Increasing the amount of solvent, AcOH, 
from 7.0 equivalents to 14.0 equivalents slightly improved the yield from to 70% to 74% 
(Table 3.3, entry 10). 
Considering that the function of the Ag-salt in this method is presumably as an iodide 
abstractor we investigated if the Ag-salt could be reduced to 1.0 equivalent. Satisfyingly, a 
significant improvement in yield to 83% was obtained when the amount of Ag2CO3 was 
reduced to 0.5 equivalents (Table 3.3, entry 11). 
It has been found that κ1-coordination (crucial for ortho C–H cleavage) between Pd(II) and 
the carboxyl group is favoured in the presence of inorganic counter cations such as K, Cs, 
and ammonium salts.88,103 Therefore, the addition of inorganic salts, K2CO3 and Cs2CO3, was 
investigated which satisfyingly improved the yields to 92% and 90% of meta-arylated 
product 37, respectively (Table 3.3, entries 12 and 13). 
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Table 3.3 Optimisation of the formal meta-arylation using PEPPSI-IPra 
 
Entry T (°C) Ag2CO3 (eq) AcOH (eq) PEPPSI-IPr (mol %) Yield of 3a (%) 
1 130 1.0 7.0 1 51 
2 130 1.0 7.0 2 57 
3 130 1.0 7.0 3 57 
4 130 1.0 7.0 4 56 
5 120 1.0 7.0 2 48 
6 140 1.0 7.0 2 66 
7 150 1.0 7.0 2 70 
8 160 1.0 7.0 2 68 
9 180 1.0 7.0 2 49 
10 150 1.0 14.0 2 74 
11 150 0.5 14.0 2 83 
12b 150 0.5 14.0 2 86 
12c 150 0.5 14.0 2 92 
13d 150 0.5 14.0 2 90 
a 
Unless otherwise noted, all reactions were carried out using 1.0 equiv of 2, 3.0 equiv of 36, 2 mol% of PEPPSI-
IPr, ran for 16 hours, yields were determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as an internal 
standard. 
c 
PEPPSI-Ipent was used instead of PEPPSI-IPr. 
c 
0.5 equiv of K2CO3 were used in the reaction. 
d 
0.5 
equiv of Cs2CO3 were used in the reaction. 
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3.2.3 Scope of tandem arylation/protodecarboxylation of salicylic acids 
After finding the optimised conditions for this tandem arylation/protodecarboxylation of 
salicylic acids, a number of substituted salicylic acids were examined. Gratifyingly, many 
functional groups involving both electron-withdrawing (Scheme 3.13, 38, 42-44) and 
electron-donating groups (Scheme 3.13, 39, 45) were tolerated at the C3 or C4 positions of 
the salicylic acids. Strong electron-withdrawing groups -NO2 and -CF3 were found to be 
compatible, giving 52% and 67% yields, respectively (Scheme 3.13, 40 and 41). On the other 
hand, when a strong electron-donating -OMe group was present at the C4 position of the 
acids, only 22% of desired product was obtained (Scheme 3.13, 47). This is due to the 
competitive decarboxylation of the starting material as a large amount of 4-methoxyphenol 
was observed. A substrate bearing an amide group at the C4 position also reacted smoothly, 
affording 41% of the desired product (Scheme 3.13, 46). In this case, although the amide 
group has been shown to be a good ortho-directing group,104 the carboxyl group is out 
competing under our conditions as no other regioisomer was obtained. However, a low 
yield was obtained due to competive decarboxylation of the starting material as mentioned 
with a -OMe substituted substrate. Finally, different substitutions at the C5 of salicylic acids 
were tested and found to be poorly tolerated with only a small -F substituent at the C5 
position allowed the arylation to proceed, giving 53% of the desired product (Scheme 3.13, 
50). -Me and -Cl substitutents at the C5 position did not react at all presumably due to steric 
hindrance proximity to the activated C–H bond (Scheme 3.13, 48 and 49). 
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Yields are of isolated products. 
a
 The reaction was carried out at 160 °C. 
b
 1.0 mL of AcOH were used. 
c
 K2CO3 
was not used. 
Scheme 3.13 Scope of the tandem arylation/protodecarboxylation process on substituted 
salicylic acids 
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A variety of substituted aryl iodides were then tested and both electron-withdrawing 
(Scheme 3.14, 51-56, 60-63) and electron-donating groups (Scheme 3.14, 57, 65) were 
found to be compatible in both meta- and para-positions, leading to the corresponding 
meta-arylated phenols in moderate to good yields. Interestingly, only the monoarylated 
product was obtained selectively from p-diiodobenzene as a coupling partner (Scheme 3.14, 
56). An aldehyde substituent was found to be unreactive under the standard conditions. But 
the desired product 58 could be obtained in 85% yield when an excess of salicylic acid was 
used in the reaction (Scheme 3.14, 58). This is potentially due to the weak coordinating 
ability of the aldehyde group to the Pd, thus inhibiting the Pd to coordinate to the carboxyl 
directing group in the presence of large excess of aldehydes. Similarly to the aldehyde 
substituted iodoarene, the aryl iodides containing a weak coordinating group, p-OMe, p-
CH2OH and m-COMe, proceeded in better yields when excess of salicylic acids were used 
(Scheme 3.14, 57, 59 and 77). Ortho-substituted iodoarenes were also tested and found to 
not be well tolerated, with only the small F substituent giving 24% yield (Scheme 3.14, 66), 
again highlighting one of the limitations of this method. Finally, iodoindole and idodpyridine 
were tested and found to be compatible with the process, affording the desired products 67 
and 68 in 30% and 70% yields, respectively (Scheme 3.14, 67 and 68). 
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Yields are of isolated products. 
a
 The reaction was carried out with 0.5 mmol of 1 and 0.167 mmol of 
aryl iodide at 130 °C. 
b
 Yield determined by 
1
H NMR analysis using an internal standard. 
c
 p-iodobenzyl 
alcohol was used as starting material. 
Scheme 3.14 Scope of the tandem arylation/protodecarboxylation process on substituted 
iodoarenes 
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3.2.4 Ag-free method for tandem arylation/decarboxylation of salicylic acids 
One drawback of the methodology is the need for the stoichiometric use of a Ag-salt as they 
are expensive and not environmentally friendly, especially when applying the methodology 
for a large scale synthesis and industrial processes. Recently, our group demonstrated that a 
cheap and readily available organic salt, Me4NCl, could be a highly efficient iodide 
abstractor.105 Therefore we tested if the Ag2CO3 in this present methodology could be 
replaced with Me4NCl. Three typical substrates were submitted to the standard Ag-free 
conditions that we reported before, and gratifyingly, good yields of desired meta-
arylphenols were obtained without any additional optimisation (Scheme 3.15). 
 
Scheme 3.15 Ag-free method for tandem arylation/protodecarboxylation of salicylic acids 
 
  
 
 
81 
 
3.3 One-pot meta-selective arylation of phenols 
3.3.1 Objectives 
In the previous section, we showed that various salicylic acids underwent a tandem 
arylation/protodecarboxylation process under Pd catalysis. Moreover, in the second 
chapter, we described a methodology allowing the carboxylation of phenols at atmospheric 
CO2 pressure. Considering that phenols are more commonly used starting materials and 
much cheaper in comparison to salicylic acid derivatives, we wondered if we could meta-
arylate phenols in a one-pot process. Carboxylation of phenol would give salicylic acid which 
then undergoes arylation/protodecarboxylation to afford meta-arylphenols (Scheme 3.16).  
Objective: One-pot meta-arylation of phenols using CO2 as a traceless directing group 
 
Scheme 3.16 Aim of the project 
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3.3.2 Optimisation of meta-arylation of phenols 
Meta-arylation of phenols via a tandem carboxylation/arylation/decarboxylation process 
Initially, we attempted to combine the method for carboxylation of phenols described in 
Chapter 2, and the tandem arylation/protodecarboxylation reaction of salicylic acids 
described in the previous section. We took as a starting point the reaction between m-cresol 
(35) and 5-iodo-m-xylene (36), with 2 mol % of PEPPSI-IPr, 0.5 equivalents of Ag2CO3, 3.0 
equivalents of NaH and 0.5 equivalents of 2,4,6-trimethylphenol (15) in AcOH with a CO2 
balloon, heated at 150 °C for 16 h. Unfortunately, the reaction did not work, with only 
starting material m-cresol (35) being observed by NMR analysis (Scheme 3.17). 
The reactions used 0.5 mmol of 35. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene 
as an internal standard, and confirmed by GCMS analysis. 
Scheme 3.17 Tandem carboxylation/arylation/decarboxylation process 
One-pot process for meta-arylation of phenols 
We believed that the addition of large excess of AcOH would shut down the carboxylation 
process as the carboxylate phenol process requires basic conditions. Therefore, instead of 
running the reaction as a tandem process, we began to attempt the meta-arylation of 
phenols in a one-pot procedure. Carboxylation of m-cresol (35) in the presence of 3.0 
equivalents of NaH and 0.5 equivalents of 2,4,6-trimethylphenol (15). After that time, 
PEPPSI-IPr, Ag2CO3, iodoarene 36 and AcOH were then added into the system, and heated 
for 150 °C for 16 h. Fortunately, about 10% of meta-arylated product was obtained (Scheme 
3.18). This result was encouraged us to carry on with further optimisation. 
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The reaction used 0.5 mmol of 35. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as 
an internal standard. 
Scheme 3.18 One-pot meta-arylation of phenols (1) 
To find the reason why the reaction above afforded low yield, we tested the effect of 2,4,6-
trimethylphenol (15) in the arylation/decarboxylation of 4-methylsalicylic acid (17) reaction. 
It was found that the addition of 2,4,6-trimethylphenol (15) reduced the 
arylation/decarboxylation of 4-methylsalicylic acid (17) from 71% (Scheme 3.13, 45) to 5% 
(Scheme 3.19). We thought this was probably due to the strong coordinating ability of 2,4,6-
trimethylphenol (15) to the Pd, which prevented the Pd catalyst from coordinating with the 
carboxyl group.  
The reaction used 0.5 mmol of 17. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as 
an internal standard. 
Scheme 3.19 Investigation of the effect of 2,4,6-trimethylphenol (15) 
Therefore, we tried the one-pot meta-arylation without using 2,4,6-trimethylphenol (15), 
and remarkably, the yield was improved to 40% (Scheme 3.20), highlighting that 2,4,6-
trimethylphenol (15) is not compatible with the standard arylation/protodecarboxylation of 
salicylic acids. 
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The reaction used 0.5 mmol of 35. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as 
an internal standard. 
Scheme 3.20 One-pot meta-arylation of phenols (2) 
The effect of Na-salt was also tested in the standard arylation/decarboxylation of 4-
methylsalicylic acid (17). As NaH reacts vigorously with AcOH, we decided to use Na2CO3 
instead, as both would react with the large excess of AcOH to form NaOAc. The result 
showed that in the presence of Na2CO3 the final product was obtained in a lower yield 62% 
(Scheme 3.21), in comparison with K2CO3 where the meta-arylated phenol was afforded in 
71% (Scheme 3.13, 45).  
The reaction used 0.5 mmol of 17. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as 
an internal standard. 
Scheme 3.21 Investigation of the metal cation for the reaction. 
Based upon the experiment above, we decided to replace NaH with KOH in the 
carboxylation step. To avoid the separate operation for the preparation and desiccation of 
potassium phenoxide in the classic Kolbe-Schmitt carboxylation procedure, we simply mixed 
the phenol starting material 35 and KOH in toluene, and heated for 30 minutes. And then 
toluene was removed in a stream of argon, water that generated from the reaction between 
phenols and base, on the other hand, was also removed due to the binary azeotrope with 
toluene, and consequently avoided the need for desiccation of potassium phenoxide. After 
that time, the reaction flask was submitted into an autoclave at 25 atm of CO2 pressure for 
 
 
85 
 
carboxylation, followed by a Pd-catalysed arylation/protodecarboxylation process. 
Gratifyingly, an increase of yield was achieved, with 52% of the desired meta-arylphenol 
product (Scheme 3.22). 
The reaction used 0.5 mmol of 35. Yield was determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as 
an internal standard. 
Scheme 3.22 One-pot meta-arylation of phenols (3) 
Considering that the Kolbe-Schmitt carboxylation did not give excellent yields, we wondered 
whether the yield could be improved by using the iodoarene as a limiting reagent instead of 
phenol. Gratifyingly, the meta-arylated phenol product 45 was improved to 64% when using 
5-iodo-m-xylene (36) as a limiting reagent and 3.0 equivalents of m-cresol (35) (Scheme 
3.23). In this case, the temperature can be reduced from 150 °C to 130 °C in the 
arylation/protodecarboxylation step. Additionally, the use of iodoarenes as limiting reagents 
makes the method of lower cost as iodoarenes are much more expensive than the phenol 
starting materials. 
The reaction used 0.167 mmol of 36 and 0.5 mmol of 35. Yield was determined by 
1
H NMR analysis using 1,3,5-
trimethoxybenzene as an internal standard. 
Scheme 3.23 One-pot meta-arylation of phenols (4) 
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Further improvement of the yield was successfully obtained by stirring the reaction for 40 h 
and adding in total 4 mol % of Pd(OAc)2 in two 2 mol % batches. The corresponding meta-
arylated product 45 was obtained in 75% yield (Scheme 3.24). In this case, there was no 
improvement in yield was obtained when using PEPPSI-IPr.  
 The reaction used 0.167 mmol of 36 and 0.5 mmol of 35, Pd(OAc)2 was added in two batches.  
Scheme 3.24 One-pot meta-arylation of phenols (5) 
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3.3.3 Substrate scope 
Having found suitable conditions for the one-pot meta-arylation of phenols, we started to 
test the scope of substituted phenols (Scheme 3.25). Most of the meta-arylated phenol 
derivatives that were made by using the tandem arylation/protodecarboxylation process of 
salicylic acids could be directly accessed from the parent phenols with this protocol. 
(Scheme 3.25, 38, 39, 43-45, 47, 50). Furthermore, taking advantage of the myriad of readily 
available phenol starting materials, many more new meta-arylphenol derivatives were also 
synthesised by this methodology (Scheme 3.25, 69-75). Gratifyingly, many functional groups 
involving both electron-withdrawing (Scheme 3.25, 38, 43, 44, 69) and electron-donating 
groups (Scheme 3.25, 39, 45, 70-74) were tolerated at the ortho- or meta-positions of the 
phenols, as well as ortho- and meta-disubstituted substrate, affording 74% of the desired 
product 75 (Scheme 3.25, 75). However, in terms of the strongly electron-withdrawing -NO2 
group substituted on the phenol, the desired product was not obtained, due to the 
prevention of the carboxylation step (Scheme 3.25, 40). On the other hand, the substrate 
containing a strong electron-donating -OMe group, a low 25% yield was obtained potentially 
due to the decarboxylation of the salicylic acid derivative intermediate (Scheme 3.25, 47). 
The replacement of a -OMe group with a less electron-donating -OCF3 group afforded 69% 
of desired product (Scheme 3.25, 72). Para-substituted phenols were found not to be 
compatible, with only para-fluorophenol giving 11% of meta-arylated product analysed by 
NMR (Scheme 3.25, 50). 
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a
 Yields are of pure isolated product. 
b
 2 mol % PEPPSI-IPr, was used instead of Pd(OAc)2 and the reaction 
stirred for 16 h. 
c
 Yield determined by 
1
H NMR analysis using 1,3,5-trimethoxybenzene as an internal standard. 
Scheme 3.25 Scope of meta-arylation of phenols on substituted phenols 
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Substituents on aryl iodides were then examined by coupling with simple phenol (Scheme 
3.26). In this case, the reaction using 4 mol % of Pd(OAc)2 for 40 h led to the same yield with 
the procedure using 2 mol % of PEPPSI-IPr for 16 h. Regarding the reaction time, all the 
substituted iodoarenes were tested under the conditions in the presence of 2 mol % PEPPSI-
IPr and heated for 16 h. Most of the iodoarenes substrates, which were compatible with the 
tandem arylation/protodecarboxylation process of salicylic acids, were found to be suitable 
for this one-pot meta-arylation of phenols methodology. Substituted aryl iodides containing 
both electron-withdrawing (Scheme 3.26, 51, 53-55, 62, 63, 76) and electron-donating 
groups (Scheme 3.26, 37, 57, 64) were found to be compatible at both meta- and para-
positions, leading to the corresponding meta-arylphenols in moderate yields. The easily 
oxidised aldehyde functionality was found to be tolerated, affording desired product in 50% 
(Scheme 3.26, 58). The iodoarene containing benzylic alcohol functionality was also found 
to be compatible, with an in situ acetylation occurred, leading to the acetyl ester 59 in 59% 
(Scheme 3.26, 59). Iodoindole and iododpyridine were tested and afforded the desired 
products 67 and 68 in 28% and 48% yields, respectively (Scheme 3.26, 67 and 68). Ortho-
substituted iodoarenes were also tested and found to be not well tolerated, nor was the 
small F substituent (Scheme 3.26, 66), which is a limitation of this method. 
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a
 Yields are of pure isolated product. 
b
 para-Iodobenzyl alcohol was used as starting material. 
Scheme 3.26 Scope of meta-arylation of phenols on substituted iodoarenes 
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3.3.4 Applications 
Scale up reaction 
Next, we set up the reaction in gram level scale, and 70% of meta-arylated product was 
obtained under the standard conditions without any modification (Scheme 3.27), suggesting 
that this methodology can be easily scalable. 
 
Scheme 3.27 One-pot meta-arylation of phenols in a gram scale 
Transformations  
A variety of meta-functionalised biaryls are easily accessed from the meta-arylphenols 
(Scheme 3.28): a) A diarylether subunit was achieved by simply mixing 45 and chloroarene 
in the presence of base (Scheme 3.28, 78);106 b) Similarly to the formation of diarylether, O-
alkylation occurs in the presence of base, leading to 96% of 79 (Scheme 3.28, 79);107 c) 
Amine functionality can be introduced via Buchwald-Hartwig amination of aryl triflate, 
which prepared from the corresponding phenol 45 (Scheme 3.28, 80);108 d) The Suzuki 
coupling of aryl triflate led to the unsymmetrical meta-triaryls 81 (Scheme 3.28, 81);109 e) 
Finally, a cyano group was also introduced, giving the product in 90% yield by tosylatation of 
45, followed by Pd-catalysed coupling reaction (Scheme 3.28, 82).110 
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Scheme 3.28 Transformations of 45 into a variety of meta-functionalised biaryls 
Synthesis of ϒ-secretase inhibitor 89 
We also synthesised the ϒ-secretase inhibitor 89, which was studied for the treatment of 
Alzheimer’s disease. 111 The previous synthesis of 89 required eight separate reaction steps 
and purifications starting from 1,3-dibromo-5-fluorobenzene 90, with 6% overall yield. We 
envisaged that our traceless directing group strategy will be applicable to the development 
of other useful one-pot meta-functionalisation processes. The whole synthetic process was 
accomplished in only three steps from 3-bromophenol (83), with the key meta-arylation 
step using 84 as coupling partner, forming 85 in 64% isolated yield. And subsequently O-
arylation112 of 85 with diaryl iodonium salt 86, affording 87 which followed by α-alkylation113 
afforded the ϒ-secretase inhibitor 89, with 41% overall yield after only three steps (Scheme 
3.29).  
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Scheme 3.29 Synthesis of ϒ-secretase inhibitor 89 
 
 
3.3.5 Reaction studies 
As the one-pot meta-arylation of phenols afforded moderate yields in most cases, we 
decided to investigate the side products which were generated in the reaction (Scheme 
3.30). Small amounts of the acetylated meta-arylphenol 91 were detected, as well as traces 
of acetylated meta-diarylphenol 92 was determined by GCMS analysis. The iodoarene 
coupling partner reacted with acetic acid to form phenylacetic acid 93 as a main by-product 
was found. Moreover, carboxylated phenol products at both ortho- and para-positions (2 
and 2’) were observed. 
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Scheme 3.30 Side products in one-pot meta-arylation of phenol 
A mixture of salicylic acid (2) and 4-hydroxybenzoic acid (2’) in a 48:23 ratio was found when 
we analysed the reaction after the carboxylation step. Then, we submitted 2 and 2’ to the 
tandem arylation/ protodecarboxylation conditions respectively, and interestingly, both 
hydroxybenzoic acids 2 and 2’ afforded the meta-arylated phenol product 37. Traces of 92 
were observed in the tandem arylation/protodecarboxylation reaction of 2’ but not in the 
reaction of 2 (Scheme 3.31). 
 
Scheme 3.31 Mechanistic study 
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The iodoarene 36 was also submitted to the tandem arylation/protodecarboxylation 
conditions in the absence of salicylic acid (2), interestingly, 50% of arylacetic acid 93 was 
obtained (Scheme 3.32). A plausible catalytic cycle involves the oxidative addition of Pd(0) 
with iodoarene to form species I, followed by the ligand exchange with AgOAc to form 
species II, then species II reacts with the α-depronated AcOH III, leading to species V via a 
Heck-type cross coupling. Finally, the reductive elimination of species V produces the metal 
phenyl acetate VI which is transformed to phenyl acetic acid 93 in situ, and simultaneously 
regenerates the Pd(0) catalyst (Scheme 3.32).114 
 
Scheme 3.32 Proposed catalytic cycle for α-arylation of acetic acid 
3.3.6 Proposed catalytic cycle 
A plausible catalytic cycle for the formation of meta-arylated phenol from the salicylic acid 
intermediate was proposed in Scheme 3.33. Initially, Pd(II) κ1-coordinates to the carboxyl 
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group on salicylic acid 2 in the presence of KOAc to form complex A, which then undergoes 
ortho C–H activation to form palladacycle B. The oxidative addition of palladacycle B with 
iodoarene generates Pd(IV) complex C, followed by ligand exchange to give Pd(IV) species D. 
Then the reductive elimination of species D produces species E, which subsequently 
undergoes decarboxylation to give Pd-aryl species F. Salicylic acid (2) mediated 
protometallation of Pd-aryl species F gives the desired meta-arylphenol product and 
regenerates A.  
 
Scheme 3.33 Plausible catalytic cycle for the tandem arylation/protodecarboxylation of 
salicylic acid 
An alternative hypothesis is that the mechanism proceeds via the formation of a dimeric 
palladacycle G, rather than the monomeric species B, which is then transformed into a 
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Pd(III)−Pd(III) bimetallic species H through an oxidative addition of the aryl iodide. The 
Pd(III)−Pd(III) bimetallic species H would undergo iodide abstraction, reductive elimination 
and decarboxylation to afford meta-arylated phenol (Scheme 3.34). 
 
Scheme 3.34 Plausible catalytic cycle via Pd(II)/Pd(III) 
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3.4 A tandem oxidation/arylation/protodecarboxylation reaction of 
salicylaldehydes: expanded access to meta-arylphenols 
3.4.1 Objectives 
The method of a one-pot meta-arylation provides a powerful tool for the synthesis of meta-
arylphenol derivatives from cheap phenols in a single synthetic operational step. However, 
the requirement of high CO2 pressure (25 atm) and high temperature (190 °C) during the 
carboxylation instalment is a limitation of the methodology (Scheme 3.35, a). 
Consequently, we aimed to discover a functionality that is easily introduced and removed, 
as well as an ability of beling a directing group directed ortho C–H functionalisation. It is 
well-known that aldehyde groups can be easily and efficiently introduced into phenol 
derivatives under mild conditions.75 Therefore, we were interested to explore whether the 
aldehyde functionality could facilitate ortho-functionalisation and be subsequently cleaved 
(Scheme 3.35, b). 
 
Scheme 3.35 Meta C–H functionalisation by the use of traceless directing groups 
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3.4.2 Optimisation 
Initially, we took salicylaldehyde 94 and reacted it with 1-iodo-3,5-dimethylbenzene 36 in 
the presence of 2 mol % of Pd(OAc)2, 0.5 equivalents of Ag2CO3 in AcOH, heated at 150 °C 
for 16 h. Gratifyingly, 17% of desired meta-arylphenol product 37 was obtained and 15% of 
side product 95 was obtained by the coupling between salicylaldehyde and iodoarene via 
cleavage of the aldehyde C–H bond (Table 3.4, entry 1). 115 It is to be noticed that in all 
cases, the by-product 95 was observed. Importantly, none of the arylated salicylaldehyde 
was observed, suggesting that the aldehyde can be easily cleaved after C–H arylation in situ, 
which meets our requirement for the idea of aldehyde being a removable directing group.  
Increasing the amount of Ag2CO3 to 1.0 equivalent improved the yield to 27% (Table 3.4, 
entry 2), while, the yield reduced to 18% when the amount of Ag2CO3 was increased to 2.0 
equivalents (Table 3.4, entry 3). The screening of the Pd sources suggested that PEPPSI-IPr 
was more efficient than Pd(OAc)2 in delivering the product, affording 35% of meta-arylated 
product (Table 3.4, entry 4).  
Due to the similar conditions with the tandem arylation/protocarboxylation reaction, we 
thought that the reaction may proceed via oxidation of salicylaldehyde to salicylic acid 
which facilitates a tandem arylation/protodecarboxylation process to afford meta-
arylphenols. Strong oxidants such as para-benzoquinone and m-CPBA were then used in the 
reaction to facilitate oxidation of the aldehyde group to a carboxylic acid. Unfortunately, no 
desired product was obtained (Table 3.4, entries 5 and 6).  
Similarly to the tandem arylation/decarboxylation of salicylic acids, the addition of K2CO3 
was crucial in improving the yields of the reactions (Table 3.4, entries 7 and 8). This is 
possibly due to the favoured κ1-coordination between Pd(II) and the carboxyl group, which 
forms from the oxidation of aldehyde group, in the presence of the K-salt.88,103 Finally, 72% 
of the product 37 was achieved by increasing the amount of Pd catalyst to 5 mol %. (Table 
3.4, entry 9). 
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Table 3.4 Optimisation of meta-arylation from salicylaldehyde 
 
Entrya Pd (mol %) Ag2CO3 (equiv) 
K2CO3 
(equiv) 
Yield of 37 
(%) 
Yield of 95 
(%) 
1 Pd(OAc)2 (2) 0.5 0 17 15 
2 Pd(OAc)2 (2) 1.0 0 27 20 
3 Pd(OAc)2 (2) 1.5 0 18 23 
4 PEPPSI-IPr (2) 1.0 0 35 30 
5b PEPPSI-IPr (2) 1.0 2.0 0 0 
6c PEPPSI-IPr (2) 1.0 2.0 0 0 
7 PEPPSI-IPr (2) 1.0 0.5 54 18 
8 PEPPSI-IPr (2) 1.0 2.0 60 21 
9 PEPPSI-IPr (5) 1.0 2.0 72 24 
a 
Reactions were carried out using 0.25 mmol of 94 and 0.75 mmol of 36. Yields were determined by 
1
H NMR 
analysis using an internal standard. 
b
 1.0 equiv of p-benzoquinone was added. 
c
 1.0 equiv of m-CPBA was 
added. 
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 3.4.3 Scope on substrates 
To explore the generality of this new method, we examined a variety of subsitituted aryl 
iodides (Scheme 3.36). We were pleased to find that many substituents, such as -Me, -F, -Br, 
-Cl, -CF3, were tolerated at the meta- and para-positions of the iodoarenes without any 
further modification. In general, all the yields obtained were moderate due to the 
unpreventable side reaction of aldehyde C–H activation. In particular, when para-
iodoanisole was submitted to this catalytic system, only 21% of the desired product was 
obtained, and instead, the side product of 2-hydroxyphenyl)(4-methoxyphenyl)methanone 
via cleavage of the aldehyde C–H  bond was observed as a main product in 53% (Scheme 
3.36, 57). Finally, an ortho-substituted iodoarene was examined and found to be not 
compatible, possible due to the steric hindrance proximal to the activated C–H (Scheme 
3.36, 65). 
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3.0 equiv of iodoarenes respect to 94 were used. 
a
 Yield of (2-hydroxyphenyl)(4-methoxyphenyl)methanone 
(57’)  instead of biaryls 57. 
Scheme 3.36 Scope of the domino oxidation/arylation/protodecarboxylation process on 
substituted iodoarenes 
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We also tested a variety of substituted salicylaldehyde derivatives to further demonstrate 
the generality of this new method (Scheme 3.37). We were pleased to find that both 
electron-donating (Scheme 3.37, 39, 45, 47, 70, 74) and electron-withdrawing group 
(Scheme 3.37, 38, 42, 43, 69, 100) are tolerated at the C3 and C4 position of the 
salicylaldehyde derivatives. However, due to the unpreventable side reaction of aldehyde C–
H activation, all of the yields are moderate. The strong electron-donating -OMe group is not 
tolerated well for salicylaldehyde derivatives. In this case, 3-methoxyphenol was obtained 
after the reaction probably due to the ‘formal’ decarbonylation of the starting material 
(Scheme 3.37, 47). Similarly to the ortho-substituted iodoarenes, the substituents at the C5 
position of the salicylaldehyde derivatives are not tolerated due to the steric hindrance 
proximal to the activated C–H bond (Scheme 3.37, 48).  
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3.0 equiv of 36 respect to salicylaldehyde derivatives were used. 
Scheme 3.37 Scope of the domino oxidation/arylation/protodecarboxylation process on 
salicylaldehydes 
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3.4.4 Preliminary mechanistic study 
A preliminary mechanistic study has been undertaken to understand in more depth how the 
meta-arylphenols are formed from salicylaldehydes. It has been shown before that 
benzaldehydes and its derivatives can undergo ortho-arylation116 and decarbonylation117 
under Pd catalysis. Additionally, it is well-known that aldehydes can be easily oxidised into 
the corresponding carboxylic acids in the presence of Tollens’ reagent. In our case, we 
postulated that Ag2CO3 could oxidise salicylaldehyde to salicylic acid.  Based upon these 
assumptions, three possible pathways have been proposed (Scheme 3.38):  
1) The transformation involves ortho-arylation of salicylaldehyde, followed by a Pd-catalysed 
decarbonylation, giving the meta-arylphenol (Scheme 3.38, Path 1).  
2) The transformation involves Pd-catalysed ortho-arylation of salicylaldehyde, followed by 
oxidation of the ortho-arylated salicylaldehyde intermediate to the corresponding benzoic 
acid, which then undergoes protodecarboxylation to generate meta-arylated phenol 
(Scheme 3.38, Path 2).  
3) Salicylaldehyde is oxidised to salicylic acid which then arylates and protodecarboxylates 
to afford meta-arylphenol (Scheme 3.38, Path 3). 
 
Scheme 3.38 Possible reaction pathways 
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Analysis of the crude reaction mixture revealed that 72% of meta-arylated phenol (37) and 
20% of salicylic acid (2) were formed after reaction, but no ortho-arylated salicylaldehyde 
intermediate (101) was obtained (Scheme 3.39, a). This indicated that the third pathway 
may be in operation. To investigate the mechanism further, salicylaldehyde was submitted 
to the catalytic cycle in the absence of the iodoarene 37, and 42% of salicylic acid was 
observed (Scheme 3.39, c). Interestingly, oxidation of the salicylaldehyde (94) to the 
corresponding acid 2 did not occur without the addition of Pd catalyst (Scheme 3.39, b). 
Finally, replacing Ag2CO3 for NMe4OAc as an iodide abstractor
118 did not provide the meta-
arylated product 37 (Scheme 3.39, d). This suggested that the oxidation of salicylaldehyde 
proceeds via a Wacker oxidation process.119  
Based on the above experiments, we suggested that this transformation of salicylaldehydes 
to meta-arylphenols proceeds via a tandem oxidation/arylation/proto-decarboxylation 
process.   
 
Scheme 3.39 Investigation of the reactions 
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3.5 Conclusions 
To summarise, we have reported that salicylic acid derivatives can undergo a tandem 
arylation/protodecarboxylation process, affording meta-arylphenols (Scheme 3.40). A broad 
range of substituents on both salicylic acids and iodoarenes were tested and found to be 
well tolerated.  
 
Scheme 3.40 Tandem arylation/protodecarboxylation of salicylic acids 
Considering that phenols are more widely available and much cheaper compared to salicylic 
acid derivatives, we aimed to develop a method for meta-arylation of phenols. In Chapter 2, 
we described a method for carboxylation of phenols at ambient CO2 pressure in the 
presence of 2,4,6-trimethylphenol (15) and NaH. However, 2,4,6-trimethylphenol (15) 
proved to inhibit the tandem arylation/protodecarboxylation process. After serval 
explorations, we successfully developed a one-pot meta-arylation of phenols process 
through a Kolbe-Schmitt carboxylation followed by a tandem arylation/ 
protodecarboxylation of salicylic acid intermediates (Scheme 3.41). This methodology 
provides an efficient synthesis of a broad of meta-arylation of phenol derivatives from the 
wide availability of cheap phenol starting materials. Application of this methodology was 
explored by showing the efficient synthesis of the ϒ-secretase inhibitor 89 and 
transformation of meta-arylphenols products to a variety of 1,3-biaryls adducts. 
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Scheme 3.41 One-pot meta-arylation of phenols 
An alternative to access meta-arylphenol derivatives was presented by the use of aldehyde 
as a traceless directing group (Scheme 3.42). This methodology allows access to meta-
arylphenol derivatives from salicylaldehydes via a tandem oxidation/arylation/ 
protodecarboxylation process. Importantly, as an aldehyde group is easily introduced and 
removed after C–H functionalisation, it can be used as a convenient removable directing 
group to control site selectivity towards C–H functionalisation methodologies. 
 
Scheme 3.42 Tandem oxidation/arylation/protodecarboxylation of salicylaldehydes 
 
  
 
 
109 
 
3.6 Future work 
Encouraged by the success of the one-pot process for meta-arylation of phenols, we would 
like to develop a unified methodology which would allow the introduction of various 
functional groups at the meta-position of phenols. (Scheme 3.43). These unified 
methodologies would be very useful in organic synthesis providing a variety of meta-
substituted phenols.  
Our investigation is going to start with ortho-functionalisation/protodecarboxylation of 
salicylic acids for the delivery of meta-substituted phenols. Hopefully, after finding the 
optimal conditions for the functionalisation of salicylic acids, our efforts will be focused 
towards meta-functionalisation of phenols in a one-pot process. We believe that the 
carboxyl directed hydroxylation, iodination, alkylation, olefination and acylation is worth 
investigating as these processes have not been described for phenols. 
 
Scheme 3.43 Meta-functionalisation of phenols 
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Chapter 4 
  
 
 
111 
 
Chapter 4 Enantioselective C–H arylation of arenes chromium 
tricarbonyl complexesii 
4.1 Introduction 
As described in the first chapter, transition metal catalysed direct C–H functionalisation is of 
great importance in synthetic chemistry as it allows simple and efficient access to myriad 
molecules from abundant hydrocarbon compounds. However, due to the ubiquitous nature 
of C–H bonds, it is difficult to distinguish the reactivity among the plentiful C–H bonds in a 
molecule. As a result, it is a challenge to achieve a high level of selective C–H 
functionalisation. In the third chapter, we presented a methodology for the regioselective 
arylation of phenols through the use of a transient carboxyl directing group. This overcomes 
the ‘natural’ reactivity of phenol, allowing arylation at the meta-position. In this section, we 
turned our attention towards transition metal-catalysed enantioselective C–H 
functionalisation. 
Very generally, there are two fundamental approaches for enantioselective C–H 
functionalisation. One strategy utilises the insertion of metal-bound complexes, such as 
carbenes and nitrenes (scheme 4.1, a), into a C–H bond. Another strategy involves C–H 
activation, achieving enantioselective C–H functionalisation via a metal-carbon species 
(Scheme 4.1, b).  
 
Scheme 4.1 Strategies for C–H functionalisation 
                                                     
ii
 This work was carried out in collaboration with Katrina Krämer, the contributions where included will be 
highlighted in the text. 
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In this introduction, enantioselective C–H functionalisation reactions involving transient 
metal-carbon species will be discussed, with particular focus towards Pd-catalysed 
enantioselective C–H functionalisation. C–H bond insertion by metal carbenoids and related 
species will only be very briefly discussed. 
 
4.1.1 Enantioselective C–H functionalisation involves metal carbenoids and 
nitrenoids 
Metal carbenoids 
Rhodium carbenes are the most studied metal carbenes for insertion of C–H bonds in an 
enantioselective manner.120 Generally, this type of reaction uses a high energy diazo 
compound 4.1 to react with Rh catalyst 4.4 to generate reactive metal carbenoids 4.5, with 
a driving force of forming N2, followed by the insertion of the metal carbene species 4.5 into 
C–H bond 4.2 to form the product 4.3 and regenerate the catalyst 4.4 (Scheme 4.2). 
 
Scheme 4.2 Metal carbenoids insertion of C–H bond 
Early work was reported by McKervey and co-workers who used a chiral Rh(II) prolinate 
catalyst 4.8 with α-diazo-β-ketosulfone 4.6, affording the cyclised product 4.7 in >90% yield 
but with only ca.12%  ee (Scheme 4.3).121 
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Scheme 4.3 McKervey’s work on Rh carbene insertion into a C(sp3)–H bond 
This field has been extensively expanded upon,122 with Davies’ development of Rh2{(R/S)-
DOSP}4 being one of  the most important advances. The Rh2{(R/S)-DOSP}4 catalyst proved to 
be highly effective for both intra- and intermolecular insertions, with excellent yields and ee 
values (Scheme 4.4).123 
 
Scheme 4.4 Davies’s work on Rh carbene intra- and intermolecular reactions 
 
Metal Nitrenes 
Instead of forming C–C bonds by the insertion of metal carbenes into C–H bonds, the 
insertion of metal nitrenes into C–H bonds affords the formation of C–N bonds. The C–H 
amination with [Rh2(OAc)4] and other transition metal complexes was reported as early as 
the 1980s,124 however, the development of its corresponding enantioselective processes has 
not been achieved until relatively recently. Many catalysts, such as Ikegami’s Rh2{(S)-PTPA}4 
(4.18), 125  Pirrung’s Rh2{(R)-BNP}4 (4.19),
126  Hashimoto’s Rh2{(S)-TCPTTL}4 (4.20),
127  and 
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Davies’s Rh2{(S)-TCPTAD}4 (4.21),
128 have been developed for the enantioselective amination 
through Rh nitrenes insertion. Among these catalysts, Rh2{(S)-TCPTAD}4 was found to be the 
most efficient for intermolecular C–H amination both in terms of yield and ee value (Scheme 
4.5). 
 
Entry Rh(II) Yield (%) ee (%) 
1 Rh2{(S)-PTPA}4 (4.18) 77 7 
2 Rh2{(R)-BNP}4 (4.19) 71 31 
3 Rh2{(S)-TCPTTL}4 (4.20) 51 73 
4 Rh2{(S)-TCPTAD}4 (4.21) 95 94 
 
Scheme 4.5 Asymmetric C–H amination by the insertion of Rh(II) nitrenes 
4.1.2 Enantioselective C–H functionalisation via C–H activation 
Though tremendous efforts have been made on the area of catalytic C–H activation, the 
development of the corresponding enantioselective C–H activation reactions still remains a 
challenge in part due to the lack of suitable chiral ligands that can promote the cleavage of 
C–H bond and be compatible with other steps in the catalytic cycle. The following text will 
focus on Pd-catalysed enantioselective C–H activation. 
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Generally, there are three mechanistic scenarios described for Pd-catalysed enantioselective 
C–H activation (Scheme 4.6): a) Enantioselective C–H activation involving a Pd(II)/Pd(0) 
catalytic cycle. In this approach, C–H activation takes place in the presence of a Pd(II) 
catalyst, which transmetallates with an organometallic reagent to form RR’PdIILn, followed 
by reductive elimination to give the product R-R’ and Pd0Ln species. The Pd(II) species will be 
regenerated in the presence of an oxidant to complete the catalytic cycle; b) 
Enantioselective C–H activation involving a Pd(0)/Pd(II) catalytic cycle. In this strategy, a 
Pd(0) species undergoes oxidative addition to form a R-PdIIXLn species that cleaves the C–H 
bond of the coupling partner H-R’, followed by the reductive elimination of RR’PdIILn to 
generate the product R-R’, and simultaneously regenerate the Pd(0) species; c) 
Enantioselective C–H activation involving a Pd(II)/Pd(IV) catalytic cycle. In this process, after 
the formation of R-PdX(II)Ln via C–H activation, an oxidative addition to produce Pd(IV) 
species ocurrs, which followed by reductive elimination,  forms the product R-R’ with 
concomitant regeneration of catalyst. 
 
Scheme 4.6 Possible Pd catalytic cycle for enantioselective C–H functionalisation 
 
Enantioselective C–H functionalisation via Pd(II)/Pd(0) catalysis 
A breakthrough in this area was achieved by Yu and co-workers who used an N-protected 
chiral amino acid 4.24 as a suitable ligand in the Pd(II)-catalysed enantioselective C–H 
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functionalisation of pro-chiral 2-benzhydrylpyridine derivatives 4.22 with boronic acids 
(Scheme 4.7). 129 The authors suggested that the N-protected chiral amino acid 4.24 ligand 
coordinates to the Pd centre in an N,O-bidentate manner, so a large group at the α-carbon 
can improve the stereo-control. (-)-Men-L-Leu-OH (4.24) was found to be an optimal ligand 
for this catalytic cycle, with up to 96% yield and 95% ee being obtained. The same strategy 
was applied to the substrates containing carboxylate groups in place of the 2-pyridyl group, 
showing Boc-L-Ile-OH could enable enantioselective C–H olefination of sodium 
diphenylcarboxylates with styrene derivatives.130 
 
Scheme 4.7 Pd(II)-catalysed asymmetric C–H functionalisation of 2-benzhydrylpyridines 
A theoretical study was carried by Musaev, Yu and co-workers to understand this 
transformation, lending weight to the hypothesis that the N,O-bidentate coordination of the 
ligand to Pd was crucial for high enantioselectivity.131 Relevant mechanistic steps are shown 
in Scheme 4.8. Cleavage of N–H bond in the ligand occurs by the coordinated acetate, 
eliminating AcOH. Acetate-assisted metalation of the arene occurs to give palladacycle 4.28, 
again with elimination of AcOH. Subsequent functionalisation of this intermediate (4.28) via 
transmetallation with the organoboronic acid and reductive elimination affords the desired 
product 4.23.  
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Scheme 4.8 Crucial steps in enantioselective functionalisation of 2-benzhydrylpyridine 
N-protected chiral amino acid ligands were also applied to the construction of planar-chiral 
ferrocene derivatives. Work on asymmetric arylation of N,N-dialkylaminomethylferrocenes 
(4.29) was reported by Gu, You and co-workers. Boc-L-Val-OH (4.31) was found to be the 
optimal ligand for this process, leading to excellent enantioselectivity (Scheme 4.9).132 Later 
on, Cui, Wu and co-workers reported a similar method for enantioselective olefination of 
ferrocene derivatives by the use of Boc-L-Phe-OH as a chiral ligand.133  
 
Scheme 4.9 Pd-catalysed asymmetric arylation of N,N-dialkylaminomethylferrocenes 
Yamaguchi, Itami and co-workers developed a method for preparing axial chiral biaryl 
molecules using cooperation of Fe and Pd catalysis. The use of Pd(II)-sulfoxide-oxazoline 
4.35 and Fe-phthalocyanine 4.36 co-catalysts allowed enantioselective C–H arylation of 
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thiophenes 4.32 with arylboronic acids 4.33, although moderate yields and ees were 
obtained.134 
 
Scheme 4.10 The synthesis of axial chiral biaryl molecules 
An example of enantioselective C(sp3)–H bond was reported by Yu’s group.135 After an 
intensive screening of amino acids, the ligand containing an N-Boc group and 2,6-
difluorobenzyl substituent at the α-carbon (4.39) enabled enantioselective alkylation, 
arylation and vinylation of 1,1-disubstituted cyclopropanes (4.37) incorporating an acidic N-
arylamide as a weak coordinating directing group. 
 
Scheme 4.11 Enantioselective C–H functionalisation of 1,1-disubstituted cyclopropanes 
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Enantioselective C–H functionalisation via Pd(0)/Pd(II) catalysis 
Enantioselective C–H functionalisations via a Pd(0)/Pd(II) catalytic cycle has also received 
considerable attention over the past decade. Early work in this area was reported by 
Alkicker and Cramer who synthesised chiral indane derivatives 4.41 using a Pd catalyst 
ligated by a specifically designed taddol-based phosphoramidite ligand 4.42 (Scheme 4.12, 
a).136 Later on, the same group extended this method to the enantioselective synthesis of 
dibenzazepinone derivatives 4.45 by the use of Pd(dba)2 catalyst and the simplest taddol-
based phosphoramidite 4.43 as a suitable chiral ligand (Scheme 4.12, b).137  
 
Scheme 4.12 Pd(0)-catalysed enantioselective C–H functionalisation 
Kang, Gu and co-workers reported a highly enantioselective Pd(0)-catalysed direct C−H 
intramolecular arylation of ferrocene and ruthenocene derivatives with aryl iodides by the 
use of an enantioenriched BINAP ligand (Scheme 4.13).138 At the same time, Gu, You and co-
workers reported a method for the enantioselective intramolecular arylation of ferrocene 
with aryl bromides under very similar conditions. A planar chiral ferrocene phosphine ligand 
was synthesised from the planar chiral ferrocene product in this case, showing the power of 
this method in organic synthesis applications.139 
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Scheme 4.13 Pd(0)-catalysed enantioselective C−H intramolecular arylation of metallocenes 
Pd(0)-catalysed enantioselective C(sp3)–H bond functionalisation reactions have been 
explored in more depth than the corresponding Pd(II)-catalysed reactions. A selected 
example reported by Kündig’s group is shown in Scheme 4.14. The methodology allows easy 
access to enantioenriched indoline derivatives, a motif commonly found in drugs and 
natural products.140 Fused indolines 4.49 bearing trans [3.4.0]- or [3.5.0]-bicyclic backbones 
could be synthesised via intramolecular enantioselective C(sp3)–H bond arylation of N-
cycloalkyl substituted carbamates (4.48, PG = CO2Me)  catalysed by a Pd complex (either 
preformed or generated in situ) ligated by a bulky chiral NHC ligand 4.50 (Scheme 4.14, 
a). 141  This ligand 4.50 also allows the enantioselective C(sp3)–H arylation of N-alkyl 
substituted carbamates (4.51, PG = CO2Me). The authors showed that regiodivergent 
C(sp3)–H bond functionalisations occur both at the terminal methyl and methylene group, 
leading to 2-substituted indolines 4.52 in higher yields but moderate level of ee’s, whereas 
2,3-disubstituted indolines 4.53 were the minor products but with excellent ee’s (Scheme 
4.14, b).142 Efforts on this area have also been made by Kagan’s143 and Cramer’s144 groups. 
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Scheme 4.14 The synthesis of enantioenriched indoline derivatives 
Enantioselective C–H functionalisation via Pd(II)/Pd(IV) catalytic cycle 
Enantioselective C–H activation involving a Pd(II)/Pd(IV) catalytic cycle has not been 
explored until recently. In 2013, Yu, Wang and co-workers reported a method for the 
synthesis of chiral benzofuranones by enantioselective C–H activation of phenylacetic acids 
4.54 with Pd(II) species via an intramolecular C–O bond formation.145 The catalytic cycle 
involves the reductive elimination facilitated by the oxidation of the Pd(II) metallacycle 4.56 
to a transient Pd(IV) intermediate 4.55 with a strong iodonium oxidant (Scheme 4.15).  
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Scheme 4.15 The synthesis of chiral benzofuranones 
An enantioselective C–H iodination of a substrate containing trifluoromethanesulfonamide 
4.58 as a directing group using an N-benzoyl-protected amino acid 4.60 has been developed 
by Yu’s group (Scheme 4.16).146 The author proposed an intermediate (4.60) containing Cs 
triflamide directing group coordinated with Pd(II) as a neutral σ-donor, and bidentate 
coordination with the chiral ligand. However, it is not clear whether a Pd(IV) intermediate is 
involved in the catalytic cycle.  
 
Scheme 4.16 L-MPAA enables enantioselective iodination 
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Based upon the work above, Yu’s group also developed a kinetic resolution via Pd-catalysed 
enantioselective C(sp2)–H iodination of benzylic amines 4.62. In this process, one of the 
enantiomers (racemic benzylic amines) undergoes C(sp2)–H bond activation faster than the 
other, thus affording enantioenriched products 4.63. The remaining enantiomers of the 
starting material 4.64 could be converted to the opposite configuration of enantioenriched 
iodinated products 4.65 by the use of the chiral ligand with the opposite configuration 
(Scheme 4.17). The exceedingly high relative rate ratio ((kfast/kslow) is as high as 244 when a 
fluoro group is substituted at the 3-position of the β-phenyl, and high levels of 
enantioselectivity between 94% and 99% ees was obtained in all cases.147 However, whether 
a Pd(IV) intermediate is involved in the catalytic cycle was not mentioned by the authors. 
 
Scheme 4.17 Enantioselective iodination of benzylic amines via kinetic resolution 
More recently, Yu’s group reported the first example of enantioselective arylation of C(sp3)–
H bond via a Pd(II)/Pd(IV) catalytic cycle (Scheme 4.18). 148 The method allows the synthesis 
of chiral cis-aryl-cyclopropylmethylamine 4.67 using Pd(II)/MPAA catalysts in excellent yields 
and ees. Although the Pd(IV) intermediate has not been isolated in support of Pd(II)/Pd(IV) 
catalytic cycle, the authors suggested that the Pd(II)/Pd(IV) catalytic cycle has been 
demonstrated for the reaction of the Pd(II) palladacycle with aryl iodides by Daugulis.149 
Moreover, a Pd(II)/Pd(0) catalytic cycle has never been conceived or experimentally 
supported for C–H arylation of a substrate containing a directing group with aryl iodides. A 
Pd(II)/Pd(III) catalytic cycle is also unlikely due to the bidentate coordination between 
catalyst and MPAA ligand, inhibiting the dimerization via the bridging carboxylate.150 
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Scheme 4.18 Pd(II)-catalysed enantioselective arylation of cyclopropylmethylamine  
 
4.1.3 Conclusions 
Direct C–H functionalisation has received considerate attention as a promising tool for 
organic synthesis. The insertions of carbenes and nitrenes into C–H bond in a pro-chiral 
substrate have been achieved in synthetically useful enantioselectivity. The development of 
direct enantioselective C–H functionalisation via C–H activation, on the other hand, still 
remains a big challenge. State of the art Pd-catalysed enantioselective C–H activation is 
presented in this section. The Pd(0)/Pd(II), Pd(II)/Pd(0) and Pd(II)/Pd(IV) catalytic cycles have 
all been involved as possible mechanisms for enantioselective C–H activation. Both C(sp2)–H 
and C(sp3)–H bonds have been shown to be reactive in an enantioselective fashion under 
certain conditions. Despite these successful explorations, further efforts on new catalyst and 
ligand design are required to improve the reactivity and selectivity. Another significant 
limitation is the substrate scope as most methodologies for enantioselective C–H 
functionalisation only occur at specialised positions such as those close in proximity to a 
directing group, and allylic positions. Thus, it is highly desirable to improve the practicality 
and versatility of enantioselective C–H functionalisation by expanding the substrate scope.   
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4.2 Objectives of the project 
Planar chiral compounds, such as chiral ferrocene derivatives, are of great interest in the 
research areas of asymmetric catalysis, materials and biomedical research. 151  Nice 
methodologies for the construction of planar chiral ferrocene derivatives via direct C–H 
functionalisation have been reported by Gu’s, You’s, and Kang’s group as described above. 
η6-Arene chromium tricarbonyl complexes have been found to be interesting compounds in 
organic synthesis for many reasons. Several transformations which can not be carried out 
with simple arenes but become feasible with the metal complexation of the arene.152 The 
easy preparation and purification of these compounds, as well as the unambiguous 
detection by NMR, make the arene chromium complexes practical in synthetic chemistry. 
Planar chiral chromium complexes, on the other hand, have been extensively used as 
stoichiometric auxiliaries for asymmetric synthesis.153 Ligands based on planar-chiral η6-
arene chromium scaffolds have also found widespread application in asymmetric 
synthesis.154 However, to synthesise the planar chiral η6-arene chromium complexes, the 
most common strategy is to use a chiral Li base to enantioselectivity deprotonate a pro-
chiral substrate (or use an achiral Li base to enantioselectivity deprotonate a chiral 
substrate), followed by an electrophilic addition.35 One impressive example of this strategy 
is the use of (-)-sparteine, which enables the synthesis of both enantiomers of the planar-
chiral chromium complex by altering the amount of base used in the reaction (Scheme 
4.19). When 1 equivalent of (-)-sparteine and n-BuLi are used, the planar-chiral complex 
(4.70) was obtained after an electrophilic quench, such as (CH2O)n, leading to 58% yield and 
92% ee. On the other hand, when 2.5 equivalents of (-)-sparteine and n-BuLi are used, 
complex (4.71) was obtained after an electrophilic quench, obtaining 30% yield and 95% ee 
when (CH2O)n was used as an electrophile.
155  
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Scheme 4.19 The synthesis of the planar chiral η6-arene chromium complexes 
The catalytic direct enantioselective C–H functionalisation of η6-arene chromium complexes, 
which provides an efficient alternative to planar chiral chromium complexes, has never been 
achieved before. In this part, we aimed to develop a methodology for the synthesis of 
planar chiral arene chromium tricarbonyl complexes by direct C–H arylation (Scheme 
4.20). 
 
Scheme 4.20 Enantioselective C–H arylation of η6-arene chromium tricarbonyl complexes 
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4.3 Pd-catalysed enantioselective C–H arylation of monofluoroarene 
chromium tricarbonyl complexes 
4.3.1 Previous results 
Our group has demonstrated that π-complexation to a Cr(CO)3 unit can significantly enhance 
reactivity of otherwise unreactive monofluoroarenes in Pd-catalysed direct C–H arylation 
with iodoarenes (Scheme 4.21). 156  Although it is well-known that the chromium 
complexation increases the acidity of protons on the complexed arene, our computational 
work indicated that the out-of-plane bending of the reacting C–H bond in the transition 
state was the major contributor to increasing the reactivity of chromium-complexed arenes 
in a CMD-type C–H activation mechanism. To extend this methodology to electron-rich 
arenes, our group has also shown that Cr(CO)3-complexation could enhance the reactivity of 
anisole derivatives, allowing ortho-arylation of alkoxyarenes.157  
 
Scheme 4.21 Cr-enhanced the reactivity of monofluorobenzene derivatives 
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Based upon this, Katrina Krӓmer found that it is possible to achieve an enantioselective C–H 
arylation of monofluoroarene chromium complexes by the use of a chiral phosphine ligand. 
Importantly, the use of different carboxylic acids makes a big difference in terms of both 
reactivity and selectivity. With an extensive screening of carboxylic acids together with 
phosphine ligands, Katrina Krӓmer successfully achieved 42% yield of desired monoarylation 
product with 60% ee by the use of 5 mol % of Pd(dba)2, 5 mol % of (S) or (R)-BINAP, 0.5 
equivalents of dicyclohexylacetic acid, 2.0 equivalents of TMP (2,2,6,6-
tetramethylpiperidine), 2.0 equivalents of K2CO3 and 0.65 equivalents of Ag2CO3 in PhMe, 
heated at 50 °C for overnight (Scheme 4.22). Pd(dba)2 is a good replacement for Pd(PPh3)4. 
The weak coordination between Pd and dba (dibenzylideneacetone) makes it possible for a 
chiral ligand to coordinate with Pd. More interestingly, the use of TMP (2,2,6,6-
tetramethylpiperidine) crucially increased the reactivity, suggesting a silver-TMP complex 
was formed to enhance the reactivity. 
 
Scheme 4.22 Best results obtained by Katrina Krӓmer 
4.3.2 General statements 
After this time, an initial screen of the catalyst and temperature found that the same yield 
and ee was observed at a lower temperature (Table 4.1, entry 2), and with lower loading of 
catalyst and ligand (Table 4.1, entry 3). Pd2(dba)3·CHCl3 was found to be compatible as well 
(Table 4.1, entry 4). A detailed optimisation regarding the catalyst and temperature will be 
presented later. I have reported these results here to establish that small changes in the 
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nature of the catalyst (Pd(dba)2 vs Pd2(dba)3·CHCl3), the catalyst loading (5 mol % vs 3 mol 
%) and reaction temperature have very little effect on the yield and enantioselectivity. This 
will be important as slightly different conditions are sometimes used when screening 
phosphine ligands and carboxylic acids in the reaction.  However, we presume that any 
difference in yield or enantioselectivity is the effect of the phosphine ligand or acid addition, 
and not the small changes between the standard conditions. 
Table 4.1 Standard conditions 
  
entries [Pd] (mol %) 
S-BINAP 
(mol %) 
T (°C) 
Yield 102 
(%) 
ee 102 
(%) 
Yield 103 
(%) 
1 Pd(dba)2 (5) 5 50 43 60 28 
2 Pd(dba)2 (5) 5 40 42 60 31 
3 Pd(dba)2 (3) 3 40 43 62 17 
4 Pd2(dba)3·CHCl3 (1.5) 3 40 47 60 30 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
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4.3.3 Screening of phosphine ligands 
Having determined dicyclohexylacetic acid provides both best reactivity and selectivity 
among the carboxylic acid derivatives examined by Katrina Krӓmer, we carried on the 
screening of chiral phosphine ligands (Table 4.2). In order to allow for comparisons to be 
made, the results presented in the Table 4.2 are based on both Katrina Krӓmer’s and my 
work.  
As good selectivity was observed when S- or R-BINAP was used, a large number of bidentate 
ligands containing biaryl atropisomeric backbones were tested. As we know, the most 
important factors of a chiral ligand are steric and electronic properties. In terms of this type 
of bidentate ligands containing biaryl atropisomeric backbone, a molecule model is shown in 
Scheme 4.23. The dihedral angle θ is the angle between the biaryl backbone, which is 
geometrically related to the bite angle β of P-M-P. With concern to sterics only, the smaller 
bite angle θ is, the higher interaction between the ligand and substrate should be.158  
 
Scheme 4.23 Birayl atropisomeroc backone 
The electronic properties were estimated by measuring the carbonyl stretching frequency of 
[RhCl(P*P)(CO)] complexes by IR spectroscopy. The higher the carbonyl stretching frequency 
is, the higher the π-acidic character and lower electron-donating ability of the ligand.159 The 
steric and electronic properties of some typical ligands are shown in Scheme 4.24.160 
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Scheme 4.24 The steric and electronic properties of ligands 
Based upon the results in Table 4.2, a phosphine ligand with a smaller dihedral angle θ still 
gave good enantioselectivity. For example, the MeO-BIPHEP (Scheme 4.25, L6) (72.3° vs. 
86.6° in BINAP) gave exactly the same results as with BINAP (Table 4.2, entry 6). While a 
ligand with a very small dihedral angle θ gave a slightly lower ee compared with BINAP: For 
example, SEGPHOS (Scheme 4.25, L3) with a dihedral angle θ of 67.6°, afforded 45% yield 
and 50% ee (Table 4.2, entry 3). DifluoroPhos (Scheme 4.25, L4) which has a similar dihedral 
angle θ to SEGPHOS, however, only gave 20% ee probably due to the poor electron-donating 
ability (see Scheme 4.24: π-acidic character 2023 cm-1 vs. 2016 cm-1 in SEGPHOS and 2017 
cm-1 in BINAP) (Table 4.2, entry 4). 
Different MeO-BIPHEP derivatives were tested (Scheme 4.25, L6-10), and the most bulky 
ligand L9 resulted in no reaction (Table 4.2, entry 9). The more sterically hindered L7 gave 
lower ee compared to L6 (Table 4.2, entries 6 and 7). A furyl substituted phosphine L10 gave 
a similar yield with L6 but with significantly decreased ee (Table 4.2, entry 10). The ligand 
with dichlorosubstituted at the biaryl backbone of MeO-BIPHEP (Scheme 4.25, L5) afforded 
similar yield to L6 but significantly decreased ee (Table 4.2, entry 5). 
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Some other commonly used bidentate ligands containing biaryl atropisomeric backbone 
(Scheme 4.25, L11-L15) were also tested, and (S)-H8-BINAP performed best with regard to 
the ee (Table 4.2, entry 15).  
A phenol derivative ligand, (S)-BINOL (Scheme 4.25, L17) was tested, and 40% yield was 
observed, whereas only 2% ee was obtained (Table 4.2, entry 17). Finally, a (S)-BINAP-PdCl2 
complex L17 was used in the reaction and a slightly lower ee was obtained compared to 
BINAP (Table 4.2, entry 17). 
Some other bidentate phosphines not based on the axial chirality (Scheme 4.25, L18-25) 
were tested, but most of them result in low reactivity and selectivity (Table 4.2, entries 18-
25), except L20 which afforded 30% yield and 56% ee (Table 4.2, entry 20).  
P*N type bidentate ligands (Scheme 4.25 and 4-26, L26-28) were also tried, and the reaction 
did not work when employing a ligand containing a primary amine group (Table 4.2, entries 
26 and 28). And the oxazole containing ligand L27 gave a low yield and ee (Table 4.2, entry 
27). 
Monodentate ligands containing one phosphine and one etheric oxygen (Scheme 4.26, L29 
and L30) gave good reactivity but no enantioselectivity. For example, the MOP (L29) ligand 
gave 46% yield, but only 8% ee was observed (Table 4.2, entry 29). A more bulky MOP 
derivative L30 with a naphthalene substituent was made and tried, but similar results were 
obtained with MOP ligand (Table 4.2, entry 30). Phosphoramidite ligand L31 resulted in no 
reaction (Table 4.2, entry 31).   
Table 4.2 Screening of chiral ligands 
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Entries Ligand Yield 102 ee 102 Yield 103 
1 L1  42 64 31 
2 L2  40 36 26 
3 L3 45 50 28 
4 L4 45 20 17 
5 L5 42 43 35 
6b L6 43 64 27 
7b L7 47 38 30 
8b L8 50 54 20 
9b L9 0 - 0 
10b L10 40 28 38 
11 L11 38 10 16 
12 L12 45 54 29 
13 L13 41 58 27 
14 L14 52 50 6 
15 L15 45 68 31 
16b,d L16 40 2 12.5 
17b,e L17 48 52 32 
18 L18 32 1 9 
19b L19 30 3 <5 
20 L20 30 56 4 
21 L21 39 2 29 
22c L22 37 20 10 
23 L23 29 4 5 
24 L24 0 - 0 
25 L25 39 18 23 
26 L26 0 - 0 
27 L27 15 18 0 
28 L28 0 - 0 
29a L29 46 8 34 
30b,d L30 45 6 30 
31a L31 0 - 0 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
a
 10 mol % of ligands were used. 
b
 The reactions were 
performed at 40 °C. 
c
 1.5 mol % of Pd2(dba)3·CHCl3 and 3.3 mol % of phosphine ligands were used. 
d
 3 mol % of 
Pd(dba)2 and 3.3 mol % of ligands were used. 
e
 Only 5 mol % of L17 without using Pd(dba)2 was used in the 
reaction. 
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Scheme 4.25 library of chiral phosphine ligands (1) 
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Scheme 4.26 library of chiral phosphine ligands (2) 
  
 
 
136 
 
4.3.4 The exploration of mono-oxidised bidentate phosphine ligands 
Based upon the proposed transition state suggested for the Pd-catalysed arylation of 
monofluoroarenes chromium complex (Scheme 4.27, a),37 a transition state was speculated 
for this Pd-catalysed enantioselective arylation of monofluoroarenes chromium complex 
ligates with bidentate phosphine (Scheme 4.27, b).  
Considering that a transition state with five bonds to Pd ligated with ligands is hard to 
achieve for C–H activation and it has never been reported to our knowledge. Thus, we 
hypothesised that a mono-oxidised BINAP ligand could be a promising alternative to achieve 
this enantioselective C–H activation. Due to the weakly coordinating ability of the phosphine 
oxide, the mono-oxidised BINAP could potentially not only act as a bidentate ligand but also 
as a monodentate phosphine, consequently, making it possible for enantioselective C–H 
activation to proceed via a transition state with four bonds coordination with Pd (Scheme 
4.27, c). 
 
Scheme 4.27 Proposed transition states 
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Encouragingly, a better ee was observed when employing the S-BINAP(O) (Scheme 4.26, 
L32) ligand compared to S-BINAP (Table 4.3, entries 1 and 2). The use of S-H8-BINAP(O) 
(Scheme 4.26, L33) afforded a slightly higher ee compared to S-BINAP(O) (Table 4.3, entry 
3).  
Finally, given that the carbonyl group could also weakly coordinate to Pd in a similar way to 
phosphine oxide, phosphine ligands containing a carbonyl group L34 and L35 were 
synthesised and tested in this reaction (Scheme 4.26). As it was expected, both L34 and L35 
gave ee as good as S-BINAP(O), affording 71% and 72% ees, respectively (Table 4.3, entries 4 
and 5). Importantly, L34 and L35 gave much less undesired bisarylation product 103.  
Table 4.3 Screening of phosphine ligands 
 
Entries Ligand Yield 102 (%) ee 102 (%) Yield 103 (%) 
1 L1 43 60 28 
2 L32 48 72 23 
3 L33 49 78 22 
4 L34 42 71 7.5 
5 L35 42 72 15 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
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4.3.5 Screening of temperatures  
Different temperatures varying from 25 °C to 60 °C were tested, and it was found that the 
reactions did not make any difference at 40 °C and 50 °C (Table 4.4, entries 3 and 4). 
However, lowering the temperature to 30 °C afforded slightly lower yield and decreased ee 
(Table 4.4, entry 2). Leaving the reaction at room temperature (25 °C) decreased both yield 
and ee (Table 4.4, entry 1). Increasing the temperature, on the other hand, resulted in a 
slightly lower yield but a significantly decreased ee (Table 4.4, entry 5). In this case, a 
demetallation of the starting material 100 was observed. 
Table 4.4 Screening of temperatures 
 
Entry T (°C) Yield 102 (%) ee 102 (%) Yield 103 (%) 
1 25 38 54 9 
2 30 44 64 13 
3 40 48 72 23 
4 50 47 72 25 
5 60 44 48 17 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
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4.3.6 Screening Pd and Ag sources 
Based upon the results in Table 4.5, Ag3PO4 and AgOPiv quenched the reaction (Table 4.5, 
entries 2 and 3). However, Ag2O afforded similar results to Ag2CO3 (Table 4.5, entry 4). In 
terms of Pd sources, Pd(II) such as Pd(OAc)2 and Pd(TFA)2 gave a slightly lower yield but 
significantly decreased ee (Table 4.5, entries 5 and 6). Pd2(dba)3·CHCl3 which is more stable 
compared to Pd(dba)2, was found to be compatible for this transformation, affording same 
results compared to Pd(dba)2 (Table 4.5, entry 7). 
Table 4.5 Screening of chiral ligands  
 
Entry [Pd] (mol %) [Ag] (equiv) 
Yield 102 
(%) 
ee 102 (%) 
Yield 103 
(%) 
1 Pd(dba)2 (5) Ag2CO3 (0.75) 43 60 28 
2 Pd(dba)2 (5) Ag3PO4 (0.5) 0 - 0 
3 Pd(dba)2 (5) AgOPiv (1.5) 0 - 0 
4 Pd(dba)2 (5) Ag2O (0.75) 45 62 33 
5 Pd(OAc)2 (5) Ag2CO3 (0.75) 39 49 10 
6 Pd(OCOCF3)2 (5) Ag2CO3 (0.75) 41 25 13 
7 Pd2(dba)3·CHCl3 (2.5) Ag2CO3 (0.75) 47 60 30 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
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4.3.7 Screening amounts of Pd and Ligands 
Different amounts of Pd and phosphine ligand were examined, and it was found that the 
lower loading of Pd and (S)-BINAP(O) caused lower yields to be obtained, whereas only a 
slightly lower ee was observed (Table 4.6, entries 1 and 2). However, when increased to 3 
mol % of Pd and (S)-BINAP(O), the reactions gave similar results to 5 mol % (Table 4.6, 
entries 3-5). The reaction used 1:2 ratio of Pd(dba)2 to (S)-BINAP(O) afforded same yield and 
ee of desired product 102 but significantly increased the bisarylation side-product 103 
(Table 4.6, entry 6).  
Table 4.6 Screening amounts of Pd and Ligand (1) 
 
Entry 
Pd(dba)2 
(mol %) 
S-BINAP(O) 
 (mol %) 
Yield 102 (%) ee 102 (%) Yield 103 (%) 
1 1.0 1.0 29 66 0 
2 2.0 2.0 35 61 8 
3 3.0 3.0 49 71 24 
4 4.0 4.0 50 73 35 
5 5.0 5.0 50 70 27 
6 2.5 5.0 47 72 41 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
Unlike (S)-BINAP(O), a significantly decreased yield and ee was obtained when only 1 mol % 
of Pd(dba)2 and (S)-BINAP were used in the reaction (Table 4.7, entry 1). Increasing amounts 
of Pd(dba)2 and (S)-BINAP to 2.5 mol % gave an improved 47% yield and 63% ee (Table 4.7, 
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entry 2), similar results were obtained when using 5 mol % of Pd(dba)2 and (S)-BINAP (Table 
4.7, entry 3). Interestingly, when the reaction used a 1:2 ratio of Pd(dba)2 to (S)-BINAP, an 
essentially racemic product 102 was obtained (Table 4.7, entry 4). 
Table 4.7 Screening amounts of Pd and Ligand (2) 
 
Entry 
Pd(dba)2 
(mol %) 
S-BINAP 
 (mol %) 
Yield 102 (%) ee 102 (%) Yield 103 (%) 
1 1.0 1.0 25 31 0 
2 2.5 2.5 47 63 19 
3 5.0 5.0 42 64 31 
4 5.0 10.0 46 4 13 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
4.3.8 Screening carboxylic acids 
Chiral carboxylic acids 
Based upon the proposed transition state described in Scheme 4.27, both phosphine ligand 
and the carboxylate could be the chirality-inducing components in this transformation. 
Thus, some selected chiral carboxylic acids were tested. It is easy to create 
matched/mismatched cases when using two chiral components of which both are ligated in 
close proximity to catalyst centre. In the case of C1, a low 7% ee was obtained when C1 was 
used in conjunction with R-BINAP (Table 4.8, entry 1). However, the ee increased to 14% 
when the opposite configuration ligand, S-BINAP was employed (Table 4.8, entry 2). A chiral 
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carboxylic acid C1 as a single chirality-inducing component by the use of rac-BINAP or simple 
PPh3 were also tested, affording 34% and 22% ee, respectively (Table 4.8, entries 3 and 4). 
To avoid this ‘mismatched’ combination, the chiral carboxylic acids C2 and C3 were tested in 
conjunction with both S- and R-BINAP, both affording enantioselectivity to some extent 
(Table 4.8, entries 5-9), suggesting that chiral carboxylic acid could be the chirality-inducing 
component in this transformation. Further efforts on the screening of chiral carboxylic acids 
are required to find the optimum one. 
Table 4.8 Screening of chiral carboxylic acids 
 
entries Phosphine (mol %) Acid (equiv) Yield 102 ee 102 Yield 103 
1a R-BINAP (3) C1 (0.25) 42 34 7 
2a S-BINAP (3) C1 (0.25) 39 20 14 
3a Rac-BINAP (3) C1 (0.25) 20 34 4.5 
4a PPh3 (3) C1 (0.25) 41 22 28 
5 S-BINAP (5) C2 (0.5) 41 30 12 
6 R-BINAP (5) C2 (0.5) 36 30 36 
7b Rac-BINAP (3) C3 (0.5) 21 16 5 
8b S-BINAP (3) C3 (0.5) 18 14 0 
9b R-BINAP (3) C3 (0.5) 21 16 0 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
a
 1.5 mol % of Pd2(dba)3·CHCl3 was used instead of 5 mol % of 
Pd(dba)2. 
b
 3 mol % of Pd(dba)2 was used. 
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Amount of carboxylic acids 
The effect of the amounts of dicyclohexylacetic acids was tested, and it was found that it 
made no difference with regard both reactivity and selectivity when the amounts of 
dicyclohexylacetic acids ranged from 0.10 equivalents to 0.75 equivalents were used (Table 
4.9, entries 1-4). Both yield and ee decreased slightly when further decreasing the amount 
of dicyclohexylacetic acid (Table 4.9, entry 5). Interestingly, there was still 38% of desired 
product obtained when no carboxylic acid was used, whereas no enantioselectivity was 
observed (Table 4.9, entry 6), suggesting that a carboxylic acid plays a crucial role to achieve 
enantioselective C–H functionalisation, probably due to the interaction between the chiral 
ligand and the carboxylic acid, inducing carboxylic acid assists enantioselective C–H 
activation. 
Table 4.9 Screening the amounts of carboxylic acids 
 
Entry Cy2CH2CO2H (equiv) Yield 102 (%) ee 102 (%) Yield 103 (%) 
1 0.750 50 71 27 
2 0.500 49 71 24 
3 0.250 49 73 29 
4 0.100 49 69 29 
5 0.066 43 63 39 
6 0.000 38 2 11 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
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4.3.9 Screening of amine bases 
It has been mentioned that TMP (2,2,6,6-tetramethylpiperidine) plays a crucial role to  
increase the reactivity. Differening amounts of TMP were firstly tested and it was found that 
the optimum amount was 2.0 equivalents (Table 4.10, entry 1-3). The reaction without 
adding TMP resulted in no reactivity (Table 4.10, entry 4). Screening of piperidine 
derivatives (B2-5) was then undertaken, and none of the amine additives gave good results 
(Table 4.10, entries 5-8), nor did the 2,6-dimethylpyridine B6, 1,10-phenanthroline B7 and 
1,4-DABCO B8 (Table 4.10, entries 9-11). A selection of chiral amine bases (B9-11) was 
tested. Similarly to the screening of chiral carboxylic acids, to avoid a ‘mismatched’ 
combination, all the chiral amine bases were tested in conjunction with both S- and R-
BINAP. However, only brucine B11 gave a compatible yield to TMP, but maximum 17% ee 
was obtained (Table 4.10, entry 16).  
Table 4.10 Screening of amine bases 
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Entry Phosphine (mol %) Amine (equiv) Yield 102 ee 102 Yield 103 
1 R-BINAP B1 (2.0) 42 64 31 
2 R-BINAP B1 (1.0) 14 22 0 
3 R-BINAP B1 (3.0) 41 56 14 
4 S-BINAP - 0 - 0 
5 R-BINAP B2 (2.0) 7 - 0 
6 R-BINAP B3 (2.0) 28 18 4 
7 R-BINAP B4 (2.0) 23 6 0 
8 R-BINAP B5 (2.0) 18 2 0 
9 R-BINAP B6 (2.0) 5 - 0 
10 R-BINAP B7 (2.0) 29 26 0 
11 R-BINAP B8 (2.0) 24 4 0 
12a S-BINAP B9 (2.0) 15 12 - 
13a R-BINAP B9 (2.0) 18 6 - 
14a S-BINAP B10 (2.0) 11 19 0 
15a R-BINAP B10 (2.0) 12 8 0 
16a S-BINAP B11 (2.0) 42 17 7 
17a R-BINAP B11 (2.0) 35 5 - 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC. 
a
 The reactions were performed at 40 °C. 
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4.3.10 Prolonged reaction 
A time profile for this reaction was shown in Table 4.11, the major enantiomer was assigned 
as S-102. From Figure 4.1, the amounts of S-102 increased dramatically at the beginning of 
the reaction and the rate of production decreased over time. The yield of R-102, however, 
increased during the first couple of hours and then slowly decreased. The amounts of 
bisarylated product 103, on the other hand, keep rising during the whole reaction time. 
Interestingly, the ee of 102 increased at a same rate to the increase in amounts of 
bisarylation product 103 throughout the reaction time. 
Table 4.11 Time profile 
 
Entry t (h) Yield 102 ee 102 Yield 103 
Yield 
 S-102 
Yield  
R-102 
1 0.5 5 48 0 3.7 1.3 
2 1.0 11 50 0.5 8.25 2.75 
3 2.0 23 48 2 17.02 5.98 
4 3.0 30 50 4.5 22.5 7.5 
5 4.0 36 52 7.5 27.36 8.64 
6 5.0 39 54 9.5 30.03 8.97 
7 7.0 41 58 11.5 32.39 8.61 
8 16.0 45 70 24 38.25 6.75 
0.1 mmol of 100 and 1.3 equiv of 101 were used in the reactions, yields were determined by 
1
H NMR using an 
internal standard, ees were determined by HPLC.  
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Figure 4.1 Reaction time profile 
An in situ kinetic resolution has been proposed to explain why the ee values keep increasing 
over time. Based upon the results in Table 4.11, a ratio 74:26 of S-102:S103 was obtained at 
the beginning of the reaction, which means our catalytic system is moderately selective for 
the activation of the C–HA bond (k1 > k2). Similarly, as the C–H
A bond is more reactive than 
the C–HB bond, the C–HB bond in S-102 is less reactive than the C–HA bond in R-102, 
consequently, the reaction from R-102 to 103 must be faster than the reaction from S-102 
to 103 (k3 > k4). Thus the formation of 103 would consume R-102 more than S-102, which 
leads to an increasing excess of S-102 to R-102 (Scheme 4.28). 
 
Scheme 4.28 In situ kinetic resolution proposal 
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Based upon these, it was thought that a higher ee would be obtained when leaving the 
reaction for a longer time. The best ligand, S-H8-BINAP(O) (L33), was chosen to test this 
assumption. To compensate for the consumption of the iodoarene via bisarylation, 2.0 
equivalents of methyl-4-iodo-benzoate 101 were used. As we predicted, the prolonged 
reaction under argon protection gave a similar yield of 102, and higher yield of bisarylation 
product 103, while the ee increases from 78% to 90% (Scheme 4.29). 
 
Scheme 4.29 Prolonged reaction 
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4.4 Conclusions and future work 
The construction of planar chiral complexes via an asymmetric C–H arylation on pro-chiral 
arene chromium substrates under very mild conditions has been explored. The ee value has 
been reached to 90% by extensive optimisation. However, only a moderate yield, 41% of 
desired planar chiral compound was obtained, concomitant with 45% of undesired achiral 
bisarylation product which can not be avoided under the current conditions. An 
investigation of the development of ees over time showed that the formation of achiral 
bisarylation product increases the ee of the remaining planar-chiral monoarylated product. 
Future work could focus on improving the yield of the desired monoarylation product. 
However, the point to reduce the bisarylation product is still to improve the selectivity of 
the catalytic system. The phosphine ligands containing carbonyl group (L34 and L35) have 
shown their potential in this enantioselective transformation, affording the same yield and 
ee of the monoarylation product but significantly decreaseing the undesired bisarylation 
product. Thus further efforts on designing and synthesising a set of this type of ligand by 
changing the substituents on the carbonyl group could be desirable.  
The carboxylic acid, on the other hand, is crucial to achieve enantioselective C–H 
functionalisation. A test of chiral carboxylic acid showed that the chiral carboxylic acid could 
also be the chirality-inducing component in this transformation. Thus, the development of 
chiral carboxylic acids, such as N-protected amino acids, as the ligands would also be 
explored in the future. 
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Chapter 5 
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Chapter 5 Experimental 
5.1 General experimental information 
All chemicals were purchased from commercial sources (Sigma Aldrich, Acros, Alfa Aesar, 
Strem, Fluorochem) and used without further purification unless otherwise stated. 
Anhydrous THF, PhMe, DCM, and Et2O were obtained from a Grubbs type solvent 
purification system. Analytical thin-layer chromatography was performed on pre-coated 
Merk silica gel F254 plates and visualized under a UV light. Melting points were obtained 
using a Bibby Stuart Scientific apparatus and are uncorrected. IR spectra were recorded 
using a Bruker Tensor 37 FTIR machine and are quoted in cm-1. 1H NMR spectra, recorded at 
400 MHz, are referenced to the residual solvent peak at 7.26 ppm (CDCl3) and 2.05 ppm 
(acetone-d6). 
13C NMR spectra, recorded at 101 MHz, are referenced to the residual solvent 
peak at 77.0 ppm (CDCl3) and 29.8 ppm (acetone-d6). HRMS were performed at the EPSRC 
National Mass Spectrometry Service Centre, Swansea. HPLC analysis was carried out on an 
Agilent1100 machine using Chiralcel IB or IC columns with a mixture of hexane and 
isopropanol as the eluent and a flow rate of 0.8 ml/min. Specific rotation was detected by 
Rudolph Research Analytical polarimeter. Calculated for specific rotation = 100a/lc {a = 
observed angle of rotation, l = length of cell in dm, c = weight of sample (gram) in 100 mL of 
solution}. Polarimeter cell part number: 14J-8.5-100-6.0-S/DT, length of cell is 1 dm. 
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5.2 Experimental procedures for the synthesis of salicylic acids - Chapter 2 
5.2.1 General procedures 
General procedure 1.  Carboxylation of phenols at atmospheric pressure 
In glovebox, to a vial containing phenol substrate (0.25 mmol) and 2,4,6-trimethylphenol (34 
mg, 0.25 mmol, 1.0 equiv) was added NaH (60% dispersion in mineral oil, 40 mg, 2.0 mmol, 
4.0 equiv), heating the mixture at 100 °C for 5 minutes. Then, the mixture was cooled down 
to room temperature and purged with CO2, and reacted under a balloon filled with CO2 at 
185 °C for 2 h. After this time, the reaction mixture was cooled to room temperature, 
quenched with 10 mL of H2O and acidified to the pH ~4 with concentrated HCl, and then 
extracted with EtOAc (3 x 10 mL). The organic layers were dried over anhydrous MgSO4, 
evaporated to dryness and purified by column chromatography (n-hexanes:EtOAc) to afford 
salicylic acids. 
General procedure 2. Carboxylation of phenols at 5 atm 
In glovebox, to a vial containing phenol substrate (0.5 mmol) and 2,4,6-trimethylphenol (68 
mg, 0.25 mmol, 1.0 equiv) was added NaH (60% dispersion in mineral oil, 80 mg, 2.0 mmol, 
4.0 equiv), heating the mixture at 100 °C for 5 minutes. Then, the mixture was cooled down 
to room temperature and purged with CO2, and reacted in the autoclave under 5 atm of CO2 
at 185 °C for 2 h. After this time, the reaction mixture was cooled to room temperature, 
quenched with 10 mL of H2O and acidified to the pH ~4 with concentrated HCl, and then 
extracted with EtOAc (3 x 10 mL). The organic layers were dried over anhydrous MgSO4, 
evaporated to dryness and purified by column chromatography (n-hexanes:EtOAc) to afford 
salicylic acids. 
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5.2.2 Characterisations of salicylic acid derivatives 
Salicylic acid (2) 
Following general procedure 1 with phenol (23.5 mg. 0.25 mmol) to 
obtain 2 as a white solid (22.0 mg, 64%). 1H NMR (400 MHz, acetone-d6) 
δ 11.37 (bs, 1H), 7.91-7.89 (m, 1H), 7.56-7.52 (m, 1H), 6.97-6.93 (m, 2H) 
ppm. 13C NMR (101 MHz, acetone-d6) δ 172.8, 163.2, 137.0, 131.4, 120.2, 
118.3, 113.3 ppm. These data are consistent with those previously reported.161 
2-Hydroxy-3-methylbenzoic acid (6) 
Following general procedure 1 with o-cresol (27.0 mg, 0.25 mmol) to 
obtain 6 as a white solid  (29.1 mg, 77%). 1H NMR (400 MHz, acetone-
d6) δ 11.91 (bs, 1H), 11.38 (bs, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.40 (d, J = 
7.6 Hz, 1H), 6.84 (app. t, J = 7.6 Hz, 1H), 2.22 (s, 3H) ppm. 13C NMR 
(101 MHz, acetone-d6) δ 173.3, 161.5, 137.6, 128.9, 127.2, 119.5, 112.5, 15.7 ppm. These 
data are consistent with those previously reported.41 
2-Hydroxy-4-methylbenzoic acid (17) 
Following general procedure 1 with m-cresol (27.0 
mg, 0.25 mmol) to obtain 17 (major:minor = 85:15) 
as white solid as a white solid (33.3 mg, 88%). 1H 
NMR (400 MHz, acetone-d6) δ 7.76 (d, J = 8.1 Hz, 
1H) (major), 7.32 (dd, J = 8.2, 7.6 Hz, 0.13H) (minor), 6.79-6.75 (m, 2.26H) (major + 
minor), 2.58 (s, 0.35H) (minor), 2.33 (s, 3H) (major) ppm. 
13
C NMR (101 MHz, acetone-d6) 
Major:δ 172.7, 163.1, 148.0, 131.1, 121.1, 118.2, 110.5, 21.7 ppm. Minor: δ 174.1, 164.2, 
142.5, 135.1, 123.4, 116.1, 113.1, 23.9 ppm. These data are consistent with those previously 
reported.161, 162 
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2-Hydroxy-4-methylbenzoic acid (18) 
Following general procedure 1 with p-cresol (27.0 mg, 0.25 mmol) to 
obtain 18 as a white solid (27.6 mg, 73%). 1H NMR (400 MHz, acetone-
d6) δ 7.69 (d, J = 2.3 Hz, 1H), 7.35 (dd, J = 8.5, 2.3 Hz, 1H), 6.85 (d, J = 
8.5 Hz, 1H), 2.28 (s, 3H) ppm. 
13
C NMR (101 MHz, acetone-d6) δ 171.8, 
160.1, 136.8, 130.0, 128.2, 117.0, 111.8, 19.4 ppm. These data are consistent with those 
previously reported.161 
2-hydroxy-3,4-dimethylbenzoic acid (19) 
Following general procedure 1 with 2,3-dimethyphenol (30.5 mg, 0.25 
mmol) to obtain 19 as a white solid (37.3 mg, 90%). mp: 192-193 °C. 
IR: 2914.7, 1640.8, 1620.4, 1456.1, 1245.3, 1090.0, 774.6, 686.2, 
619.7 cm-1. 1H NMR (400 MHz, acetone-d6) δ 11.77 (bs, 1H), 11.44 (bs, 
1H), 7.64 (d, J = 8.0 Hz, 1H), 6.76 (d, J = 8.0 Hz, 1H), 2.30 (s, 3H), 2.15 (s, 3H) ppm. 13C NMR 
(101 MHz, acetone-d6) δ 173.4, 161.2, 146.2, 128.1, 125.2, 121.5, 110.3, 20.7, 11.3 ppm. 
HRMS: calcd for C9H10O3, 166.0624 (M); found, 166.0625. 
2-Hydroxy-3,5-dimethylbenzoic acid (20) 
Following general procedure 1 with 2,4-dimethyphenol (30.5 mg, 0.25 
mmol) to obtain 20 as a white solid (31.6 mg, 76%). mp: 181-182 °C. 
IR: 2920.1, 1655.5, 1452.4, 1290.7, 1221.7, 794.8, 546.1 cm-1. 1H NMR 
(400 MHz, acetone-d6) δ 11.81 (bs, 1H), 11.16 (s, 1H), 7.53 (s, 1H), 
7.23 (s, 1H), 2.24 (s, 3H), 2.18 (s, 3H) ppm. 13C NMR (101 MHz, acetone-d6) δ 173.3, 159.7, 
138.7, 128.5, 128.5, 127.0, 112.2, 20.5, 15.7 ppm. HRMS: calcd for C9H10O3, 166.0624 (M); 
found, 166.0624. 
2-Hydroxy-4,6-dimethylbenzoic acid (21) 
Following general procedure 1 with 3,5-dimethyphenol (30.5 mg, 0.25 
mmol) to obtain 21 as a white solid (15.2 mg, 37%). mp: 166-167 °C. 
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IR: 2923.5, 1641.3, 1619.7, 1543.8, 1257.4, 1200.0, 916.7, 840.7, 793.0, 763.1, 611.8, 574.1 
cm-1. 1H NMR (400 MHz, acetone-d6) δ 11.96 (bs, 1H), 11.68 (s, 1H), 6.62 (s, 1H), 6.61 (s, 1H), 
2.55 (s, 3H), 2.26 (s, 3H) ppm. 13C NMR (101 MHz, acetone-d6) δ 174.3, 164.8, 146.4, 142.6, 
124.9, 116.5, 110.4, 24.1, 21.6 ppm. HRMS: calcd for C9H11O3, 167.0708 (M+H
+); found, 
167.0702. 
2-Hydroxy-3-ethylbenzoic acid (22) 
Following general procedure 1 with 2-ethylphenol (30.5 mg, 0.25 
mmol) to obtain 22 as a white solid (31.6 mg, 76%). mp: 112-113 °C. 
IR: 2936.6, 1659.7, 1610.9, 1297.1, 1242.5, 1162.7, 884.6, 759.8, 
698.9 cm-1.  1H NMR (400 MHz, acetone-d6) δ 11.49 (bs, 1H), 7.76 (d, J 
= 8.0 Hz, 1H), 7.42 (d, J = 7.2 Hz, 1H), 6.87 (app. t, J = 7.6 Hz, 1H), 2.67 (q, J = 7.6 Hz, 2H), 
1.20 (t, J = 7.6 Hz, 3H) ppm. 13C NMR (101 MHz, acetone-d6) δ 173.4, 161.2, 136.1, 133.2, 
129.0, 119.7, 112.7, 23.5, 14.4 ppm. HRMS: calcd for C9H10O3, 166.0624 (M); found, 
166.0619. 
4-(tert-Butyl)-2-hydroxybenzoic acid (23) 
Following general procedure 1 with 3-tert-butylphenol (37.6 mg, 0.25 
mmol) to obtain 23 as a white solid (42.7 mg, 88%). mp: 139-140 °C. 
IR: 2960.9, 1655.6, 1616.5, 1445.1, 1199.0, 940.8, 787.7, 653.0, 604.1 
cm-1.  1H NMR (400 MHz, acetone-d6) δ 11.14 (bs, 1H), 7.81 (d, J = 8.4 
Hz, 1H), 7.01 (d, J = 8.4 Hz, 1H), 6.95 (s, 1H), 1.32 (s, 9H) ppm. 13C NMR (101 MHz, acetone-
d6) δ 172.7, 163.1, 161.1, 131.0, 117.7, 114.9, 110.7, 35.9, 31.3 ppm. HRMS: calcd for 
C11H14O3, 194.0937 (M); found, 167.0932. 
2-Hydroxy-4-methoxybenzoic acid (24) 
Following general procedure 1 with 3-methoxyphenol (31.0 mg, 0.25 
mmol) to obtain 24 as a white solid (33.5 mg, 80%). 1H NMR (400 
MHz, acetone-d6) δ 7.79 (d, J = 8.8 Hz, 1H), 6.50 (dd, J = 8.8 Hz, J = 
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2.5 Hz, 1H), 6.45 (d, J = 2.5 Hz, 1H), 3.85 (s, 3H) ppm. 13C NMR (101 MHz, acetone-d6) δ 
172.6, 167.0, 165.4, 132.7, 108.1, 106.1, 101.6, 56.1 ppm. These data are consistent with 
those previously reported.161 
4-(Dimethylamino)-2-hydroxybenzoic acid (25) 
Following general procedure 1 with 3-(dimethylamino)phenol (34.3 
mg, 0.25 mmol) to obtain 25 as a pink solid (28.0 mg, 62%). mp: 134-
135 °C. IR: 2917.8, 2567.8, 1644.2, 1563.8, 1445.0, 1310.9, 1178.8, 
894.8, 763.8, 687.4 cm-1.  1H NMR (400 MHz, acetone-d6) δ 11.22 (bs, 
1H), 7.66 (d, J = 9.2 Hz, 1H), 6.31 (dd, J = 9.2 Hz, 2.4 Hz, 1H), 6.09 (d, J = 2.4 Hz, 1H), 
3.04 (s, 6H) ppm. 
13
C NMR (101 MHz, acetone-d6) δ 172.8, 164.8, 156.9, 132.2, 104.9, 
101.0, 98.3, 40.0 ppm. HRMS: calcd for C9H12O3N, 182.0812 (M+H
+); found, 182.0812. 
1-Hydroxy-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (26) 
Following general procedure 1 with 5,6,7,8-tetrahydro-1-naphthol 
(37.1 mg, 0.25 mmol) to obtain 26 as a white solid (43.7 mg, 91%). 
mp: 164-165 °C. IR: 2933.7, 2858.8, 1654.8, 1620.1, 1454.3, 1252.7, 
888.9, 770.8 cm-1. 1H NMR (400 MHz, acetone-d6) δ 11.73 (bs, 1H), 
11.43 (s, 1H), 7.61 (d, J = 8.0 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 2.76-2.74 (m, 2H), 2.65-2.62 (m, 
2H), 1.77-1.75 (m, 4H) ppm. 13C NMR (101 MHz, acetone-d6) δ 173.2, 161.3, 146.5, 127.4, 
126.1, 120.6, 109.5, 30.6, 23.2, 23.1, 23.1 ppm. HRMS: calcd for C11H12O3, 192.0781 (M); 
found, 192.0779. 
6-hydroxybenzo[d][1,3]dioxole-5-carboxylic acid (27) 
Following general procedure 1 with sesamol (34.5 mg, 0.25 mmol) to 
obtain 27 as a white solid (34.0 mg, 75%). mp: 208-209 °C. IR: 2928.1, 
1638.9, 1614.0, 1440.4, 1195.6, 1125.1, 1037.1, 931.5, 855.3, 693.1 
cm-1. 1H NMR (400 MHz, acetone-d6) δ 11.42 (bs, 1H), 7.20 (s, 1H), 
6.46 (s, 1H), 6.05 (s, 2H) ppm. 13C NMR (101 MHz, acetone-d6) δ 172.7, 161.7, 155.2, 141.7, 
107.8, 104.5, 103.1, 98.8 ppm. HRMS: calcd for C8H6O5, 182.0210 (M); found, 182.0208. 
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6-Hydroxy-2,3-dihydro-1H-indene-5-carboxylic acid (28) 
Following general procedure 1 with 5-indanol 
(33.5 mg, 0.25 mmol) to obtain 28 (major:minor = 
79:21) as a white solid (41.0 mg, 92%). 1H NMR 
(400 MHz, CDCl3) δ 10.69 (s, 0.26H) (minor), 10.39 
(s, 1H) (major), 7.73 (s, 1H) (major), 7.35 (d, J = 8.3 Hz, 0.27H) (minor), 6.87 (s, 1H) (major), 
6.82 (d, J = 8.3 Hz, 0.26H) (minor), 3.27 (t, J = 7.5 Hz, 0.57H) (minor), 2.93-2.84 (m, 4.57H) 
(major + minor), 2.13-2.05 (m, 2.53H) (major + minor) ppm. 13C NMR (101 MHz, CDCl3) 
major + minor: δ 176.3, 175.6, 161.9, 161.6, 155.5, 148.2, 136.2, 135.7, 132.3, 125.7, 115.8, 
113.4, 109.1, 108.9, 35.7, 33.7, 32.1, 31.7, 25.8, 25.2 ppm. These data are consistent with 
those previously reported.41 
3-Chloro-2-hydroxybenzoic acid (29) 
Following general procedure 2 with 2-chlorophenol (64.3 mg, 0.50 
mmol) to obtain 29 as a white solid (47.3 mg, 55%). 1H NMR (500 
MHz, acetone-d6):  ppm 7.88 (d, J = 8.0 Hz, 1H), 7.65 (d, J = 8.0 Hz, 
1H), 6.97 (t, J = 8.0 Hz, 1H); 13C NMR (126 MHz, acetone-d6):  172.6, 
158.8, 136.8, 130.1, 122.5, 120.4, 115.0 ppm. These data are consistent with those 
previously reported. 41 
4-Chloro-2-hydroxybenzoic acid (30) 
Following general procedure 2 with 3-chlorophenol (64.3 mg, 0.50 
mmol) to obtain 30 as a white solid (58.3 mg, 68%). 1H NMR (400 
MHz, acetone-d6) δ 7.90 (d, J = 8.5 Hz, 1H), 7.01 (d, J = 1.9 Hz, 1H), 
6.98 (dd, J = 8.5, 1.9 Hz, 1H). 13C NMR (100 MHz, acetone-d6): δ 
172.2, 163.8, 141.8, 132.8, 120.6, 118.1, 112.4 ppm. These data are consistent with those 
previously reported.161 
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5-chloro-2-hydroxybenzoic acid (31) 
Following general procedure 2 with 4-chlorophenol (64.3 mg, 0.50 mmol) 
to obtain 31 as a white solid (49.3 mg, 57%). 1H NMR (400 MHz, acetone-
d6) δ 7.72 (d, J = 2.4 Hz, 1H), 7.41 (dd, J = 8.8 Hz, 2.8 Hz, 1H), 6.87 (d, J = 
8.8 Hz, 1H) ppm. 13C NMR (101 MHz, acetone-d6) δ 171.6, 161.7, 136.5, 
130.3, 124.1, 120.1, 114.5 ppm. These data are consistent with those previously reported. 
161 
4-Bromo-2-hydroxybenzoic acid (32) 
Following general procedure 2 with 3-bromophenol (86.5 mg, 0.50 
mmol) to obtain 32 as a white solid (72.7 mg, 67%). 1H NMR (400 
MHz, acetone-d6) δ 7.73 (d, J = 8.8 Hz, 1H), 7.09 (d, J = 2.0 Hz, 1H), 
7.05 (dd, J = 8.4 Hz, 2.0 Hz, 1H) ppm. 13C NMR (101 MHz, acetone-d6) 
δ 172.20, 163.52, 132.71, 130.19, 123.45, 121.11, 112.58 ppm. These data are consistent 
with those previously reported.163 
Follow general procedure 2 with estrone (135.2 mg, 0.50 
mmol) to obtain 34 as a white solid (49.8 mg, 51%). 1H NMR 
(400 MHz, acetone-d6) δ 10.80 (s, 1H), 7.81 (s, 1H), 6.68 (s, 
1H), 2.94-2.90 (m, 2H), 2.48-2.39 (m, 2H), 2.29-2.20 (m, 1H), 
2.13-2.07 (m, 2H), 1.90-1.86 (m, 1H), 1.710-1.40 (m, 7H), 0.91 (s, 3H). 13C NMR (101 MHz, 
acetone-d6) δ 219.3, 172.7, 160.8, 147.1, 132.3, 127.8, 117.5, 110.8, 51.1, 48.4, 44.5, 39.0, 
36.1, 32.5, 30.3, 26.9, 26.6, 22.1, 14.1 ppm. These data are consistent with those previously 
reported. 41 
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5.3 Experimental procedures for the synthesis of m-arylphenols 
5.3.1 Tandem arylation/decarboxylation of salicylic acids - Chapter 3.2 
General Procedure 3 To a vial containing salicylic acid derivative (0.50 mmol), PEPPSI-IPr 
catalyst (6.8 mg, 0.010 mmol), Ag2CO3 (69.0 mg, 0.25 mmol), K2CO3 (25.0 mg, 0.18 mmol), 
and aryl iodide (1.5 mmol, 3.0 equiv) was added AcOH (500 µL). The mixture was stirred at 
150 °C for 16 h. After this time, the reaction mixture was cooled down and filtered through a 
small plug of Celite® with EtOAc (4 × 5 mL). The filtrate was evaporated to dryness and 
purified by column chromatography using hexanes:EtOAc (gradient from 100:0 to 90:10) as 
the eluent.  
General Procedure 4 To a vial containing salicylic acid derivative (0.50 mmol), PEPPSI-IPr 
catalyst (2.3 mg, 3.3 μmol), Ag2CO3 (11.5 mg, 83 μmol), K2CO3 (25.0 mg, 0.18 mmol), and 
aryl iodide (0.167 mmol) was added AcOH (500 µL). The mixture was stirred at 130 °C for 16 
h. After this time, the reaction mixture was cooled down and filtered through a small plug of 
Celite® with EtOAc (4 × 5 mL). The filtrate was evaporated to dryness and purified by column 
chromatography using hexanes:EtOAc (gradient from 100:0 to 90:10) as the eluent. 
5.3.2 Ag-free arylation of salicylic acids - Chapter 3.2 
General Procedure 5 To a mixture of Pd(OAc)2 (5.6 mg, 25 μmol), salicylic acid derivative 
(0.50 mmol), Me4NCl  (68.5 mg, 0.63 mmol), KOAc (98.0 mg, 1.0 mmol) and 1-iodo-3,5-
dimethylbenzene (218 µL, 1.5 mmol) was added AcOH (43 µL, 0.75 mmol). The mixture was 
was stirred at 120 °C for 24 h. Then, the mixture was cooled down to room temperature, 
extra Me4NCl (44.0 mg, 0.4 mmol) and KOAc (39.0 mg, 0.4 mmol) were added into the 
mixture and heated at 120 °C for extra 16 h. After this time, the reaction mixture was 
filtered through a plug of Celite® with EtOAc (4 × 5 mL). The filtrate was evaporated to 
dryness. The crude product was purified by column chromatography. 
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5.3.3 One-pot meta-selective arylation of phenols - Chapter 3.3 
General Procedure 6 To a mixture of the phenol substrate (0.50 mmol) and KOH (33.3 mg, 
0.50 mmol) was added PhCH3 (1.0 mL), the mixture was stirred at 50 °C for 10 min. After this 
time, PhCH3 was removed in a stream of argon, the reaction flask was purged with CO2, 
followed by stirring in an autoclave under 25 atm of CO2 at 190 °C for 2 h. The reaction 
mixture was then cooled down to room temperature, and PEPPSI-IPr (2.3 mg, 3.3 μmol), 
Ag2CO3 (11.5 mg, 83 μmol), the iodoarene (0.167 mmol) and AcOH (400 µL) were added. 
The resulting slurry was heated at 130 °C for 16 h. After this time, the reaction mixture was 
filtered through a plug of Celite with EtOAc (3 × 5 mL). The filtrate was evaporated to 
dryness and purified by column chromatography. 
General Procedure 7 To a mixture of the phenol substrate (0.50 mmol) and KOH (33.3 mg, 
0.5 mmol) was added PhCH3 (1.0 mL), the mixture was stirred at 50 °C for 10 min. After this 
time, PhCH3 was removed in a stream of argon, the reaction flask was purged with CO2, 
followed by stirring in an autoclave under 25 atm of CO2 at 190 °C for 2 h. The reaction 
mixture was then cooled down to room temperature, and Pd(OAc)2 (0.7 mg, 3.3 μmol), 
Ag2CO3 (11.5 mg, 83 μmol), the iodoarene (0.167 mmol) and AcOH (400 uL) were added. The 
resulting slurry was heated at 130 °C for 16 h. Then, a second addition of Pd(OAc)2 (0.7 mg, 
3.3 μmol) was added, heating the mixture at 130 °C for another 24 h. After this time, the 
reaction mixture was filtered through a plug of Celite with EtOAc (3 × 5 mL). The filtrate was 
evaporated to dryness and purified by column chromatography. 
5.3.4 Tandem oxidation/arylation/decarboxylation of salicylaldehydes - Chapter 
3.4 
General Procedure 8 To a mixture of PEPPSI-IPr (8.5 mg, 13 μmol), Ag2CO3 (69.0 mg, 0.25 
mmol), K2CO3 (69.0 mg, 0.50 mmol), salicylaldehyde (0.25 mmol) and iodoarene (0.75 mmol) 
was added AcOH (500 µL). The mixture was stirred at 150 °C for 16 h. After this time, the 
reaction mixture was cooled down to room temperature and filtered through a plug of 
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Celite® with EtOAc (4 × 5 mL). The filtrate was evaporated to dryness. The crude product 
was purified by column chromatography. 
General Procedure 9 To a mixture of PEPPSI-IPr (6.8 mg, 10 μmol), Ag2CO3 (55.0 mg, 0.20 
mmol), K2CO3 (55.0 mg, 0.40 mmol), salicylaldehyde (0.20 mmol) and iodoarene (0.60 mmol) 
was added AcOH (500 µL). The mixture was stirred at 150 °C for 16 h. After this time, the 
mixture was cooled down to room temperature and filtered through a plug of Celite® with 
EtOAc (4 × 5 mL). The filtrate was evaporated to dryness. The crude product was purified by 
column chromatography. 
5.3.5 Characterisation of meta-arylphenols 
3',5'-Dimethyl-[1,1'-biphenyl]-3-ol (37) 
Following general procedure 3 to obtain 37 as a light orange oil 
(80.0 mg, 81%). The reaction following general procedure 5 
afforded 37 in 60% yields (59.5 mg). The reaction following 
general procedure 6 afforded 37 in 65% yields (21.5 mg). The 
reaction following general procedure 8 afforded 37 in 60% yields (29.7 mg). IR: 3327, 2916, 
1582, 1178, 846, 780 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.29 (t, J = 7.9 Hz, 1H), 7.20 (s, 2H), 
7.17-7.15 (m, 1H), 7.07-7.05 (m, 1H), 7.01 (s, 1H), 6.80 (ddd, J = 8.0, 2.6, 0.9 Hz, 1H), 4.76 (s, 
1H), 2.38 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.7, 143.3, 140.8, 138.3, 129.9, 129.1, 
125.1, 119.9, 114.1, 114.0, 21.4 ppm. HRMS: calcd for C14H15O, 199.1123 (M+H
+); found, 
199.1117. 
4-Fluoro-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (38) 
Following general procedure 3 but with 1.0 mL of AcOH and 
heated at 160 °C to obtain 38 as a yellow oil (81.1 mg, 75%). The 
reaction following general procedure 7 afforded 38 in 68% yields 
(24.6 mg). The reaction following general procedure 8 afforded 38 
in 60% yields (32.2 mg). IR: 3372, 2917, 1598, 1262, 769 cm-1. 1H NMR (400 MHz, CDCl3) δ 
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7.22 (dd, J = 8.5, 2.2 Hz, 1H), 7.15 (s, 2H), 7.14-7.09 (m, 1H), 7.06-7.04 (m, 1H), 6.99 (s, 1H), 
5.17 (s, 1H), 2.37 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 150.6 (d, J = 237.4 Hz), 143.5 (d, J 
= 14.6 Hz), 140.1, 138.7 (d, J = 3.6 Hz), 138.3, 129.1, 125.0, 119.5 (d, J = 6.4 Hz), 116.0 (d, J = 
1.8 Hz), 115.5 (d, J = 18.3 Hz), 21.4 ppm. HRMS: calcd for C14H14FO, 217.1029 (M+H
+); found, 
217.1021. 
3',4,5'-Trimethyl-[1,1'-biphenyl]-3-ol (39) 
Following general procedure 3 but with 1.0 mL of AcOH and 
without adding K2CO3 to obtain 39 as an orange oil (75.3 mg, 
71%). The reaction following general procedure 5 afforded 39 in 
56% yields (59.0 mg). The reaction following general procedure 7 
afforded 39 in 49% yields (17.3 mg). The reaction following the general procedure 9 
afforded 39 in 42% yields (17.9 mg). IR: 3409, 2917, 1578, 1119, 808 cm-1. 1H NMR (400 
MHz, CDCl3) δ 7.18-7.16 (m, 3H), 7.08 (dd, J = 7.7, 1.7 Hz, 1H), 7.01-7.00 (m, 1H), 6.98 (s, 1H), 
4.69 (s, 1H), 2.37 (s, 6H), 2.29 (s, 3 H) ppm. 13C NMR (101 MHz, CDCl3) δ 153.9, 140.8, 140.8, 
138.2, 131.2, 128.8, 124.9, 122.5, 119.6, 113.7, 21.4, 15.4 ppm. HRMS: calcd for C15H17O, 
213.1279 (M+H+); found, 213.1275. 
3',5'-dimethyl-5-nitro-[1,1'-biphenyl]-3-ol (40) 
Following general procedure 3 to obtain 40 as a yellow solid (63.2 
mg, 52%). mp: 147-148 °C. IR: 3424, 3092, 1591, 1343, 745 cm-1. 
1H NMR (400 MHz, CDCl3) δ 8.03 (dd, J = 2.0, 1.6 Hz, 1H), 7.64 
(app. t, J = 2.2 Hz, 1H), 7.38 (dd, J = 2.4, 1.5 Hz, 1H), 7.21 (s, 2H), 
7.07(s, 1H), 5.36 (s, 1H), 2.40 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.3, 149.5, 144.5, 
138.8, 138.4, 130.3, 125.0, 120.3, 114.8, 108.9, 21.4 ppm. HRMS: calcd for C14H13NO3, 
243.0895 (M+); found, 243.0890. 
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3',5'-dimethyl-5-(trifluoromethyl)-[1,1'-biphenyl]-3-ol (41) 
Following general procedure 3 to obtain 41 as a brownish red oil 
(89.0 mg, 67%). IR: 3350, 2918, 1599, 1120, 699 cm-1. 1H NMR 
(400 MHz, CDCl3) δ 7.40-7.39 (m, 1H), 7.21-7.20 (m, 1H), 7.18 (s, 
2H), 7.04 (s, 2H), 5.08 (s, 1H), 2.39 (s, 6H) ppm. 13C NMR (101 
MHz, CDCl3) δ 156.0, 144.2, 139.4, 138.6, 132.3 (q, J = 32.3 Hz), 129.8, 123.9 (q, J = 272.4 
Hz), 125.0, 117.4, 116.6 (q, J = 3.9 Hz), 110.9 (q, J = 3.8 Hz), 21.3 ppm. HRMS: calcd for 
C15H13F3O, 266.0918 (M
+); found, 266.0913. 
5-fluoro-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (42) 
Following general procedure 3 to obtain 42 as a brownish orange 
solid (73.1 mg, 68%). The reaction following general procedure 8 
afforded 42 in 50% yields (27.1 mg). mp: 95-96 °C. IR: 3375, 2917, 
1620, 1126, 840cm-1. 1H NMR (400 MHz, CDCl3) δ 7.16-7.15 (m, 
2H), 7.02-7.01 (m, 1H), 6.87 (ddd, J = 9.8, 2.3, 1.5 Hz, 1H), 6.83-6.82 (m, 1H), 6.54 (dt, J = 9.8, 
2.3 Hz, 1H), 4.90 (s, 1H), 2.37 (s, 6H) ppm. 13C NMR(101 MHz, CDCl3) δ 163.8 (d, J = 244.9 
Hz), 156.8 (d, J = 12.0 Hz), 144.6 (d, J = 9.8 Hz), 139.7 (d, J = 2.6 Hz), 138.4, 129.7, 124.9, 
109.9 (d, J = 2.7 Hz), 106.7 (d, J = 22.3 Hz), 101.8 (d, J = 24.9 Hz), 21.4 ppm. HRMS: calcd for 
C14H13FO, 216.0959 (M
+); found, 216.0945. 
5-Chloro-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (43) 
 
Following general procedure 3 but without adding K2CO3 and 
heated at 160 °C to obtain 43 as a light orange solid (73.3 mg, 
63%). The reaction following general procedure 7 afforded 43 in 
69% yields (26.7 mg). The reaction following general procedure 8 
afforded 43 in 52% yields (30.0 mg). mp: 85-87 °C. IR: 3219, 2916, 1573, 832, 679 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 7.15-7.14 (m, 3H), 7.02 (s, 1H), 6.93-6.92 (m, 1H), 6.82-6.81 (m, 
1H), 4.84 (s, 1H), 2.37 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.3, 144.4, 139.5, 138.4, 
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135.1, 129.7, 124.9, 120.1, 114.4, 112.6, 21.3 ppm. HRMS: calcd for C14H13
35ClO, 232.0655 
(M+); found, 232.0649. 
5-Bromo-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (44) 
Following general procedure 3 to obtain 44 as a light yellow solid 
(92.5 mg, 67%). The reaction following general procedure 6 
afforded 44 in 60% yields (27.6 mg). The reaction following 
general procedure 8 afforded 44 in 50% yields (34.6 mg). mp: 93-
94 °C. IR: 3206, 2915, 1568, 830, 678 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.30 (app. t, J = 1.6 
Hz, 1H), 7.15 (s, 2H), 7.02 (s, 1H), 6.97 (app. p, J = 2.3 Hz, 2H), 4.83 (s, 1H), 2.37 (s, 6H) ppm. 
13C NMR (101 MHz, CDCl3) δ 156.4, 144.7, 139.4, 138.4, 129.7, 125.0, 123.0 (CH+C), 117.3, 
113.1, 21.4 ppm. HRMS: calcd for C14H14
79BrO, 277.0228 (M+H+); found, 277.0225. 
3',5,5'-trimethyl-[1,1'-biphenyl]-3-ol (45) 
Following general procedure 3 to obtain 45 as a light orange solid 
(75.2 mg, 71%). The reaction following general procedure 5 
afforded 45 in 70% yields (74.0 mg). The reaction following 
general procedure 7 afforded 45 in 75% yields (26.5 mg). The 
reaction following general procedure 8 afforded 45 in 52% yields (27.7 mg). mp: 93-95 °C. 
IR: 3227, 2916, 1589, 1336, 837 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.18 (s, 2H), 6.99-6.97 (m, 
2H), 6.85-6.84 (m, 1H), 6.63 (s, 1H), 4.66 (s, 1H), 2.37 (s, 6H), 2.36 (s, 3H) ppm. 13C NMR (101 
MHz, CDCl3) δ 155.7, 143.1, 140.9, 139.9, 138.2, 129.0, 125.0, 120.8, 114.8, 111.3, 21.44, 
21.37 ppm. HRMS: calcd for C15H17O, 213.1279 (M+H
+); found, 213.1275. 
N-(5-hydroxy-3',5'-dimethyl-[1,1'-biphenyl]-3-yl)acetamide (46) 
Following general procedure 3 but without adding K2CO3 to 
obtain 46 as a light brown solid (52 mg, 41%). mp: 238-240 °C. IR: 
3355, 3098, 1746, 1626, 1656, 1592, 1552, 1268, 695 cm-1. 1H 
NMR (400 MHz, acetone-d6) δ 9.09 (s, 1H), 8.35 (s, 1H), 7.37 (s, 
1H), 7.28 (s, 1H), 7.17 (s, 2H), 6.98 (s, 1H), 6.80-6.78 (m, 1H), 2.33 (s, 6H), 2.09 (s, 3H). 13C 
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NMR (101 MHz, acetone-d6) δ 168.9, 158.9, 143.7, 141.9, 141.9, 138.9, 129.8, 125.5, 109.9, 
109.7, 106.1, 24.4, 21.4. HRMS: calcd for C16H17NO2, 255.1259 (M
+); found, 255.1254. 
5-Methoxy-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (47) 
Following general procedure 3 but without adding K2CO3 to 
obtain 47 as a brownish orange oil (25.0 mg, 22%). The reaction 
following general procedure 6 afforded 47 in 25% yields (9.5 mg). 
The reaction following general procedure 8 afforded 47 in 21% 
yields (11.8 mg). IR: 3387, 2917, 1702, 1588, 1147, 834, 690 cm-1. 1H NMR (400 MHz, CDCl3) 
δ 7.17 (s, 2H), 7.00 (s, 1H), 6.71-6.70 (m, 1H), 6.65-6.64 (m, 1H), 6.39 (app. t, J = 2.3 Hz, 1H), 
4.83 (s, 1H), 3.84 (s, 3H), 2.37 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 161.1, 156.8, 144.1, 
140.8, 138.2, 129.3, 125.0, 106.9, 105.7, 100.3, 55.4, 21.4. HRMS: calcd for C15H17O2, 
229.1229 (M+H+); found, 229.1224. 
6-fluoro-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (50) 
Following general procedure 3 to obtain 50 as an orange solid 
(58.0 mg, 53%). mp: 53-54 °C. IR: 3352, 2916, 1420, 1204, 765 cm-
1. 1H NMR (400 MHz, CDCl3) δ 7.15 (s, 2H), 7.03-6.98 (m, 2H), 6.89-
6.86 (m, 1H), 6.76-6.72 (m, 1H), 4.70 (s, 1H), 2.37 (s, 6H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 154.4 (d, J = 239.9 Hz), 151.6 (d, J = 2.3 Hz), 138.1, 135.6 (d, J = 1.4 
Hz), 130.3 (d, J = 15.5 Hz), 129.7, 126.9 (d, J = 2.9 Hz), 117.1 (d, J = 3.5 Hz), 116.9 (d, J = 25.1 
Hz), 115.1 (d, J = 8.1 Hz), 21.5 ppm. HRMS: calcd for C14H13FO, 216.0950 (M
+); found, 
216.0945. 
4'-Nitro-[1,1'-biphenyl]-3-ol (51) 
Following general procedure 3 to obtain 51 as a yellow solid 
(64.5 mg, 60%). The reaction following general procedure 6 
afforded 51 in 54% yields (19.4 mg). mp: 194-196 °C. IR: 3409, 
3091, 1581, 785 cm-1. 1H NMR (400 MHz, acetone-d6) δ 8.61 (s, 
1H), 8.36-8.32 (m, 2H), 7.94-7.91 (m, 2H), 7.38 (t, J = 7.9 Hz, 1H), 7.27-7.23 (m, 2H), 6.98 
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(ddd, J = 8.1, 2.4, 0.9 Hz, 1H) ppm. 13C NMR (101 MHz, acetone-d6) δ 159.0, 148.3, 148.1, 
141.0, 131.2, 128.7, 124.8, 119.5, 116.8, 115.0 ppm. HRMS: calcd for C12H10NO3, 216.0661 
(M+H+); found, 216.0657. 
4'-(trifluoromethyl)-[1,1'-biphenyl]-3-ol (52) 
Following general procedure 3 to obtain 52 as a pale yellow 
solid (79.5 mg, 67%). The reaction following general procedure 
8 afforded 52 in 51% yields (30.2 mg). mp: 73-75 °C. IR: 3261, 
1573, 1322, 840 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.73-7.68 
(m, 4H), 7.37 (t, J = 7.9 Hz, 1H), 7.21 (ddd, J = 7.7, 1.6, 0.9 Hz, 1H), 7.11-7.10 (m, 1H), 6.91 
(ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 4.91 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.0, 144.2, 
141.6, 130.3, 129.6 (q, J = 32.5 Hz), 124.3 (q, J = 272.0 Hz), 127.4, 125.7 (q, J = 3.8 Hz), 119.9, 
115.1, 114.3 ppm. HRMS: calcd for C13H9F3O, 238.0605 (M
+); found, 238.0600. 
4'-Fluoro-[1,1'-biphenyl]-3-ol (53) 
Following general procedure 3 to obtain 53 as an off white solid 
(64.9 mg, 69%). The reaction following general procedure 6 
afforded 53 in 46% yields (14.5 mg). The reaction following 
general procedure 9 afforded 53 in 58% yields (21.9 mg). mp: 77-
79 °C. IR: 3270, 1453, 1189, 832 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.56-7.50 (m, 2H), 7.30 (t, 
J = 7.9 Hz, 1H), 7.15-7.09 (m, 3H), 7.02-7.01 (m, 1H), 6.82 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 4.83 
(bs, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 162.6 (d, J = 246.6 Hz), 155.9, 142.1, 136.9 (d, J = 
3.2 Hz), 130.1, 128.7, 128.6, 119.7, 115.6 (d, J = 21.4 Hz), 114.1 (d, J = 18.4 Hz) ppm. HRMS: 
calcd for C12H10FO, 189.0716 (M+H
+); found, 189.0710. 
4'-Chloro-[1,1'-biphenyl]-3-ol (54) 
Following general procedure 3 to obtain 54 as a light orange solid 
(69.5 mg, 68%). The reaction following the general procedure 6 
afforded 54 in 65% yields (22.1 mg). The reaction following the 
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general procedure 9 afforded 54 in 50% yields (20.3 mg). mp: 47-48 °C. IR: 3245, 1587, 1197, 
777 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.51-7.48 (m, 2H), 7.41-7.38 (m, 2H), 7.31 (t, J = 7.9 
Hz, 1H), 7.13 (ddd, J = 7.7, 1.6, 0.9 Hz, 1H), 7.03-7.02 (m, 1H), 6.83 (ddd, J = 8.1, 2.5, 0.9 Hz, 
1H), 4.85 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.0, 141.8, 139.2, 133.6, 130.1, 128.9, 
128.4, 119.6, 114.5, 114.0 ppm. HRMS: calcd for C12H10
35ClO, 205.0420 (M+H+); found, 
205.0412. 
4'-Bromo-[1,1'-biphenyl]-3-ol (55) 
Following general procedure 3 to obtain 55 as a light orange solid 
(74.7 mg, 60%). The reaction following the general procedure 6 
afforded 55 in 61% yields (25.3 mg). The reaction following the 
general procedure 9 afforded 55 in 53% yields (26.2 mg). mp: 86-
88 °C. IR: 3246, 1470, 1197, 777 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.58-7.54 (m, 2H), 7.45-
7.42 (m, 2H), 7.31 (t, J = 7.9 Hz, 1H), 7.13 (ddd, J = 7.7, 1.6, 0.9 Hz, 1H), 7.03-7.02 (m, 1H), 
6.83 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 4.79 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.1, 
141.9, 139.8, 132.0, 130.3, 128.8, 121.9, 119.7, 114.7, 114.1 ppm. HRMS: calcd for 
C12H9
79BrO, 247.9837 (M+); found, 247.9828. 
4'-iodo-[1,1'-biphenyl]-3-ol (56) 
Following general procedure 3 to obtain 56 as an orange solid 
(59.2 mg, 40%). mp: 123-126 °C. IR: 3335, 1593, 1445, 1388, 1194, 
1002, 878, 823, 780, 688 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.75 
(d, J = 8.4 Hz, 2H), 7.33-7.29 (m, 3H), 7.12 (d, J = 7.8 Hz, 1H), 7.02-
7.01 (m, 1H), 6.83 (dd, J = 8.0, 2.5 Hz, 1H), 4.84 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 
155.9, 141.9, 140.2, 137.9, 130.2, 129.0, 119.6, 114.6, 113.8, 93.3 ppm. HRMS: calcd for 
C12H10IO, 296.9776 (M+H
+); found, 296.9771. 
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4'-Methoxy-[1,1'-biphenyl]-3-ol (57) 
Following general procedure 4 to obtain 57 as an off white solid 
(27.7 mg, 83%).  The reaction following the general procedure 6 
afforded 57 in 64% yields (21.0 mg). The reaction following the 
general procedure 8 afforded 57 in 21% yields (10.6 mg). mp: 
115-116 °C. IR: 3419, 2976, 1596, 1205, 829 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.53-7.49 (m, 
2H), 7.28 (t, J = 8.0 Hz, 1H), 7.13 (ddd, J = 7.7, 1.6, 1.0 Hz, 1H), 7.03-7.02 (m, 1H), 6.99-6.95 
(m, 2H), 6.78 (ddd, J = 8.0, 2.5, 0.9 Hz, 1H), 4.78 (s, 1H), 3.85 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 159.3, 155.8, 142.6, 133.3, 129.9, 128.1, 119.4, 114.2, 113.7, 113.6, 55.4 ppm. 
HRMS: calcd for C13H13O2, 201.0916 (M+H
+); found, 201.0910. 
3'-Hydroxy-[1,1'-biphenyl]-4-carbaldehyde (58) 
Following general procedure 4 to obtain 58 as a white solid 
(28.2 mg, 85%). The reaction following general procedure 6 
afforded 58 in 50% yields (16.5 mg). mp: 173-175 °C. IR: 3214, 
2840, 1669, 1584, 1562, 1303, 1199, 831, 783, 708 cm-1. 1H 
NMR (400 MHz, acetone-d6) δ 10.09 (s, 1H), 8.56 (s, 1H), 8.01-7.99 (m, 2H), 7.86-7.84 (m, 
2H), 7.34 (app. t, J = 7.7 Hz, 1H), 7.23-7.19 (m, 2H), 6.94-6.91 (m, 1H) ppm. 13C NMR (101 
MHz, acetone-d6) δ 192.5, 158.9, 147.6, 142.0, 136.6, 131.1, 130.9, 128.4, 119.4, 116.4, 
115.0 ppm. HRMS: calcd for C13H10O2, 198.0681 (M
 +); found, 198.0676. 
(3'-Hydroxy-[1,1'-biphenyl]-4-yl)methyl acetate (59) 
Following general procedure 4 to obtain 59 as an off white 
solid (32.3 mg, 80%). The reaction following general 
procedure 6 afforded 59 in 59% yields (23.8 mg). mp: 112-
114 °C. IR: 3387, 1716, 1601, 1233, 911, 737 cm-1.  1H NMR 
(400 MHz, CDCl3) δ 7.58-7.55 (m, 2H), 7.43-7.41 (m, 2H), 7.31 (t, J = 7.9 Hz, 1H), 7.16-7.14 
(m, 1H), 7.07-7.06 (m, 1H), 6.83 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 5.26 (s, 1H), 5.15 (s, 2H), 2.13 
(s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 171.2, 156.0, 142.4, 140.9, 135.1, 130.0, 128.8, 
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127.3, 119.7, 114.4, 114.1, 66.1, 21.1 ppm. HRMS: calcd for C15H14O3, 242.0943 (M
 +); found, 
242.0935. 
3',5'-dinitro-[1,1'-biphenyl]-3-ol (60) 
Following general procedure 3 to obtain 60 as a yellow solid 
(82.1 mg, 63%). mp: 208-210 °C. IR: 3440, 3076, 1522, 1336, 727 
cm-1. 1H NMR (400 MHz, acetone-d6) δ 8.93 (t, J = 2.1 Hz, 1H), 
8.84 (d, J = 2.1 Hz, 2H), 8.70 (s, 1H), 7.44 (t, J = 7.8 Hz, 1H), 7.38 
(ddd, J = 7.7, 1.7, 1.1 Hz, 1H), 7.34 (t, J = 2.0 Hz, 1H), 7.04 (ddd, J = 8.0, 2.4, 1.1 Hz, 1H) ppm. 
13C NMR (101 MHz, acetone-d6) δ 159.2, 150.0, 145.2, 138.9, 131.6, 127.6, 119.4, 117.8, 
117.5, 115.0 ppm. HRMS: calcd for C12H8N2O5, 260.0433 (M
+); found, 260.0428. 
3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-3-ol (61) 
Following general procedure 3 to obtain 61 as a white solid (97.0 
mg, 63%). The reaction following general procedure 8 afforded 
61 in 42% yields (32.0 mg). mp: 93-94 °C. IR: 3296, 1378, 701 cm-
1. 1H NMR (400 MHz, CDCl3) δ 7.99 (s, 2H), 7.86 (s, 1H), 7.38 (t, J = 
7.9 Hz, 1H), 7.18 (ddd, J = 7.7, 1.6, 0.9 Hz, 1H), 7.08 (t, J = 2.4 Hz, 1H), 6.92 (ddd, J = 8.1, 2.5, 
0.8 Hz, 1H), 4.96 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 156.2, 142.8, 140.0, 132.1 (q, J = 33.2 
Hz), 130.6, 123.4 (q, J = 272.7 Hz), 127.2 (d, J = 2.7 Hz), 121.1 (dt, J = 7.8, 3.8 Hz), 119.8, 
115.8, 114.2. HRMS: calcd for C14H8F6O, 306.0479 (M
+); found, 306.0474. 
3'-(Trifluoromethyl)-[1,1'-biphenyl]-3-ol (62) 
Following general procedure 3 to obtain 62 as an off white solid 
(80.9 mg, 68%). The reaction following general procedure 6 
afforded 62 in 46% yields (18.3 mg). mp: 64-66 °C. IR: 3336, 1332, 
1115, 698 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.81 (s, 1H), 7.75-
7.73 (m, 1H), 7.62-7.53 (m, 2H), 7.34 (t, J = 7.9 Hz, 1H), 7.17 (ddd, J = 7.7, 1.6, 0.9 Hz, 1H), 
7.08-7.07 (m, 1H), 6.87 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 4.85 (s, 1H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 156.0, 141.5, 131.2 (q, J = 32.2 Hz), 130.4, 130.4, 130.3, 129.2, 124.2 (q, J = 272.4 
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Hz), 124.2 (q, J = 3.8 Hz), 123.9 (q, J = 3.8 Hz), 119.8, 115.0, 114.2 ppm. HRMS: calcd for 
C13H9F3O, 238.0605 (M
+); found, 238.0597. 
1-(3'-Hydroxy-[1,1'-biphenyl]-3-yl)ethanone (63)  
Following general procedure 4 to obtain 63 as a light orange oil 
(27.3 mg, 77%). The reaction following general procedure 6 
afforded 63 in 56% yields (23.4 mg). IR: 3314, 1665, 1195, 776 
cm-1. 1H NMR (400 MHz, CDCl3) δ 8.17 (app. t, J = 1.6 Hz, 1H), 
7.93 (ddd, J = 7.7, 1.7, 1.2 Hz, 1H), 7.77 (ddd, J = 7.7, 1.9, 1.1 Hz, 1H), 7.53 (t, J = 7.7 Hz, 1H), 
7.33 (t, J = 7.9 Hz, 1H), 7.18 (ddd, J = 7.7, 1.6, 1.0 Hz, 1H), 7.12-7.11 (m, 1H), 6.88 (ddd, J = 
8.1, 2.5, 0.9 Hz, 1H), 5.34 (s, 1H), 2.66 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 198.5, 156.2, 
141.9, 141.3, 137.6, 131.8, 130.2, 129.1, 127.5, 126.9, 119.7, 114.8, 114.2, 26.8 ppm. HRMS: 
calcd for C14H12O2, 212.0837 (M
+); found, 212.0830. 
3'-Methyl-[1,1'-biphenyl]-3-ol (64) 
Following general procedure 3 to obtain 64 as an orange oil (50.6 
mg, 55%). The reaction following general procedure 6 afforded 
64 in 60% yields (18.3 mg). The reaction following the general 
procedure 8 afforded 64 in 51% yields (23.4 mg). IR: 3315, 2917, 
1578, 772 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.40-7.28 (m, 4H), 7.18-7.16 (m, 2H), 7.07-7.06 
(m, 1H), 6.82 (ddd, J = 8.0, 2.6, 0.9 Hz, 1H), 4.84 (s, 1H), 2.42 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 155.8, 143.2, 140.7, 138.4, 129.9, 128.7, 128.3, 127.9, 124.2, 119.8, 114.1, 114.1, 
21.5 ppm. HRMS: calcd for C13H12O, 184.0888 (M
 +); found, 184.0881. 
2'-fluoro-[1,1'-biphenyl]-3-ol (66) 
Following general procedure 3 to obtain 66 as a light brown solid 
(23.0 mg, 24%). mp: 99-101 °C. IR: 3222, 2926, 1571, 1584, 1180, 
759 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.43 (td, J = 7.7, 1.8 Hz, 1H), 
7.34-7.29 (m, 2H), 7.22-7.12 (m, 3H), 7.05-7.03 (m, 1H), 6.85 (ddd, J 
= 8.1, 2.6, 0.9 Hz, 1H), 4.78 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 159.7(d, J = 248.0 Hz), 
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155.5, 137.4, 130.7 (d, J = 3.4 Hz), 129.7, 129.1 (d, J = 8.3 Hz), 128.6 (d, J = 13.3 Hz), 124.3 (d, 
J = 3.7 Hz), 121.6 (d, J = 2.8 Hz), 116.2 (d, J = 17.6 Hz), 116.0 (d, J = 2.0 Hz), 114.7 ppm. 
HRMS: calcd for C12H9FO, 188.0637 (M
+); found, 188.0632. 
3-(1-Tosyl-1H-indol-5-yl)phenol (67) 
Following general procedure 3 to obtain 67 as a brown solid 
(54.5 mg, 30%). The reaction following general procedure 6 
afforded 67 in 28% yields (16.7 mg). mp: 93-94 °C. IR: 3411, 
3140, 1595, 1123, 669 cm-1. 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.6 Hz, 1H), 7.81-7.78 
(m, 2H), 7.70-7.69 (m, 1H), 7.58 (d, J = 3.7 Hz, 1H), 7.51 (dd, J = 8.6, 1.8 Hz, 1H), 7.29 (t, J = 
7.9 Hz, 1H), 7.24-7.22 (m, 2H), 7.16-7.14 (m, 1H), 7.07-7.05 (m, 1H), 6.80 (ddd, J = 8.1, 2.5, 
0.9 Hz, 1H), 6.69 (dd, J = 3.7, 0.7 Hz, 1H), 4.91 (s, 1H), 2.34 (s, 3H) ppm. 13C NMR (101 MHz, 
CDCl3) δ 155.9, 145.1, 143.1, 136.3, 135.3, 134.3, 131.3, 130.0, 130.0, 127.0, 126.9, 124.1, 
120.0, 119.8, 114.3, 114.0, 113.7, 109.3, 21.6 ppm. HRMS: calcd for C21H17NO3S, 363.0929 
(M+); found, 363.0924. 
3-(2,6-Dichloropyridin-4-yl)phenol (68) 
Following general procedure 3 to obtain 68 as a pale yellow solid 
(84.0 mg, 70%). The reaction following general procedure 6 
afforded 68 in 48% yields (19.2 mg). mp: 103-106 °C. IR: 3534, 
3267, 1580, 1528, 1170, 767 cm-1. 1H NMR (400 MHz, CDCl3) δ 
7.45 (s, 2H), 7.37 (t, J = 7.9 Hz, 1H), 7.17-7.15 (m, 1H), 7.06-7.05 (m, 1H), 6.95 (ddd, J = 8.1, 
2.5, 0.9 Hz, 1H) 5.01 (bs, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 156.4, 153.7, 151.1, 137.4, 
130.7, 120.9, 119.5, 117.3, 114.1 ppm. HRMS: calcd for C11H7
35Cl2NO, 238.9905 (M
+); found, 
238.9899. 
4-Bromo-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (69) 
Following general procedure 7 to obtain 69 as a colourless oil 
(28.5 mg, 62%). The reaction following general procedure 9 
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afforded 69 in 51% yields (28.4 mg). IR. 3505, 2917, 1567, 1468, 1300, 1178, 1027, 848, 797 
cm-1. 1H NMR (400 MHz, CDCl3) δ 7.49 (d, J = 8.3 Hz, 1H), 7.24 (d, J = 2.1 Hz, 1H), 7.17 (s, 2H), 
7.05-7.01 (m, 2H), 5.52 (s, 1H), 2.38 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 152.4, 143.0, 
139.8, 138.4, 132.0, 129.5, 124.9, 120.7, 114.7, 109.0, 21.4 ppm. HRMS: calcd for 
C14H14
79BrO, 277.0228 (M+H+); found, 277.0224. 
3',5'-Dimethyl-4-(trifluoromethoxy)-[1,1'-biphenyl]-3-ol (70) 
Following general procedure 7 to obtain 70 as colorless oil 
(39.2 mg, 83%). The reaction following general procedure 8 
afforded 70 in 51% yields (35.9 mg). IR: 3195, 2921, 1595, 1204, 
1160, 850, 827, 805, 788, 678 cm-1. 1H NMR (400 MHz, CDCl3) δ 
7.28-7.25 (m, 2H), 7.17 (s, 2H), 7.12 (dd, J = 8.5, 2.2 Hz, 1H), 7.01 (s, 1H), 5.54 (s, 1H), 2.38 (s, 
6H) ppm. 13C NMR (101 MHz, CDCl3) δ 147.8, 141.8, 139.7, 138.4, 135.7 (d, J = 1.5 Hz), 129.5, 
125.0, 121.4 (d, J = 0.9 Hz), 120.81 (q, J = 258.9 Hz), 119.6, 116.0, 21.4 ppm. HRMS: calcd for 
C15H13F3O2, 282.0868 (M
 +); found, 282.0861. 
4-Ethyl-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (71) 
Following general procedure 7 to obtain 71 as an orange oil (17.5 
mg, 46%). IR: 3527, 2965, 1401, 1168, 1121, 848, 819 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 7.19-7.17 (m, 3H), 7.11 (dd, J = 7.8, 1.8 
Hz, 1H), 6.99-6.98 (m, 2H), 4.68 (s, 1H), 2.67 (q, J = 7.6 Hz, 2H), 
2.37 (s, 6H), 1.28 (t, J = 7.6 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 153.5, 140.7, 140.6, 
138.2, 129.5, 128.8, 128.7, 124.9, 119.7, 113.9, 22.7, 21.4, 14.0 ppm. HRMS: calcd for 
C16H19O, 227.1436 (M+H
+); found, 227.1430. 
3',5'-Dimethyl-5-(trifluoromethoxy)-[1,1'-biphenyl]-3-ol (72) 
Following general procedure 6 to obtain 72 as a yellow oil (32.5 
mg, 69%). IR: 3360, 2922, 1595, 1250, 1213, 1160, 843, 647 cm-1. 
1H NMR (400 MHz, CDCl3) δ 7.15 (s, 2H), 7.03 (s, 1H), 7.01 (s, 1H), 
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6.97-6.96 (m, 1H), 6.69 (s, 1H), 4.97 (bs, 1H), 2.38 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 
156.6, 150.3, 144.6, 139.5, 138.5, 129.8, 125.0, 120.49 (q, J = 257.5 Hz), 112.6, 112.2, 107.0, 
21.3 ppm. HRMS: calcd for C15H13F3O2, 282.0868 (M
+); found, 282.0866. 
5-Ethyl-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (73) 
Following general procedure 7 to obtain 73 as an orange solid 
(25.3 mg, 67%). mp: 64-67 °C. IR: 3259, 2920, 1589, 1345, 845, 
695 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.18 (s, 2H), 6.99 (s, 2H), 
6.88-6.84 (m, 1H), 6.66 (s, 1H), 4.66 (s, 1H), 2.66 (q, J = 7.6 Hz, 
2H), 2.37 (s, 6H), 1.27 (t, J = 7.6 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.8, 146.46, 
143.2, 141.0, 138.2, 129.0, 125.1, 119.6, 113.6, 111.5, 28.9, 21.4, 15.5 ppm. HRMS: calcd for 
C16H19O, 227.1436 (M+H
+); found, 227.1432. 
5-(tert-Butyl)-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (74) 
Following general procedure 7 to obtain 74 as an orange oil (32.5 
mg, 77%). The reaction following general procedure 8 afforded 74 
in 51% yields (32.6 mg). IR: 3272, 2960, 1590, 1179, 847, 702 cm-
1. 1H NMR (400 MHz, CDCl3) δ 7.17 (s, 2H), 7.16 (app. t, J = 1.6 Hz, 
1H), 7.00 (s, 1H), 6.85 (m, 2H), 4.70 (s, 1H), 2.38 (s, 6H), 1.35 (s, 9H) ppm. 13C NMR (101 
MHz, CDCl3) δ 155.5, 153.5, 142.9, 141.5, 138.2, 129.0, 125.2, 117.2, 111.4, 111.3, 34.86, 
31.4, 21.4 ppm. HRMS: calcd for C18H23O, 255.1749 (M+H
+); found, 255.1743. 
5-Chloro-3',4,5'-trimethyl-[1,1'-biphenyl]-3-ol (75) 
Following general procedure 7 to obtain 75 as a colorless oil (22.5 
mg, 55%). The reaction following general procedure 8 afforded 75 
in 53% yields (32.7 mg). IR: 3286, 2919, 1568, 1390, 1265, 1144, 
1019, 810 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.20 (app. d, J = 1.6 
Hz, 1H), 7.14 (s, 2H), 7.00 (m, 1H), 6.90 (app. d, J = 1.6 Hz, 1 H), 4.88 (s, 1H), 2.37 (s, 6H), 2.33 
(s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 154.6, 140.7, 139.5, 138.4, 135.6, 129.4, 124.7, 
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121.3, 120.4, 112.2, 21.4, 12.4 ppm. HRMS: calcd for C15H15
35ClO, 246.0811 (M+); found, 
246.0806. 
[1,1':4',1''-terphenyl]-3-ol (76) 
Following general procedure 6 to obtain 75 as a light brown solid 
(23.0 mg, 56%). mp: 228-229 °C. IR: 3489, 2917, 2849, 1595, 
1164, 758 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.70-7.62 (m, 6H), 
7.48-7.45 (m, 2H), 7.39-7.31 (m, 2H), 7.24-7.21 (m, 1H), 7.12-7.11 (m, 1H), 6.84 (ddd, J = 8.0, 
2.5, 0.8 Hz, 1H), 4.77 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.9, 142.5, 140.7, 140.4, 
139.6, 130.1, 128.8, 129.49, 127.46, 127.4, 127.1, 119.7, 114.3, 114.0 ppm. HRMS: calcd for 
C18H15O, 247.1123 (M+H
+); found, 247.1118. 
4'-Methyl-[1,1'-biphenyl]-3-ol (96) 
Following general procedure 8 to obtain 96 as a brownish solid 
(19.3 mg, 42%). IR: 3280.9, 2915.4, 1588.7, 1189.0, 772.5 cm-1. 
1H NMR (400 MHz, CDCl3) δ 7.49-7.46 (m, 2H), 7.30 (t, J = 7.9 Hz, 
1H), 7.25 (dd, J = 8.4, 0.6 Hz, 2H), 7.17 (ddd, J = 7.7, 1.6, 1.0 Hz, 
1H), 7.05 (dd, J = 2.3, 1.8 Hz, 1H), 6.80 (ddd, J = 8.0, 2.6, 0.9 Hz, 1H), 4.85 (s, 1H), 2.40 (s, 3H) 
ppm. 13C NMR (101 MHz, CDCl3) δ 155.8, 143.0, 137.9, 137.3, 130.0, 129.5, 127.0, 119.6, 
113.9, 21.1 ppm. MS (EI): m/z (M+), 184.0. These data are consistent with those previously 
reported.50 
3'-bromo-[1,1'-biphenyl]-3-ol (97) 
Following general procedure 9 to obtain 97 as a brownish oil (27.4 
mg, 55%). IR: 3315.4, 1557.5, 1466.1, 1194.1, 771.9, 687.8 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 7.71 (t, J = 1.7 Hz, 1H), 7.50-7.47 (m, 2H), 
7.32 (t, J = 8.0 Hz, 1H), 7.30 (t, J = 8.1 Hz, 1H), 7.13 (d, J = 7.7 Hz, 1H), 7.03-7.02 (m, 1H), 
6.86-6.83 (m, 1H), 4.81 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.9, 142.9, 141.5, 130.4, 
130.3, 130.2, 130.2, 125.7, 122.9, 119.8, 114.8, 114.1 ppm. HRMS: calcd for C12H10
79BrO, 
248.9915 (M+H+); found, 248.9910. 
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3',5'-dichloro-[1,1'-biphenyl]-3-ol (98) 
Following general procedure 8 to obtain 98 as an off white solid 
(28.5 mg, 48%). mp: 88-91 °C. IR: 3228.5, 1556.8, 1402.9, 1203.4, 
768.6 cm-1.  1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 1.9 Hz, 2H), 
7.34-7.30 (m, 2H), 7.10 (ddd, J = 7.7, 1.7, 0.9 Hz, 1H), 7.01-7.00 (m, 
1H), 6.87 (ddd, J = 8.1, 2.5, 0.9 Hz, 1H), 4.90 (s, 1H). ppm. 13C NMR (101 MHz, CDCl3) δ 156.0, 
143.7, 140.3, 135.3, 130.3, 127.4, 125.7, 119.7, 115.4, 114.1.ppm. HRMS: calcd for 
C14H9
35Cl2O, 237.9952 (M
+); found, 238.0025. 
3'-Chloro-[1,1'-biphenyl]-3-ol (99) 
Following general procedure 8 to obtain 99 as a brownish oil (34.5 
mg, 67%). IR: 3324.9, 1564.2, 1196.2, 774.0, 688.5 cm-1.   1H NMR 
(400 MHz, CDCl3) δ 7.56-7.55 (m, 1H), 7.44 (dt, J = 7.4, 1.6 Hz, 1H), 
7.38-7.30 (m, 3H), 7.14 (ddd, J = 7.7, 1.7, 0.9 Hz, 1H), 7.04-7.03 (m, 1H), 6.84 (ddd, J = 8.1, 
2.5, 0.9 Hz, 1H), 4.79 (s, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 155.9, 142.6, 141.6, 134.7, 
130.2, 130.0, 127.5, 127.3, 125.3, 119.8, 114.8, 114.1 ppm. HRMS: calcd for C12H10
35ClO, 
205.0420 (M+H+); found, 205.0415. 
4-Chloro-3',5'-dimethyl-[1,1'-biphenyl]-3-ol (100) 
Following general procedure 8 to obtain 100 as a light yellow 
solid (33.4 mg, 57%). mp: 32-35 °C. IR: 3517.5, 3025.9, 2916.7, 
1571.8, 1201.4, 1179.8, 1045.2, 848.7, 807.8 cm-1. 1H NMR (400 
MHz, CDCl3) δ 7.35 (d, J = 8.3 Hz, 1H), 7.24 (d, J = 2.1 Hz, 1H), 
7.17 (s, 2H), 7.09 (dd, J = 8.3, 2.1 Hz, 1H), 7.01 (s, 1H), 5.54 (s, 1H) 2.38 (s, 6H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 151.4, 142.1, 139.8, 138.4, 129.4, 129.0, 124.9, 120.2, 118.7, 114.8, 21.4 
ppm. MS (EI): m/z (M+), 232.1. 
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5.3.6 Experimental procedures for the synthesis of meta-biaryls - Chapter 3.3.4 
Procedure to prepare 2-((3',5'-dimethyl-[1,1'-biphenyl]-3-yl)methyl)-5-nitropyridine (78)164 
 
To a solution of 45 (53.1 mg, 0.25 mmol) in DMF (0.5 mL) was slowly added NaH (11 mg, 
0.275 mmol, 60% dispersion in mineral oil) at 0 °C. After stirring the mixture for 30 min, 2-
chloro-5-nitro-pyridine (40.0 mg, 0.25 mmol) was added into the solution, the mixture was 
then stirred room temperature for 16 h. After that time, the mixture was filtered through a 
plug of Celite® with EtOAc (4 × 5 mL), the filtrate was evaporated to dryness, the crude 
product was purified by column chromatography (Hexanes:EtOAc 85:15) to afford 2-((3',5'-
dimethyl-[1,1'-biphenyl]-3-yl)methyl)-5-nitropyridine (78) as a pale brownish solid (81.0 mg, 
97%). mp: 93-95 °C. IR: 2916, 1569, 1347, 1300, 1259, 842, 684 cm-1. 1H NMR (400 MHz, 
CDCl3) δ 9.07 (d, J = 2.8 Hz, 1H), 8.47 (dd, J = 9.1, 2.8 Hz, 1H), 7.33 (s, 1H), 7.19 (s, 2H), 7.16 
(s, 1H), 7.04 (d, J = 9.1 Hz, 1H), 7.00 (s, 1H), 6.94 (s, 1H), 2.45 (s, 3H), 2.37 (s, 6H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 167.1, 153.1, 145.2, 143.4, 140.4, 140.3, 140.2, 138.4, 134.9, 129.4, 
125.7, 125.1, 120.5, 117.3, 111.2, 21.6, 21.4 ppm. HRMS: calcd for C20H19N2O3, 335.1396 
(M+H+); found, 335.1390. 
Procedure to prepare 3-methoxy-3',5,5'-trimethyl-1,1'-biphenyl (79)165 
 
To a solution of 45 (21.2 mg, 0.10 mmol) in acetone (0.5 mL) was added K2CO3 (32 mg, 0.23 
mmol). After stirring the mixture for 5 min, MeI (14 µL, 0.23 mmol) was added into the 
solution. The mixture was then stirred at room temperature for 16 h. After this time, the 
mixture was filtered through a small plug of silica with EtOAc (4 × 5 mL), the filtrate was 
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evaporated to dryness, the crude product was purified by column chromatography (Hexanes) 
to afford 3-methoxy-3',5,5'-trimethyl-1,1'-biphenyl (79) as a colorless oil (21.7 mg, 96%). IR: 
2918, 1590, 1461, 1262, 1152, 1064, 836, 694 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.20 (s, 2H), 
7.00 (s, 2H), 6.93 (s, 1H), 6.72 (s, 1H), 3.86 (s, 3H), 2.40 (s, 3H), 2.39 (s, 6H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 159.9, 142.9, 141.3, 139.6, 138.2, 129.0, 125.1, 120.7, 113.5, 109.9, 55.3, 
21.7, 21.4 ppm. HRMS: calcd for C16H19O, 227.1436 (M+H
+); found, 227.1430. 
Procedure to prepare 3',5,5'-trimethyl-[1,1'-biphenyl]-3-yl trifluoromethanesulfonate 
(77).166 
 
To a solution of 45 (254 mg, 1.2 mmol) and pyridine (195 µL, 2.4 mmol) in anhydrous DCM 
was dropwise added a solution of trifluoromethanesulfonic anhydride (245 µL, 1.44 mmol) 
in DCM (0.6 mL) at 0 °C. After complete addition, the mixture was warmed to room 
temperature and stirred for 1 h. The mixture as then filtered through a small plug of silica 
with EtOAc (4 × 5 mL), the filtrate was evaporated to dryness, the crude product was 
purified by column chromatography (Hexanes) to afford 3',5,5'-trimethyl-[1,1'-biphenyl]-3-yl 
trifluoromethanesulfonate (77) as a colorless oil (397 mg, 96%). IR: 2924, 1584, 1422, 1206, 
1141, 959, 828, 691, 609 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.40 (s, 1H), 7.26 (s, 1H), 7.16 (s, 
2H), 7.05 (s, 2H), 2.46 (s, 3H), 2.39 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 149.9, 143.9, 
140.9, 139.3, 138.6, 129.8, 127.9, 125.1, 120.1, 118.8 (d, J = 320.7 Hz), 117.0, 21.5, 21.4 
ppm. HRMS: calcd for C16H19F3NO3S, 362.1038 (M+NH4
+); found, 362.1032. 
Procedure to prepare 3',5,5'-trimethyl-N-phenyl-[1,1'-biphenyl]-3-amine (80)167 
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Under argon, to a solution of 45 (34.4 mg, 0.1 mmol), Pd(OAc)2 (1.1 mg, 5.0 μmol), BINAP 
(5.0 mg, 8.0 μmol) and Cs2CO3 (45.6 mg, 0.14 mmol) in PhCH3 (1.0 mL) was added aniline (11 
µL, 0.12 mmol). The reaction mixture was stirred at 120 °C for 16 h. After this time, the 
mixture was filtered through a small plug of silica with EtOAc (4 × 5 mL), the filtrate was 
then evaporated to dryness and the crude product was purified by column chromatography 
(Hexanes:EtOAc 85:15) to afford 3',5,5'-trimethyl-N-phenyl-[1,1'-biphenyl]-3-amine (80) as a 
brown oil (27.6 mg, 96%). IR: 3394, 2916, 1586, 1494, 1348, 1235, 1030, 837, 741, 691 cm-1. 
1H NMR (400 MHz, CDCl3) δ 7.30-7.26 (m, 2H), 7.18 (s, 2H), 7.12-7.10 (m, 3H), 6.99-6.98 (m, 
2H), 6.96-6.92 (m, 1H), 6.88 (s, 1H), 5.72 (s, 1H), 2.37 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) 
δ 143.4, 143.3, 142.7, 141.3, 139.5, 138.2, 129.4, 128.9, 125.1, 121.1, 120.9, 117.9, 117.4, 
114.0, 21.6, 21.4 ppm. HRMS: calcd for C21H22N, 288.1752 (M+H
+); found, 288.1747. 
Procedure to prepare 3,5,5'-trimethyl-1,1':3',1''-terphenyl (81)168 
 
Under argon, To a mixture of Pd(PPh3)4 (0.6 mg, 0.5 μmol), 77 (34.4 mg, 0.1 mmol) and 
phenylboronic acid (13.7 mg, 0.112 mmol) in degased monoglyme (1.0 mL) was added a 
solution of Na2CO3 (21.2 mg, 0.2 mmol) in degased H2O (1.0 mL). The reaction mixture was 
then stirred at 95 °C for 2.5 h. After this time, the mixture was filtered through a small plug 
of silica with EtOAc (4 × 5 mL), the filtrate was then evaporated to dryness and the crude 
product was purified by column chromatography (Hexanes) to afford 3,5,5'-trimethyl-
1,1':3',1''-terphenyl (81) as a colourless oil (26.3 mg, 97%). IR: 3030, 2917, 1560, 1459, 1032, 
844, 761, 697 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.65-7.63 (m, 2H), 7.59 (s, 1H), 7.47-7.43 (m, 
2H), 7.38-7.33 (m, 3H), 7.26-7.25 (m, 2H), 7.01 (s, 1H), 2.48 (s, 3H), 2.39 (s, 6H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 142.1, 141.7, 141.5, 141.4, 138.7, 138.3, 129.0, 128.8, 127.3, 127.3, 
127.0, 126.9, 125.2, 123.5, 21.6, 21.5 ppm. HRMS: calcd for C21H21, 273.1643 (M+H
+); found, 
273.1638. 
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Procedure to prepare 3',5,5'-trimethyl-[1,1'-biphenyl]-3-yl 4-methylbenzenesulfonate (77’) 
 
To a solution of 45 (42.4 mg, 0.2 mmol) and p-Toluenesulfonyl chloride (41.9 mg, 0.22 mmol) 
in MeCN (1.0 mL) was slowly added Et3N (31 µL, 0.22 mmol). The reaction mixture was 
stirred at room temperature for 1 h. After this time, the mixture was filtered through a small 
plug of silica with EtOAc (4 × 5 mL), the filtrate was then evaporated to dryness and the 
crude product was purified by column chromatography (Hexanes) to 3',5,5'-trimethyl-[1,1'-
biphenyl]-3-yl 4-methylbenzenesulfonate (77’) as a colourless oil (69.5 mg, 95%). IR: 1598, 
1358, 1189, 1178, 965, 862, 847, 790, 671 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.3 
Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.25 (s, 1H), 7.00 (s, 2H), 6.98 (s, 1H), 6.87 (s, 1H), 6.84 (s, 
1H), 2.47 (s, 3H), 2.35 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3) δ 149.9, 145.2, 142.8, 140.0, 
139.8, 138.3, 132.7, 129.7, 129.4, 128.7, 126.6, 125.0, 121.6, 118.0, 21.7, 21.4, 21.4 ppm. 
HRMS: calcd for C22H26NO3S, 384.1633 (M+NH4
+); found, 384.1628. 
Procedure to prepare 3',5,5'-trimethyl-[1,1'-biphenyl]-3-carbonitrile (82)169 
 
Under argon, to a vial containing a mixture of Pd(OAc)2 (0.45 mg, 2.0 μmol) and CM-Phos 
(3.2 mg, 8.0 μmol) in degased anhydrous DCM (0.5 mL) was added Et3N (0.1 µL). After 
stirring the mixture at 50 °C for 5 min, DCM was removed under vacuum. 77’ (34.4 mg, 0.1 
mmol), K2CO3 (1.7 mg, 0.0125 mmol) and K4[Fe(CN)6]·H2O (21.1 mg, 0.05 mmol) were then 
charged successively to the vial, degased tBuOH (0.25 µL) and degased of H2O (0.25 µL) were 
added as solvent. The reaction mixture was stirred at 80 °C for 18 h. After this time, the 
mixture was filtered through a small plug of silica with EtOAc (4 × 5 mL), the filtrate was 
then evaporated to dryness and the crude product was purified by column chromatography 
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(Hexanes:EtOAc 85:15) to afford 3',5,5'-trimethyl-[1,1'-biphenyl]-3-carbonitrile (82) as an 
offwhite solid (21.0 mg, 95%). mp: 68-70 °C. IR: 2919, 2227, 1598, 1453, 1376, 840, 685 cm-1. 
1H NMR (400 MHz, CDCl3) δ 7.58 (s, 1H), 7.52 (s, 1H), 7.34 (s, 1H), 7.08 (s, 2H), 6.97 (s, 1H), 
2.37 (s, 3H), 2.31 (s, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 142.6, 139.5, 139.1, 138.7, 132.4, 
130.9, 129.9, 128.0, 125.0, 119.1, 112.6, 21.4, 21.3 ppm. HRMS: calcd for C16H16N, 222.1283 
(M+H+); found, 222.1277. 
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5.3.7 Experimental procedures for the synthesis of ϒ-secretase inhibitor - Chapter 
3.3.4 
Preparation of 5-bromo-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-ol (85) 
 
Following general procedure 7 with 3-bromophenol 83 (260 mg, 1.5 mmol) and 4-
iodobenzotrifluoride 84 (74.0 μL, 0.50 mmol) to obtained 5-bromo-4'-(trifluoromethyl)-[1,1'-
biphenyl]-3-ol (85) as a pale yellow solid (102 mg, 64%). mp: 89-91 °C. IR: 3256, 1576, 1328, 
1114, 834 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.3 Hz, 2H), 7.63 (d, J = 8.3 Hz, 2H), 
7.32 (t, J = 1.5 Hz, 1H), 7.06-7.05 (m, 1H), 6.99-6.98 (m, 1H), 4.93 (s, 1H) ppm. 13C NMR (101 
MHz, CDCl3) δ 156.6, 143.0, 142.8, 130.2 (q, J = 32.7 Hz), 127.4, 125.9 (dd, J = 7.3, 3.6 Hz), 
124.1 (q, J = 272.2 Hz), 123.4, 123.1, 118.4, 113.3 ppm. HRMS: calcd for C13H9
79BrF3O, 
316.9789 (M+H+); found, 316.9782. 
Preparation of 3-bromo-5-(4-fluorophenoxy)-4'-(trifluoromethyl)-1,1'-biphenyl (87) 
 
Under argon, 85 (95.0 mg, 0.30 mmol) was charged into a dry vial, a suspension of t-BuOK 
(38.4 mg, 0.33 mmol) in THF (1.5 mL) was added into the vial at 0 °C and the reaction 
mixture was stirred at 0 °C for 15 min, bis(4-fluorophenyl)iodonium triflate 86 (168 mg, 0.36 
mmol) was then added and the reaction mixture was stirred at 40 °C for 16 h. After this time, 
the mixture was evaporated to dryness and the crude was purified by flash chromatography 
(hexanes) to give 3-bromo-5-(4-fluorophenoxy)-4'-(trifluoromethyl)-1,1'-biphenyl (87) as a 
colorless oil (92 mg, 75%). IR: 2935, 2362, 1710, 1503, 1328, 1207, 839 cm-1. 1H NMR (400 
 
 
182 
 
MHz, CDCl3) δ 7.69 (d, J = 8.2 Hz, 2H), 7.62 (d, J = 8.1 Hz, 2H), 7.45 (t, J = 1.6 Hz, 1H), 7.13-
7.03 (m, 6H) ppm. 13C NMR (101 MHz, CDCl3) δ 159.4 (d, J = 239.5 Hz), 159.2, 151.7, 143.0, 
142.6, 130.3 (q, J = 32.6 Hz), 127.4, 125.9 (q, J = 3.8 Hz), 124.9, 124.1 (q, J = 272.1 Hz), 123.5, 
121.3 (d, J = 8.4 Hz), 120.4, 116.7 (d, J = 23.4 Hz), 115.6 ppm. HRMS: calcd for C19H12
79BrF4O, 
411.0002 (M+H+); found, 411.0003. 
Preparation of 2-(5-(4-fluorophenoxy)-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)pentanoic 
acid (89) 
 
Under argon, NaHMDS (0.6 M in PhMe, 217 µL, 0.13 mmol) was charged into a well-flamed 
dried vial, tert-butyl pentanoate 88 (21.0 μL, 0.11 mol) was then added dropwise into the 
vial at 0 °C and the resulting mixture was stirred at 0°C for 0.5 h. To this suspension of 
sodium enolate was then added a solution of ZnCl2 (1.0 M in THF, 260 μL, 0.26 mmol) and 
the resulting mixture was stirred at 0 °C for 0.5 h. To the suspension of zinc enolate, a 
solution of 87 (41.1 mg, 0.10 mmol), Pd(dba)2 (0.6 mg, 0.1 μmol) and Q-phos (0.7 mg, 0.1 
μmol) in PhCH3 (0.5 mL) was added. The reaction mixture was stirred at room temperature 
for 16 h. After this time, the solvent of this mixture was evaporated and TFA/DCM (1:10, 1.0 
mL) was added, followed by stirring at room temperature for 1 h. After this time, the 
reaction mixture was filtered through a plug of Celite with EtOAc (3 x 5 mL). The filtrate was 
evaporated to dryness and purified by chromatography (hexanes to hexanes:EtOAc 50:50) 
to afford 2-(5-(4-fluorophenoxy)-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)pentanoic acid (89) 
as a light yellow solid (37.0 mg, 86%). mp: 112-115 °C. IR: 1561, 1499, 1323, 1200, 1123, 
924, 832 cm-1. 1H NMR (400 MHz, CDCl3) δ 10.80 (bs, 1H), 7.67 (d, J = 8.3 Hz, 2H), 7.62 (d, J = 
8.3 Hz, 2H), 7.28 (s, 1H), 7.07-7.02 (m, 6H), 3.62 (t, J = 7.7 Hz, 1H), 2.14-2.05 (m, 1H), 1.86-
1.77 (m, 1H), 1.41-1.30 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
179.8, 159.1 (d, J = 242.4 Hz), 158.5, 152.3, 143.7, 141.9, 141.3, 129.9 (q, J = 32.6 Hz), 127.5, 
125.8 (q, J = 3.7 Hz), 124.2 (q, J = 272.1 Hz), 121.8, 120.8 (d, J = 8.3 Hz), 117.6, 116.5 (d, J = 
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23.4 Hz), 115.8, 51.3, 35.2, 20.7, 13.8 ppm. HRMS: calcd for C24H21F4O3, 433.1427 (M+H
+); 
found, 433.1419. 
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5.4 Experimental procedures for enantioselective C–H arylation of fluoro-
benzene chromium complex - Chapter 4 
5.4.1 Experimental procedures for the synthesis of chiral phosphine ligands 
Preparation of (S)-(2'-(naphthalen-2-ylmethoxy)-[1,1'-binaphthalen]-2-yl)diphenyl phosph-
ane (L30)170 
 
(S)-[1,1'-binaphthalene]-2,2'-diyl bis(trifluoromethanesulfonate) (106). Under argon, 
pyridine (2.1 mL, 26 mmol, 2.6 equiv) was added into a solution of (S)-BINOL L16 (2.94 g, 10 
mmol, 1.0 equiv) in 100 mL of dry CH2Cl2. After stirring 5 minutes, the solution was cooled to 
0 °C. Then Tf2O (3.7 mL, 22 mmol, 2.2 equiv) was added slowly and the reaction mixture was 
stirred at room temperature for 16 h. After this time, the mixture was filtered through a pad 
of silica gel using EtOAc/hexane (1:30) as eluent. Concentrate of the filtrate afforded 106 as 
a white solid (5.2 g, 9.5 mmol, 95%). 1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 9.1 Hz, 2H), 8.01 
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(d, J = 8.2 Hz, 2H), 7.63-7.57 (m, 4H), 7.44-7.40 (m, 2H), 7.26 (d, J = 8.5 Hz, 2H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 145.4, 133.1, 132.3, 132.0, 128.4, 128.0, 127.3, 126.8, 123.5, 119.4, 
118.1 (q, JC–F = 320.2 Hz) ppm. 
19F NMR (376 MHz, CDCl3) δ -74.6 ppm. MS (EI): m/z (M+NH4
+) 
568.1.  The product 106 was previously reported.182 
(S)-2'-(diphenylphosphoryl)-[1,1'-binaphthalen]-2-yl trifluoromethanesulfonate (107). 
Under argon, to a solution of 106 (825 mg, 1.5 mmol, 1.0 equiv), diphenylphosphine oxide 
(606.6 mg, 3.0 mmol, 2.0 equiv), Pd(OAc)2 (33.7 mg, 0.15 mmol, 10 mol %) and dppb (96.0 
mg, 0.23 mmol, 10 mol %) in dry DMSO (7.0 mL) was added dry iPr2NEt (1.1 mL, 6.0 mmol, 
4.0 equiv), The reaction mixture was stirred at room temperature for 20 min and then at 
110 °C for 16 h. After this time, the reaction mixture was cooled down to room temperature 
and 30 mL of H2O was added. The resulting solution was extracted with Et2O (3 x 30 mL). The 
combined organic layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to afford 107 (540 mg). The product 107 was was directly used in the next step 
without further purification. 31P NMR (162 MHz, CDCl3) δ 28.1 ppm. These data consistent 
with those previously reported.182 
(S)-(2'-(naphthalen-2-ylmethoxy)-[1,1'-binaphthalen]-2-yl)diphenylphosphine oxide (109). 
To a solution of 107 (482 mg, 0.8 mmol, 1.0 equiv) in dioxane/methanol (2:1, 7.0 mL) at 0 °C 
was added 2.5 mL of 3.0 N NaOH (aq.). The resulting mixture was stirred at room 
temperature for 16 h. After this time, the reaction mixture was concentrated under reduced 
pressure. The resulting mixture was diluted with EtOAc (20 mL) and H2O (10 mL), 
concentrated HCl was then slowly added to adjust the pH to ~3 at 0 °C. The resulting 
solution was extracted with EtOAc (3 x 20 mL) and the combined organic layers were dried 
over anhydrous MgSO4 and concentrated to afford crude 108 (300 mg). Then, a mixture of 
108 (300 mg, 0.63 mmol, 1.0 equiv) and K2CO3 (331.8 mg, 2.4 mmol, 4.0 equiv) was 
dissolved in analytical-grade acetone (30 mL), 1-(bromomethyl)naphthalene (535 mg, 2.4 
mmol, 4.0 equiv) was then added, the mixture was then heated at 60 °C for 40 h. After this 
time, the mixture was cooled to room temperature, and then filtered through Celite with 
Et2O (3 x 10 mL). The filtrate was concentrated and the resulting residue was purified by 
flash chromatography (EtOAc/hexane 2:1) to afford 109 as a white foam (210 mg, 0.35 
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mmol, 55%). 1H NMR (400 MHz, CDCl3) δ 8.08-8.02 (m, 2H), 7.97-7.92 (m, 1H), 7.80-7.78 (m, 
1H), 7.69-7.59 (m, 4H), 7.56-7.44 (m, 5H), 7.33-7.23 (m, 7H), 7.17-7.05 (m, 6H), 6.98-6.91 (m, 
3H), 5.16-5.10 (m, 2 H) ppm. 13C NMR (101 MHz, CDCl3) δ 154.0, 140.8 (d, J = 8.6 Hz), 135.0 
(d, J = 2.2 Hz), 134.9, 134.2, 133.8, 133.3 (d, J = 11.7 Hz), 133.1, 132.7, 132.1, 132.0 (d, J = 
9.7 Hz), 131.3 (d, J = 9.9 Hz), 131.1 (d, J = 2.7 Hz), 130.8, 130.7 (d, J = 2.8 Hz), 130.5, 129.8, 
129.2 (d, J = 11.2 Hz), 128.6, 128.1 (d, J = 6.0 Hz), 127.9, 127.9, 127.8, 127.7, 127.6, 127.5, 
127.2, 127.1, 127.0, 126.3, 126.1, 125.8, 125.7, 125.3, 124.5, 123.5, 120.6 (d, J = 4.8 Hz), 
113.7, 70.1 ppm. Some doublets due to C-P couplings can not be assigned due to complexity 
of the spectrum and they are listed as singlets. 31P NMR (162 MHz, CDCl3) δ 29.2 ppm. HRMS: 
calcd for C43H32O2P, 611.2140 (M+H
+); found, 611.2145. 
(S)-(2'-(naphthalen-2-ylmethoxy)-[1,1'-binaphthalen]-2-yl)diphenyl phosphane (L30). To a 
solution of 109 (120 mg, 0.16 mmol, 1.0 equiv), Et3N (0.80 mL, 6.4 mmol, 40.0 equiv) in dry 
PhMe (3.2 mL) was slowly added trichlorosilane (0.16 mL, 1.6 mmol, 10 equiv) at 0 °C. The 
reaction mixture was stirred at rrom temperature for 30 min and then stirred at 110 °C for 
16 h. After this time, the mixture was cooled down to room temperature and filtered 
through a pad of silica, the filtrate was concentrated and the resulting residue was purified 
by flash chromatography (Et2O/hexane 1:10) to afford L30 as white foam (95 mg, 80%). 
1H 
NMR (400 MHz, CDCl3) δ 7.96-7.90 (m, 3H), 7.84 (d, J = 8.2 Hz, 1H), 7.76-7.74 (m, 1H), 7.62 
(d, J = 8.5 Hz, 1H), 7.54-7.47 (m, 2H), 7.47-7.40 (m, 3H), 7.35-7.33 (m, 2H), 7.31-7.25 (m, 3H), 
7.22-7.09 (m, 9H), 7.02-6.98 (m, 4H), 5.08 (d, J = 13.1 Hz, 1H), 4.89 (d, J = 13.1 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3) δ 152.9 (d, J = 1.9 Hz), 141.4, 141.1, 137.0 (d, J = 10.4 Hz), 136.8 
(d, J = 9.9 Hz), 134.9 (d, J = 10.0 Hz), 134.0, 133.1 (d, J = 2.1 Hz), 132.7, 132.7, 132.5, 132.4, 
132.2, 132.1, 132.1, 131.6, 129.3 (d, J = 1.7 Hz), 127.8, 127.1 (d, J = 2.8 Hz), 127.0, 126.9, 
126.9, 126.8 (d, J = 1.1 Hz), 126.7, 126.6, 126.5, 125.8 (d, J = 2.6 Hz), 125.7, 125.3, 124.9, 
124.6, 124.4, 123.9, 123.2, 122.5, 121.8 (d, J = 9.0 Hz), 113.3, 68.9 ppm. Some doublets due 
to C-P couplings can not be assigned due to complexity of the spectrum and they are listed 
as singlets. 31P NMR (162 MHz, CDCl3) δ -13.4 ppm. HRMS: calcd for C43H32OP, 595.2191 
(M+H+); found, 595.2157. Specific rotation: [α]D (25.4 °C) = -135.9° (c = 0.05, CH2Cl2). 
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Preparation of S-BINAP(O) (L32)171 
 
Under argon, to a dry Schlenk flask containing PdI2 (3.7 mg, 0.010 mmol, 2.5 mol %) and (S)-
BINAP (250 mg, 0.40 mmol, 1.0 equiv) was added 2.5 mL of dry CH2Cl2. The mixture was 
then stirred at room temperature for 3 h until PdI2 was dissolved completely. A aqueous 
solution of NaOH (0.23 g, 5.75 mmol in 1.5 mL of H2O) was then added, followed by 1,2-
dibromoethane (0.50 g, 2.66 mmol, 6.7 equiv). The resulting mixture was stirred at 50 °C for 
16 h. After this time, the mixture was cooled down and 20% H3PO4 solution was added to 
adjust the pH to ~4, followed by adding dppe (10 mg) and stirred at room temperature for 5 
min to remove Pd. The resulting solution was extracted with CH2Cl2 (3 x 10 mL), the 
combined organic layers were dried over MgSO4 and evaporated to dryness. The crude was 
purified by flash chromatography (CH2Cl2:EtOAc = 10:1) to afford S-BINAP(O) (L32) as a 
white solid (130 mg, 0.2 mmol, 51%). 1H NMR (400 MHz, CDCl3): δ 7.92 (dd, J = 8.6, 2.2 Hz, 
1H), 7.82 (d, J = 8.2 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 8.2 Hz, 1H), 7.62-7.57 (m, 
3H), 7.41 (dd, J = 8.5, 2.9 Hz, 1H), 7.38-7.31 (m, 6H), 7.29-7.20 (m, 7H), 7.16-7.13 (m 1H), 
7.10-7.01 (m, 4H), 6.97-6.93 (m, 2H), 6.90-6.87 (m, 1H), 6.81 (d, J = 8.2 Hz, 1H), 6.74-6.70 (m, 
1H), 6.64 (d, J = 8.4 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 144.9 (d, J = 7.5 Hz), 144.8 (d, J 
= 7.4 Hz), 142.8 (d, J = 4.6 Hz), 142.5 (d, J = 4.6 Hz), 138.7 (d, J = 12.8 Hz), 137.1 (d, J = 13.5 
Hz), 136.8 (d, J = 11.3 Hz), 134.7 (d, J = 22.3 Hz), 134.5, 134.0 (d, J = 2.1 Hz), 133.6 (d, J = 3.0 
Hz), 133.5, 133.4, 133.2, 133.14, 133.10, 133.06, 133.03, 132.98, 132.2, 132.1, 131.5 (d, J = 
9.5 Hz), 131.2 (d, J = 2.7 Hz), 130.7 (d, J = 2.7 Hz), 129.9 (d, J = 2.1 Hz), 129.1 (d, J = 2.3 Hz), 
128.8 (d, J = 12.9 Hz), 128.4 (d, J = 7.7 Hz), 128.1 (d, J = 2.0 Hz), 128.04, 128.01, 127.9 (d, J = 
1.2 Hz), 127.8, 127.7, 127.63, 127.59, 127.5, 127.4, 127.0 (d, J = 2.6 Hz), 126.1, 126.0, 125.5. 
Some doublets due to C-P couplings can not be assigned due to complexity of the spectrum 
and they are listed as singlets. 31P NMR (162 MHz, CDCl3) δ 27.1, -15.34 ppm. MS (EI): m/z 
(M+H+) 639.3. Specific rotation: [α]D (25.4 °C) = -113.7° (c = 0.05, CH2Cl2). The 
1H NMR and 
31P NMR are consistent with those previously reported.180 
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Preparation of L34 and L35.172 
 
 
Methyl (S)-2'-(((trifluoromethyl)sulfonyl)oxy)-[1,1'-binaphthalene]-2-carboxylate (110). A 
mixture of 106 (2.00 g, 3.6 mmol), Pd(OAc)2 (146 mg, 0.65 mmol, 18 mol %), and 1,3-
bis(diphenylphosphino)propane (132 mg, 0.32 mmol, 9.0 mol %) was charged in a dry round 
bottle flask filled with CO. 3/2 mixture of DMSO and MeOH (167 mL) was added, followed 
by adding NEt3 (6.7 mL, 36 mmol, 10.0 equiv ). The mixture was stirred at 70 °C for 16 h. 
After this time, the mixture was cooled down and concentrated. The resulting red-brown 
residue was dissolved in Et20 and washed with a large amount of H20. The combined organic 
layer was dried over MgS04, concentrated under reduced pressure and the residue was 
purified by silica gel column chromatography (n-hexane:EtOAc = 5:1) to afford 110 (817 mg, 
49%). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.7 Hz, 1H), 8.08 (t, J = 8.8 Hz, 2H), 8.00-7.97 
(m, 2H), 7.60- 7.52 (m, 3H), 7.36-7.31 (m, 2H), 7.16 (t, J = 7.9 Hz, 2H), 3.57 (s, 3H) ppm. 13C 
NMR (101 MHz, CDCl3) δ 166.7, 144.3, 135.1, 133.7, 133.4, 132.5, 132.1, 130.3, 129.7, 129.4, 
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128.6, 128.3, 128.2, 128.1, 127.6, 127.4, 127.2, 126.9, 126.5, 126.1, 119.3, 118.1 (q, JC–F = 
320.0 Hz), 52.2 ppm. 19F NMR (376 MHz, CDCl3) δ -74.8 ppm. MS (EI): m/z (M+H
+) 461.1. 
hese data are consistent with those previously reported.181 
Methyl (S)-2'-(diphenylphosphoryl)-[1,1'-binaphthalene]-2-carboxylate (111). To a solution 
of 110 (690 mg, 1.5 mmol), diphenylphosphine oxide (606.6 mg, 3.0 mmol), Pd(OAc)2 (33.6 
mg, 0.15 mmol), and 1,3-bis(diphenylphosphino)propane (dppp) (64.2 mg, 0.075 mmol) in 
DMSO (10 mL) was added iPr2NEt (1.26 mL, 7.2 mmol), and the mixture was stirred at 100 °C 
for 24 h. After the reaction, the mixture was cooled down and diluted with EtOAc, washed 
with a large amount of H2O and extracted, the combined organic layer was dried over 
MgSO4, concentrated under reduced pressure and the residue was purified by column 
chromatography (n-hexane:EtOAc = 1:2) to afford 111 (420 mg). The product 111 was 
directly used in the next step without further purification. 31P NMR (162 MHz, CDCl3) δ 27.7 
ppm. MS (EI): m/z (M+H+) 513.2. These data are consistent with those previously 
reported.181 
Methyl (S)-2'-(diphenylphosphanyl)-[1,1'-binaphthalene]-2-carboxylate (112). Under 
argon, to a solution of 111 (380 mg, 0.74 mmol) and Et3N (4.0 mL, 29 mmol, 40 equiv) in dry 
PhMe (20 mL) was slowly added trichlorosilane (1.2 mL, 11 mmol, 15 equiv) at 0 °C, the 
mixture was stirred at room temperature for 30 min and then at 110 °C for 16 h. After this 
time, the mixture was cooled down to room temperature and diluted with Et2O slowly. The 
resulting suspension was filtered through a pad of silica, and the combined organic layer 
was dried over MgS04 and concentrated under reduced pressure to afford 112 (320 mg). 
31P 
NMR (162 MHz, CDCl3) δ -15.5 ppm. The product 112 was directly used in the next step 
without further purification. MS (EI): m/z (M+H+) 497.2. These data are consistent with 
those previously reported.181 
(S)-2'-(diphenylphosphanyl)-[1,1'-binaphthalene]-2-carboxylic acid (113). To a solution of 
112 (300 mg, 0.60 mmol) in MeOH (7.5 mL) was added 1.5 mL of 40% KOH solution, and the 
mixture was stirred at 80 °C for 16 h. After this time, the mixture was cooled down and 
acidified (pH a 2) by addition of concentrated HCl at 0 °C. After extracting with EtOAc, the 
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combined organic layer was dried over MgS04 and concentrated under reduced pressure to 
afford 113 (260 mg). The product 113 was directly used in the next step without further 
purification. 31P NMR (162 MHz, CDCl3) δ -15.0 ppm. MS (EI): m/z (M+H
+) 483.2. These data 
are consistent with those previously reported.181 
(S)-(2'-(diphenylphosphanyl)-[1,1'-binaphthalen]-2-yl)(pyrrolidin-1-yl)methanone (L34). To 
a solution of 113 (97 mg, 0.2 mmol, 1.0 equiv) in CH2Cl2 was added a drop of DMF, and 
(ClCO)2 (25 μL, 0.3 mmol, 1.5 equiv) at 0 °C, the mixture was then stirred at room 
temperature for 3.5 h. After this time, Et3N (140 μL, 1.0 mmol, 5 equiv) and pyrrolidine (85 
μL, 1.0 mmol, 5 equiv) was then added, the mixture was stirred at room temperature for an 
hour. The mixture was then directly concentrated under reduced pressure and the residue 
was purified by silica gel column chromatography to afford L34 as a white solid (12 mg, 0.02 
mmol, 10%) 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 8.1 Hz, 1H), 7.81 
(dd, J = 8.3, 2.5 Hz, 2H), 7.61 (d, J = 8.5 Hz, 1H), 7.47-7.39 (m, 3H), 7.30-7.20 (m, 5H), 7.17-
7.07 (m, 8H), 6.87 (d, J = 8.2 Hz, 1H), 3.39-3.23 (m, 3H), 3.13-3.06 (m, 1H), 1.53-1.43 (m, 2H), 
1.16-1.05 (m, 1H), 0.90-0.84 (m, 1H) ppm. 31P NMR (162 MHz, CDCl3) δ, -15.8 ppm. HRMS: 
calcd for C37H31NOP, 536.2143 (M+H
+); found, 536.2140. Specific rotation: [α]D (26.3 °C) = -
255.7° (c = 0.024, CH2Cl2). 
(S)-2'-(diphenylphosphanyl)-N,N-diphenyl-[1,1'-binaphthalene]-2-carboxamide (L35). To a 
solution of 113 (97 mg, 0.2 mmol, 1.0 equiv) in CH2Cl2 was added a drop of DMF, and 1.5 
equivalents of ClCOCOCl slowly at 0 °C, the mixture was then stirred at room temperature 
for 3.5 h. After this time, Et3N (140 μL, 1.0 mmol, 5 equiv) and diphenylamine (67.7 mg, 0.4 
mmol, 2.0 equiv) was then added, the mixture was stirred at room temperature for an hour. 
The mixture was then directly concentrated under reduced pressure and the residue was 
purified by silica gel column chromatography to afford L35 as a white solid (15 mg, 0.02 
mmol, 10%). 1H NMR (400 MHz, CDCl3) δ 7.87-7.77 (m, 4H), 7.68 (d, J = 8.6 Hz, 1H), 7.48-7.45 
(m, 1H), 7.39-7.29 (m, 6H), 7.18-7.14 (m, 1H), 7.10-6.96 (m, 11H), 6.87-6.83 (m, 1H), 6.76-
6.58 (m, 7H) ppm. 31P NMR (162 MHz, CDCl3) δ, -14.7 ppm. HRMS: calcd for C45H33NOP, 
634.2300 (M+H+); found, 634.2294. Specific rotation: [α]D (26.3 °C) = -220.3° (c = 0.021, 
CH2Cl2). 
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Preparation of L33.173 
 
(S)-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diyl bis(trifluoromethanesulfona-
te) (115). Under argon, pyridine (0.7 mL, 8.8 mmol, 2.6 equiv) was added into a solution of 
(S)-H8-BINOL L16 (1.0 g, 3.4 mmol, 1.0 equiv) in 35 mL of dry DCM. After stirring 5 minutes, 
the solution was cooled to 0 °C. Then Tf2O (1.3 mL, 7.5 mmol, 2.2 equiv) was added slowly 
and the reaction mixture was stirred at room temperature for 16 h. After this time, the 
mixture was filtered through a pad of silica gel using EtOAc/hexane (1:30) as eluent. 
Concentrate of the filtrate afforded 115 as a white solid (1.86 g, 3.3 mmol, 97%). 1H NMR 
(400 MHz, CDCl3) δ 7.22 (d, J = 8.6 Hz, 2H), 7.15 (d, J = 8.5 Hz, 2H), 2.85 (t, J = 6.3 Hz, 4H), 
2.42 (dt, J = 17.0, 6.0 Hz, 2H), 2.29 (dt, J = 16.9, 6.2 Hz, 2H), 1.84-1.67 (m, 8H) ppm. 13C NMR 
(101 MHz, CDCl3) δ 144.8, 139.3, 138.3, 130.9, 127.1, 118.2 (q, JC–F = 319.8 Hz), 118.1, 29.4, 
27.5, 22.4, 22.3 ppm. 19F NMR (376 MHz, CDCl3) δ -74. 8 ppm. HRMS: calcd for 
C22H20F6O6S2Na, 581.0503 (M+Na
+); found, 581.0505. 
(S)-2'-(diphenylphosphoryl)-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalen]-2-yl trifluoro-
methanesulfonate (116). Under argon, To a solution of 115 (1.1 g, 2.0 mmol, 1.0 equiv), 
 
 
192 
 
diphenylphosphine oxide (810 mg, 4.0 mmol, 2.0 equiv), Pd(OAc)2 (22.5 mg, 0.1 mmol, 5 mol 
%) and dppb (42.6 mg, 0.1 mmol, 5 mol %) in dry DMSO (8.8 mL) was added iPr2NEt (1.4 mL, 
8.0 mmol, 4.0 equiv). The reaction mixture was stirred at room temperature for 20 min and 
then at 110 °C for 16 h. After this time, the reaction mixture was cooled down to room 
temperature, and 30 mL of H2O was added. The resulting solution was extracted with Et2O 
at least 3 times. The combined organic layer was dried over anhydrous MgSO4 and 
concentrated. The crude mixture was purified by silica gel column chromatography (n-
hexane:EtOAc = 2:1) to afford 116 as a white solid (1.08 g, 1.8 mmol, 90%). 1H NMR (400 
MHz, CDCl3) δ 7.64-7.59 (m, 2H), 7.50-7.38 (m, 6H), 7.32-7.28 (m, 2H), 7.18- 7.10 (m, 2H), 
6.99 (d, J = 8.5 Hz, 1H), 6.70 (d, J = 8.5 Hz, 1H), 2.85-2.83 (m, 2H), 2.77-2.74 (m, 2H), 2.51-
2.43 (m, 1H), 2.37-2.30 (m, 1H), 2.12-2.02 (m, 2H), 1.80-1.55 (m, 8H) ppm. 13C NMR (101 
MHz, CDCl3) δ 144.7, 142.6 (d, J = 2.6 Hz), 139.3, 138.6 (d, J = 7.7 Hz), 137.6 (d, J = 9.9 Hz), 
137.0, 134.1, 133.1, 132.1 (d, J = 9.3 Hz), 131.6 (d, J = 9.8 Hz), 131.4 (d, J = 2.7 Hz), 131.23, 
131.18 (d, J = 2.8 Hz), 131.1, 131.02 (d, J = 4.0 Hz), 130.13, 128.71, 128.66 (d, J = 13.2 Hz), 
128.3 (d, J = 11.9 Hz), 128.0 (d, J = 12.2 Hz), 127.7, 118.1 (q, JC–F = 319.7 Hz), 117.0, 30.3, 
29.5, 27.9, 26.9, 22.9, 22.48, 22.45, 22.4 ppm. Some doublets due to C-P couplings can not 
be assigned due to complexity of the spectrum and they are listed as singlets. 31P NMR (162 
MHz, CDCl3) δ 27.7 ppm. 
19F NMR (376 MHz, CDCl3) δ -75.1 ppm. MS (EI): m/z (M+H
+) 611.2. 
(S)-2'-(diphenylphosphanyl)-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalen]-2-yl trifluoro-
methanesulfonate (117). Under argon, to a solution of 116 (1.0 g, 1.6 mmol), Et3N (8.0 mL, 
64 mmol, 40 equiv) in dry PhMe (32 mL) was slowly added trichlorosilane (1.6 mL, 16 mmol, 
10 equiv). The reaction mixture was stirred at 0 °C for 10 min and then at 110 °C for 16 h. 
After this time, the reaction mixture was cooled down to room temperature and filtered 
through a pad of silica, the filtrate was concentrated under reduced pressure to afford 117 
(1.5 g). 31P NMR (162 MHz, CDCl3) δ -14.4 ppm. MS (EI): m/z (M+H
+) 595.3. The product was 
directly used in the next step without further purification. 
(S)-H8-BINAP(O) (L33). Under argon, to a solution of 117 (595 mg, 1.0 mmol, 1.0 equiv), 
diphenylphosphine oxide (303.0 mg, 1.5 mmol, 1.5 equiv), Pd(OAc)2 (22.5 mg, 0.10 mmol, 10 
mol %) and dppb (42.6 mg, 0.1 mmol, 10 mol %) in dry DMSO (7.0 mL) was added dry iPr2NEt 
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(0.7 mL, 4.0 mmol, 4.0 equiv), The reaction mixture was stirred at room temperature for 20 
min and then at 110 °C for 16 h. After this time, the reaction mixture was cooled down to 
room temperature and 20 mL of H2O was added. The resulting solution was extracted with 
Et2O (3 x 20 mL). The combined organic layer was dried over anhydrous MgSO4 and 
concentrated under reduced pressure. The crude was purified by flash chromatography 
(CH2Cl2:EtOAc = 10:1) to afford S-H8-BINAP(O) (L33) as a white solid (250 mg). 
1H NMR (400 
MHz, CDCl3) δ 7.69-7.57 (m, 4H), 7.46-7.15 (m, 16H), 7.13-7.10 (m, 1H), 7.06-7.01 (m, 2H), 
6.98-6.96 (m, 1H), 2.76-2.62 (m, 4H), 1.88-1.67 (m, 3H), 1.55-1.30 (m, 6H), 1.25-1.08 (m, 2H), 
0.78-0.68 (m, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 145.7 (app. t, J = 8.2 Hz, 2C), 144.9 (d, J 
= 3.7 Hz), 144.6 (d, J = 3.7 Hz), 141.4 (d, J = 2.6 Hz), 140.2 (d, J = 13.7 Hz), 138.0, 137.9 (d, J = 
2.5 Hz), 137.8 (d, J = 2.4 Hz), 137.3 (d, J = 14.7 Hz), 135.5, 135.5, 135.3, 134.8 (d, J = 8.4 Hz), 
134.6 (d, J = 6.6 Hz), 134.4 (d, J = 12.8 Hz), 133.4, 132.9 (d, J = 16.6 Hz), 132.3 (d, J = 2.4 Hz), 
132.3 (d, J = 2.4 Hz), 132.2 (d, J = 9.3 Hz), 131.3 (d, J = 2.1 Hz), 131.2, 131.1 (x2), 131.0 (d, J = 
2.6 Hz), 128.8 (d, J = 3.6 Hz), 128.2 (d, J = 7.8 Hz), 128.1 (d, J = 4.4 Hz), 128.0 (d, J = 4.1 Hz), 
127.9 (d, J = 4.7 Hz), 127.4 (d, J = 13.8 Hz), 126.9, 126.4 (d, J = 2.3 Hz), 30.2, 29.9, 27.7 (d, J = 
2.2 Hz), 26.9, 22.9, 22.6, 22.4, 22.2 ppm. Some doublets due to C-P couplings can not be 
assigned due to complexity of the spectrum and they are listed as singlets. 31P NMR (162 
MHz, CDCl3) δ, 27.9, -17.2 ppm. HRMS: calcd for C44H41OP2, 647.2633 (M+H
+); found, 
647.2619. Specific rotation: [α]D (25.4 °C) = -119.2° (c = 0.05, CH2Cl2). 
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5.4.2 Enantioselective C-H arylation of fluorobenzene chromium tricarbonyl 
complex 
 
Under argon, to a mixture of Pd(dba)2 (1.7 mg, 3.0 μmol, 
3.0 mol %), S-H8-BINAP(O) (2.2 mg, 3.3 μmol, 3.0 mol%), 
dicyclohexylacetic acid (11.2 mg, 0.050 mmol, 0.50 
equiv), K2CO3 (28.0 mg, 0.20 mmol, 2.0 equiv), Ag2CO3 
(28.0 mg, 0.10 mmol, 1.0 equiv),  [(fluorobenzene)Cr(CO)3] (23.2 mg, 0.10 mmol, 1.0 equiv), 
methyl p-iodobenzoate (52.4 mg, 0.20 mmol, 2.0 equiv) and 2,2,6,6-tetramethylpiperidine 
(34 μl, 0.20 mmol, 2.0 equiv) was added PhCH3 (100 μL). The mixture was covered by 
aluminium foil and stirred at 40 °C for 40 h. After this time, the reaction mixture was filtered 
through a plug of silica and washed with acetone. The filtrate was evaporated to dryness 
and purified by preparative TLC (hexane:Et2O = 50:50), affording pure desired product 102 
as a yellow solid (13.8 mg, 38%). mp: 134-136 °C. IR: 2970, 1737, 1366, 1217 cm-1. 1H NMR 
(400 MHz, acetone-d6): δ 8.11 (d, J = 8.4 Hz, 2H), 7.79 (dd, J = 8.2, 1.4 Hz, 2H), 6.27-6.24 (m, 
1H), 6.05-6.00 (m, 1H), 5.94-5.90 (m, 1H), 5.45-5.43 (m, 1H), 3.92 (s, 3H) ppm. 13C NMR (101 
MHz, acetone-d6): δ 233.0 (d, J = 1.8 Hz), 166.6, 145.9 (d, J = 265.0 Hz), 137.9, 131.6, 130.6 
(d, J = 2.6 Hz), 130.4, 99.2 (d, J = 12.7 Hz), 97.3 (d, J = 3.6 Hz), 96.2 (d, J = 7.8 Hz), 88.9, 81.0 
(d, J = 22.0 Hz), 52.6 ppm. HRMS calcd for C17H11O5
50CrF: 364.0046 (M+); found, 364.0041. 
HPLC: Chiralpak IB, hexane/isopropanol = 97:3, flow rate 0.8 ml/min, λ = 280 nm, ret. times: 
30.249 min (95.618 %), 33.623 min (4.382 %). Specific rotation: [α]D (27 °C) = +75.4° (c = 
0.05, CH2Cl2). 
Bisarylation product 103 was obtained as a main by-product 
in the reaction above (20.8 mg, 42%). IR: 2970, 1877, 1739, 
1366, 1217 cm-1. mp: 198 °C (decomposition). 1H NMR (400 
MHz, acetone-d6) δ 8.13 (d, J = 8.5 Hz, 4H), 7.86 (dd, J = 8.4, 
1.6 Hz, 4H), 6.37-6.34 (m, 2H), 5.62-5.59 (m, 1H), 3.93 (s, 6H) 
ppm. 13C NMR (101 MHz, acetone-d6) δ 232.6 (d, J = 1.8 Hz), 
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166.7, 143.8 (d, J = 265.6 Hz), 137.9 (d, J = 2.2 Hz), 131.8, 131.0 (d, J = 2.6 Hz), 130.4, 98.8 (d, 
J = 14.2 Hz), 97.8 (d, J = 3.7 Hz), 88.2, 52.6 ppm. HRMS calcd for C25H17O7
50CrF: [M]+ 
498.0413; found: [M]+ 498.0415. 
HPLC spectra of 102 separation 
 
HPLC spectra of racemic 102 separation 
 
 
  
 
 
196 
 
References 
                                                     
1
 http://www.pfizer.com/files/investors/presentations/q4performance_020310.pdf. 
2
 F. Korte and H.-G. Schicke , Chemische Berichte, 1956, 89, 2404. 
3
 R. Schmid, J. Foricher, M. Cereghetti and P. Schonholzer, Helv. Chim. Acta, 1991, 74, 370. 
4
 J.-R. Labrosse, C. Poncet, P. Lhoste and D. Sinou, Tetrahedron: Asymmetry, 1999, 10, 1069. 
5
 http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2010/. 
6
 a) J. Yamaguchi, A. D. Yamaguchi and K. Itami, Angew. Chem. Int. Ed., 2012, 51, 8960; b) L. McMurray, F. 
O’Hara and M. J. Gaunt, Chem. Soc. Rev., 2011, 40, 1885; c) C.-L. Sun, B.-J. Li and Z.-J. Shi, Chem. Rev., 2011, 
111, 1293; d) L. Ackermann, Chem. Rev., 2011, 111, 1315; e) J.Wencel-Delord, T. Droge, F. Liu and F. Glorius, 
Chem. Soc. Rev., 2011, 40, 4740; f) C. S. Yeung and V. M. Dong, Chem. Rev., 2011, 111, 1215; g) Topics in 
Current Chemistry: C–H Activation, ed. J.-Q. Yu and Z. Shi, 1st edn, 2010, Springer, Berlin Heidelberg. 
7
 S. Zhang, L. Shi and Y. Ding, J. Am. Chem. Soc., 2011, 133, 20218. 
8
 a) B. S. Lane, M. A. Brown and D. Sames, J. Am. Chem. Soc. 2005, 127, 8050; b) E. J. Hennessy and S. L. 
Buchwald, J. Am. Chem. Soc. 2003, 125, 12084; c) C. C. Hughes and D. Trauner, D. Angew. Chem. Int. Ed. 2002, 
41, 1569. 
9
 a) M. A. Campo, Q. Huang, T. Yao, Q. Tian and R. C. Larock, J. Am. Chem. Soc. 2003, 125, 11506; b) A. J. Mota, 
A. Dedieu, C. Bour and J. Suffert, J. Am. Chem. Soc. 2005, 127, 7171; c) E. Capito, J. M. Brown and A. Ricci, 
Chem. Commun. 2005, 1854. 
10
 a) M. Go’mez, J. Granell and M. Martinez, Organometallics 1997, 16, 2539; b) E. J. Hennessy and S. L. 
Buchwald, J. Am. Chem. Soc. 2003, 125, 12084; c) A. J. Mota, A. Dedieu, C. Bour and J. Suffert, J. Am. Chem. 
Soc. 2005, 127, 7171. 
11
 a) V. I. Sokolov, L. L. Troitskaya and O. A. Reutov, J. Organomet. Chem., 1979, 182, 537; b) B. Biswas, M. 
Sugimoto and S. Sakaki, Organometallics 2000, 19, 3895. 
12
 For reviews on ortho-arylation see: a) P. B. Arockiam, C. Bruneau and P. H. Dixneuf, Chem. Rev., 2012, 112, 
5879; b) D. A. Colby, R. G. Bergman and J. A. Ellman, Chem. Rev., 2010, 110, 624; c) T. W. Lyons and M. S. 
Sanford, Chem. Rev., 2010, 110, 1147. For selected examples (since 2013), see: d) B. Punji, W. Song, G. A. 
Shevchenko and L. Ackermann, Chem. Eur. J., 2013, 19, 10605; e) R. Feng, J. Yao, Z. Liang, Z. Liu and Y. Zhang, J. 
Org. Chem., 2013, 78, 3688; f) J.-H. Chu, C.-C. Wu, D.-H. Chang, Y.-M. Lee and M.-J. Wu, Organometallics 2013, 
32, 272; g) F. Yang, F. Song, W. Li, J. Lan and J. You, RSC Adv., 2013, 3, 9649; h) Y. Aihara and N. Chatani, Chem. 
Sci., 2013, 4, 664; i) P. B. Arockiam, C. Fischmeister, C. Bruneau and P. H. Dixneuf, Green Chem., 2013, 15, 67; j) 
Z. Jiang, L. Zhang, C. Dong, X. Su, H. Li, W. Tang, L. Xu and Q. Fan, RSC Adv., 2013, 3, 1025; k) C. Arroniz, A. 
Ironmonger, G. Rassias and I. Larrosa, Org. Lett., 2013, 15, 910; l) L. Y. Chan, L. Cheong and S. Kim, Org. Lett., 
2013, 15, 2186; m) W. H. Jeon, T. S. Lee, E. J. Kim, B. Moon and J. Kang, Tetrahedron 2013, 69, 5152; n) Z. Liang, 
J. Yao, K. Wang, H. Li and Y. Zhang, Chem. Eur. J., 2013, 19, 16825; o) D. Li, N. Xu, Y. Zhang and L. Wang, Chem. 
Commun., 2014, 50, 14862; p) J.-H. Chu, H.-P. Huang, W.-T. Hsu, S.-T. Chen and M.-J. Wu, Organometallics, 
2014, 33, 1190; ; q) Z. Liang, R. Feng, H. Yin and Y. Zhang, Org. Lett., 2013, 15, 4544; i) L. C. M. Castro and N. 
 
 
197 
 
                                                                                                                                                                     
Chatani, Chem. Eur. J., 2014, 20, 4548; s) C. Wan, J. Zhao, M. Xu and J. Huang, J. Org. Chem., 2014, 79, 4751; t) 
D. Li, N. Xu, Y. Zhang and L. Wang, Chem. Commun., 2014, 50, 14862;  u) J. Han, P. Liu, C. Wang, Q. Wang, J. 
Zhang, Y. Zhao, D. Shi, Z. Huang and Y. Zhao, Org. Lett., 2014, 16, 5682; v) B. Li, C. Darcel and P. H. Dixneuf, 
ChemCatChem, 2014, 6, 127; w) R. K. Chinnagolla and M. Jeganmohan, Chem. Commun., 2014, 50, 2442; x) Z. 
Fan, K. Wu, L. Xing, Q. Yao and A. Zhang, Chem. Commun., 2014, 50, 1682. 
13
 For examples of para-arylation see: a) X.Wang, D. Leow and J.-Q. Yu, J. Am. Chem. Soc., 2011, 133, 13864; b) 
C.-L. Ciana, R. J. Phipps, J. R. Brandt, F.-M. Meyer and M. J. Gaunt, Angew. Chem. Int. Ed., 2011, 50, 458; c) Z. 
Wu, F. Luo, S. Chen, Z. Li, H. Xiang and X. Zhou, Chem. Commun., 2013, 49, 7653. 
14
 a) R. J. Phipps and M. J. Gaunt, Science 2009, 323, 1593; b) H. A. Duong, R. E. Gilligan, M. L. Cooke, R. J. 
Phipps and M. J. Gaunt, Angew. Chem. Int. Ed., 2011, 50, 463. 
15
 B. Chen, X. L. Hou, Y. X. Li and Y. D.Wu, J. Am. Chem. Soc., 2011, 133, 7668. 
16
 a) D. Leow, G. Li, T. S. Mei and J.-Q. Yu, Nature 2012, 486, 518; b) H.-X. Dai, G. Li, X.-G. Zhang, A. F. Stepan 
and J.-Q. Yu, J. Am. Chem. Soc., 2013, 135, 7567; c) L. Wan, N. Dastbaravardeh, G. Li and J.-Q. Yu, J. Am. Chem. 
Soc., 2013, 135, 18056. 
17
 R. –Y. Tang, G. Li and J.-Q. Yu, Nature 2014, 507, 215. 
18
 G. Yang, P. Lindovska, D. Zhu, J. Kim, P. Wang, R.-Y. Tang, M. Movassaghi and J.-Q. Yu, J. Am. Chem. Soc., 
2014, 136, 10807. 
19
 Y. Deng, and J.-Q. Yu, Angew. Chem. Int. Ed., 2015, 54, 888. 
20
 J. Cornella, M. Righi and I. Larrosa, Angew. Chem. Int. Ed., 2011, 50, 9429. 
21
 Y. Zhang, H. Zhao, M. Zhang, and W. Su, Angew. Chem. Int. Ed. 2015, 127, 3888. 
22
 a) M. Catellani, F. Frignani and A. Rangoni, Angew. Chem. Int. Ed. 1997. 36, 119; b) F. Faccini, E. Motti and M. 
Catellani, J. Am. Chem. Soc. 2004, 126, 78; c) A. Martins, B. Mariampillai and M. Lautens, Synthesis in the key of 
Catellani: norbornene-mediated ortho C–H functionalisation. Top. Curr. Chem. 2010, 292, 1-33; d) D. J. 
Cardenas, B. Martin-Matute and A. M. Echavarren, J. Am. Chem. Soc. 2006, 128, 5033; e) Z. Dong and G. Dong, 
J. Am. Chem. Soc. 2013, 135, 18350. 
23
 X.-C. Wang, W. Gong, L.-Z. Fang, R.-Y. Zhu, S. Li, K. M. Engle and J.-Q. Yu, Nature 2015 doi: 
10.1038/nature14214. 
24
 Z. Dong, J. Wang and G. Dong, J. Am. Chem. Soc., 2015, 137, 5887. 
25
 O. Saidi, J. Marafie, A. E. Ledger, P. M. Liu, M. F. Mahon, G. Kociok-Kohn, M. K. Whittlesey and C. G. Frost, J. 
Am. Chem. Soc., 2011, 133, 19298. 
26
 N. Hofmann and L. Ackermann, J. Am. Chem. Soc., 2013, 135, 5877. 
27
a) T. Ishiyama, J. Takagi, K. Ishida, N. Miyaura, N. R. Anastasi and J. F.  Hartwig, J. Am. Chem. Soc. 2002, 124, 
390; b) R. E. Maleczka, F. Shi, D. Holmes and M. R. Smith III, J. Am. Chem. Soc. 2003, 125, 7792. c) J. M. 
Murphy, X. Liao and J. F. Hartwig, J. Am. Chem. Soc. 2007, 129 , 15434. d) J. M. Murphy, C. C. Tzschucke and J. 
F. Hartwig, Org. Lett. 2007, 9, 757; e) T. Kikuchi, Y. Nobuta, J. Umeda, Y. Yamamoto, T. Ishiyama and N. 
Miyaura, Tetrahedron 2008, 64 , 4967; f) J. F. Hartwig, Acc. Chem. Res. 2012, 45, 864; g) D. W. Robbins and J. F. 
 
 
198 
 
                                                                                                                                                                     
Hartwig, Angew. Chem. Int. Ed., 2013, 52, 933; h) J. Y. Cho, M. K. Tse, D. Holmes, R. E. Maleczka, Jr. and M. R. 
Smith III, Science 2002, 295, 305. 
28
 A. J. Martínez-Martínez, A. R. Kennedy, R. E. Mulvey and C. T. O’Hara, Science 2014, 346, 834. 
29
 J. H. P Tyman, Synthetic and Natural Phenols; Elsevier: 1996. 
30
 K. J. Ryan, Cancer Res. 1982, 42, 3342. 
31
 a) Y.-F. Zhu, J.-J. Chen, X.-M. Ji, X. Hu, T.-J. Ling, Z.-Z. Zhang, G.-H. Bao,X.-C. Wan, Food Chemistry, 2015, 170, 
110; b) P. Wu, G. Ma, N. Li, Y. Yin, R. Huang and Q. Deng, Food Chemistry, 2015, 173, 194. 
32
 G. Abts, T. Eckel and R. Wehrmann, polycarbonates in Ullmann’s encyclopedia of industrial chemistry, Wiley-
VCH, Weinheim, 2014. 
33
 N. U. Hofsløkken and L. Skattebøl, Acta. Chem. Scand., 1999, 53, 258. 
34
 B. M. Trost and F. D. Toste, J. Am. Chem. Soc., 1996, 118, 6305. 
35
 C. Jia, D. Piao, J. Oyamada, W. Lu, T. Kitamura and Y. Fujiwara, Science 2000, 287, 1992. 
36
 a) U. Sharma, T. Naveen, A. Maji, S. Manna and D. Maiti, Angew. Chem. Int. Ed., 2013, 52, 12669; b) X.-S. 
Zhang, Z.-W. Li and Z.-J. Shi, Org. Chem. Front., 2014, 1, 44. 
37
 C. Jia, W. Lu, J. Oyamada, T. Kitamura, K. Matsuda, M. Irie and Y. Fujiwara, J. Am. Chem. Soc., 2000, 122, 
7252. 
38
 D.-H. Lee, K.-H. Kwon and C. S. Yi, J. Am. Chem. Soc. 2012, 134, 7325. 
39
 R. Zhu, J. Wei and Z. Shi, Chem. Sci., 2013, 4, 3706. 
40
 a) Z. Shi and C. He, J. Org. Chem., 2004, 69, 3669; b) H. A. Wegner, S. Ahles and M. Neuburger, Chem.-Eur. J., 
2008, 14, 11310. 
41
 a) C. Huang, B. Chattopadhyay and V. Gevorgyan, J. Am. Chem. Soc., 2011, 133, 12406; b) C. Huang, N. 
Ghavtadze, B. Chattopadhyay and V. Gevorgyan, J. Am. Chem. Soc. 2011, 133, 17630; c) Y. Wang and V. 
Gevorgyan, Angew. Chem. Int. Ed., 2015, 54, 2255. 
42
 X. Zhao, C. S. Yeung, and V. M. Dong, J. Am. Chem. Soc., 2010, 132, 5837. 
43
 B. Xiao, Y. Fu, J. Xu, T.-J. Gong, J.-J. Dai, J. Yi, and L. Liu, J. Am. Chem. Soc., 2010, 132, 468. 
44
 R. B. Bedford and S. J. Coles, Angew. Chem. Int. Ed., 2003, 42, 112. 
45
 C.-L. Ciana, R. J. Phipps, J. R. Brandt, F.-M. Meyer and M. J. Gaunt, Angew. Chem. Int. Ed., 2011, 50, 458. 
46
 Z. Wu, F. Luo, S. Chen, Z. Li, H. Xiang and X. Zhou, Chem. Commun., 2013, 49, 7653. 
47
 Z. Yu, B. Ma, M. Chen, H.-H. Wu, L. Liu and J. Zhang, J. Am. Chem. Soc., 2014, 136, 6904. 
48
 a) H. Tajik, I. Mohammadpoor-Baltork and J. Albadi, Syn. Commun., 2007, 37, 323; b) R. Murashige, Y. 
Hayashi, S. Ohmori, A. Torii, Y. Aizu, Y. Muto, Y. Murai, Y. Oda and M. Hashimoto, Tetrahedron 2011, 67, 641; c) 
T. Kanda, L. Engman, L. A. Cotgreave and G. Powis, J. Org. Chem., 1999, 64, 8161; d) D. Bahulayan, L. John and 
M. Lalithambika, Syn. Commun., 2003, 33, 863; e) S. Ghosh, L. K. Kinthada, S. Bhunia and A. Bisai, Chem. 
Commun., 2012, 48, 10132 f) J. Dey, M. Saha, A. K. Pal and K. Ismail, RSC Adv., 2013, 3, 18609. 
49
 H.-X. Dai, G. Li, X.-G. Zhang, A. F. Stepan and J.-Q. Yu, J. Am. Chem. Soc., 2013, 135, 7567. 
50
 a) Y. Izawa, D. Pun and S. S. Stahl, Science 2011, 333, 209; b) Y. Izawa, C. Zheng and S. S. Stahl, Angew. Chem. 
Int. Ed., 2013, 52, 3672. 
 
 
199 
 
                                                                                                                                                                     
51
 a) A. Tlili, N. Xia, F. Monnier and M. Taillefer, Angew. Chem. Int. Ed., 2009, 48, 8725; b) K. W. Anderson, T. 
Ikawa, R. E. Tundel and S. L. Buchwald, J. Am. Chem. Soc. 2006, 128, 10694; c) Y.-Q. Zou, J.-R. Chen, X.-P. Liu, L. 
-Q. Lu, R. L. Davis, K. A. Jørgensen and W.-J. Xiao, Angew. Chem. Int. Ed., 2012, 51, 784. 
52
 L. Wan, N. Dastbaravardeh, G. Li and J.-Q. Yu, J. Am. Chem. Soc., 2013, 135, 18056. 
53
 For reviews, see: a) T. Satoh and M. Miura, Synthesis 2010, 3395; b) N. Rodriguez and L. J. Goossen, Chem. 
Soc. Rev., 2011, 40, 5030; c) J. Cornella and I. Larrosa, Synthesis 2012, 653; d) W. I. Dzik,P. P. Lange and L. J. 
Goossen, Chem. Sci., 2012, 3, 2671. For selected examples, see: e) L. J. Goossen, C. Linder, N. Rodríguez, P. P. 
Lange and A. Fromm, Chem. Commun., 2009, 7173; f) J. Cornella, C. Sanchez, D. Banawa and I. Larrosa, Chem. 
Commun., 2009, 7176; g) S. Seo, J. B. Taylor and M. F. Greaney, Chem. Commun., 2012, 48, 8270; h) R. 
Grainger, A. Nikmal, J. Cornella and I. Larrosa, Org. Biomol.Chem., 2012, 10, 3172. 
54
 a) H. Kolbe, Justus Liebigs Ann. Chem., 1860, 113, 125. b) A. Lindsey and H. Jeskey, Chem. Rev., 1957, 57, 
583. 
55
 a) M. Komiyama and H. Hirai, J. Am. Chem. Soc., 1983, 105, 2018; b) H. Wynberg, Chem. Rev., 1960, 60, 169; 
c) U. N. Hofslokken and L. Skattebol, Acta Chem. Scand., 1999, 53, 258; d) D. Chakraborty, R. R. Gowda and P. 
Malik, Tetrahedron Lett., 2009, 50, 6553. 
56
 G. H. Posner and K. A. Canella, J. Am. Chem. Soc., 1985, 107, 2571. 
57
 a) T. Sakakura, J.-C. Choi and H. Yasuda, Chem. Rev., 2007, 107, 2365; b) D. J. Darensbourg, Chem. Rev., 2007, 
107, 2388; c) P. G. Jessop, T. Ikariya and R. Noyori, Chem. Rev., 1995, 95, 259; e) G. W. Coates and D. R. Moore, 
Angew. Chem. Int. Ed., 2004, 43, 6618. 
58
 a) G. W. Ebert, W. L. Juda, R. H. Kosakowski, B. Ma, L. Dong, K. E. Cummings, M. V. B. Phelps, A. E. Mostafa 
and J. Luo, J. Org. Chem., 2005, 70, 4314; b) Ukai, M. Aoki, J. Takaya and N. Iwasawa, J. Am. Chem. Soc., 2006, 
128, 8706. 
59
 M. Shi and M. Nicholas, J. Am. Chem. Soc., 1997, 119, 5057. 
60
 T. Ohishi, M. Nishiura and Z. Hou, Angew. Chem. Int. Ed., 2008, 47, 5792. 
61
 a) K. Ukai, M. Aoki, J. Takaya and N. Iwasawa, J. Am. Chem. Soc., 2006, 128, 8706; b) J. Takaya, S. Tadami, K. 
Ukai and N. Iwasawa, Org. Lett., 2008, 10, 2697. 
62
 C. S. Yeung and V. M. Dong, J. Am. Chem. Soc. 2008, 130, 7826. 
63
 a) M. Aresta, C. F. Nobile, V. G. Albano, E. Forni and M. Manassero, J. Chem. Soc., Chem.Commun., 1975, 15, 
636; b) X. Yin and J. R. Moss, Coord. Chem. Rev., 1999, 181, 27. 
64
 A. Correa and R. Martin, J. Am. Chem. Soc., 2009, 131, 15974. 
65
 T. Fujihara, K. Nogi, T. Xu, J. Terao and Y. Tsuji, J. Am. Chem. Soc. 2012, 134, 9106. 
66
 H. Tran-Vu and O. Daugulis, ACS Catal. 2013, 3, 2417. 
67
 a) T. Leon, A. Correa and R. Martin, J. Am. Chem. Soc. 2013, 135, 1221; b) Y. Liu, J. Cornella and R. Martin, J. 
Am. Chem. Soc. 2014, 136, 11212. 
68
 L. Zhang, J. Cheng, T. Ohishi and Z. Hou, Angew. Chem. Int. Ed., 2010, 49, 8670. 
69
 O. Vechorkin, N. Hirt and X. Hu, Org. Lett., 2010, 12, 3567. 
70
 H. Mizuno , J. Takaya and N. Iwasawa, J. Am. Chem. Soc., 2011, 133, 1251. 
 
 
200 
 
                                                                                                                                                                     
71
 a) P. Elwood, M. Morgan, G. Brown and J. Pickering, Br. Med. J., 2005, 330, 1440; b) O. El-Kabbani, P. J. 
Scammells, J. Gosling, U. Dhagat, S. Endo, T. Matsunaga, M. Soda and A. Hara, J. Med. Chem., 2009, 52, 3259; 
c) S. A. Hawley, M. D. Fullerton, F. A. Ross, J. D. Schertzer, C. Chevtzoff, K. Walker, M. W. Peggie, D. Zibrova, K. 
A. Green, K. J. Mustard, B. K. Kemp, K. Sakamoto, G. R. Steinberg and D. G. Hardie, Science 2012, 336, 918; d) A. 
Ooguri, K. Nakai, T. Kurahashi and S. Matsubara, J. Am. Chem. Soc., 2009, 131, 13194; e) C. Wang, I. Piel and F. 
Glorius, J. Am. Chem. Soc. 2009, 131, 4194; f) D. L. Caulder, C. Brückner, R. E. Powers, S. König, T. N. Parac, L. A. 
Leary and K. N. Raymond, J. Am. Chem. Soc. 2001, 123, 8923; g) M. C. Roberts, M. C. Hanson, A. P. Massey, E. 
A. Barman, S. K. Mukhopadhyay, K. K. Behara, S. Dey and N. D. P. Singh, ACS Appl. Mater. Interfaces 2014, 6, 
7045; h) H. Furukawa, K. E. Cordova, M. O’Keeffe and O. M. Yaghi, Science 2013, 341, 974. 
72
 G. H. Posner and K. A. Canella, J. Am. Chem. Soc., 1985, 107, 2571. 
73
 N. S. Narasimhan and R. S. Mali, Synthesis 1983, 965. 
74
 a) M.Lim, C. M. Yoon, G. An and H. Rhee, Tetrahedron Lett., 2007, 48, 3835; b) D. Chakraborty, R. R. Gowda 
and P. Malik, Tetrahedron Lett., 2009, 50, 6553. 
75
 For reviews on formylation see: H. Wynberg, Chem. Rev., 1960, 60, 169; b) G. A. Olah, L. Ohannesian and M. 
Arvanaghi, Chem. Rev., 1987, 87, 671; c) W. Kantlehner, Eur. J. Org. Chem., 2003, 2530; For selected examples 
on formylation of phenols see: d) K. Chiba, T. Arakawa and M. Tada, Chem. Commun., 1996, 1763; e) N. U. 
Hofsløkken and L. Skattebøl, Acta Chemica Scandinavica, 1999, 53, 258; f) S. P. Cook, A. Polara and S. J. 
Danishefsky, J. Am. Chem. Soc., 2006, 128, 16440; g) S. Tang, Y. Xu, J. He, Y. He, J. Zheng, X. Pan and X. She, Org. 
Lett., 2008, 10, 1855; h) K. B. Bahnck and S. D. Rychnovsky, J. Am. Chem. Soc., 2008, 130, 13177; i) D. H. T. Phan, 
B. Kim and V. M. Dong, J. Am. Chem. Soc., 2009, 131, 15608. 
76
 a) O, Baine, G. F. Adamson, J. W. Barton, J. L. Fitch, D. R. Swayampati and H. J. Jeskey, J. Org. Chem., 1954, 
19, 510; b) F. Wessely, K. Benedikt, H. Benger, H. Friedrich and F. Prillinger, Monatsh, 1950, 81, 1071. 
77
 a) D. Cameron, H. Jeskey and O. Baine, J. Org. Chem., 1950, 15, 233; b) J. Cason and G. O. Dyke, J. Am. Chem. 
Soc., 1950, 72, 621. 
78
 a) S. Marasse, German patent 1893, 73, 279; Frdl. 3, 821; b) S. Marasse, German patent 1894, 78,708; Frdl. 
4, 152. 
79
 a) K. M. Engle, T.-S. Mei, M. Wasa and J.-Q. Yu, Acc. Chem. Res., 2012, 45, 788; b) G. Shi and Y. Zhang, Adv. 
Synth. Catal., 2014, 356, 1419. 
80
 M. Miura, T. Tsuda, T. Satoh, S. Pivsa-Art and M. Nomura, J. Org. Chem. 1998, 63, 5211. 
81
 D.-H. Wang, K. M. Engle, B.-F. Shi and J.-Q. Yu, Science 2010, 327, 315. 
82
 a) L. Achermann and J. Pospech, Org. Lett., 2011, 13, 4153; b) T. Ueyama, S. Mochida, T. Fukutani, K. Hirano, 
T. Satoh and M. Miura, Org. Lett., 2011, 13, 706; c) R. K. Chinnagolla and M. Jeganmohan, Chem. Commun., 
2012, 48, 2030. 
83
 K. L. Engelman, Y. Feng and E. A. Ison, Organometallics 2011, 30, 4572. 
84
 a) S. Mochida, K. Hirano, T. Satoh and M. Miura, J. Org. Chem. 2011, 76, 3024; b) T. Iitsuka, P. Schaal, K. 
Hirano, T. Satoh, C. Bolm and M. Miura, J. Org. Chem. 2013, 78, 7216; c) K. Ueura, T. Satoh and M. Miura, Org. 
Lett. 2007, 9, 1407; d) K. Ueura, T. Satoh and M. Miura, J. Org. Chem. 2007, 72, 5362; e) M. Shimizu, K. Hirano, 
 
 
201 
 
                                                                                                                                                                     
T. Satoh and M. Miura, J. Org. Chem. 2009, 74, 3478; f) S. Mochida, K. Hirano, T. Satoh and M. Miura, J. Org. 
Chem. 2009, 74, 6295. 
85
 T.-S. Mei, R. Giri, N. Maugel and J.-Q. Yu, Angew. Chem. Int. Ed., 2008, 47, 5215. 
86
 R. Giri and J.-Q. Yu, J. Am. Chem. Soc. 2008, 130, 14082;  
87
 a) D.-H. Wang, T.-S. Mei and J.-Q. Yu, J. Am. Chem. Soc. 2008, 130, 17676; b) H. A. Chiong , Q.-N. Pham and O. 
Daugulis, J. Am. Chem. Soc., 2007, 129, 9879. 
88
 Y.-H. Zhang and J.-Q. Yu, J. Am. Chem. Soc., 2009, 131, 14654.  
89
 R. Giri, N. L. Maugel, J.-J. Li, D.-H. Wang, S. P. Breazzano, L. B. Saunders and J.-Q. Yu, J. Am. Chem. Soc., 2007, 
129, 3510 
90
 X.-Y. Shi and C.-J. Li, Adv. Synth. Catal., 2012, 354, 2933. 
91
 A. F. Shepard, N. R. Winslow and J. R. Johnson, J. Am. Chem. Soc., 1930, 52, 2083. 
92
 a) M. Nilsson, Acta Chem. Scand. 1966, 20, 423; b) M. Nilsson and C. Ullenius, Acta Chem. Scand. 1968, 22, 
1998. 
93
 A. Cairncross, J. R. Roland, R. M. Henderson and W. A. Sheppard, J. Am. Chem. Soc. 1970, 92, 3187. 
94
 a) L. J. Goossen, W. R. Thiel, N. Rodriguez, C. Linder and B. Melzer, Adv. Synth. Catal., 2007, 349, 2241. b) L. J. 
Goossen, F. Manjolinho, B. A. Khan and N. Rodriguez, J. Org. Chem., 2009, 74, 2620. 
95
 D. Tanaka, S. P. Romeril and A. G. Myers, J. Am. Chem. Soc., 2005, 127, 10323. 
96
 J. S. Dickstein, C. A. Mulrooney, E. M. O’Brien, B. J. Morgan and M. C. Kozlowski, Org. Lett., 2007, 9, 2441. 
97
 J. Cornella, C. Sanchez, D. Banawa and I. Larrosa, Chem. Commun., 2009, 7176. 
98
 P. Lu, C. Sanchez, J. Cornella and I. Larrosa, Org. Lett., 2009, 11, 5710. 
99
 R. Grainger, J. Cornella, D. C. Blakemore, I. Larrosa and J. M. Campanera, Chem. Eur. J. 2014, 20, 16680. 
100
 L. J. Goossen, C. Linder, N. Rodriguez, P. P. Lange and A. Fromm, Chem. Commun., 2009, 7173. 
101
 A. Maehara, H. Tsurugi, T. Satoh and M. Miura, Org. Lett., 2008, 10, 1159. 
102
 S. Mochida, K. Hirano, T. Satoh and M. Miura, Org. Lett. 2010, 12, 5776. 
103
 a) K. M. Engle, D.-H. Wang and J.-Q. Yu, Angew. Chem. Int. Ed., 2010, 49, 6169; b) R. Giri and J.-Q. Yu, J. Am. 
Chem. Soc., 2008, 130, 14082; c) H. A. Chiong, Q. N. Pham and O. Daugulis, J. Am. Chem. Soc., 2007, 129, 9879. 
104
 a) X. Wan, Z. Ma, B. Li, K. Zhang, S. Cao, S. Zhang and Z. Shi, J. Am. Chem. Soc., 2006, 128, 7416; b) S. Yang, 
B. Li, X. Wan and Z. Shi, J. Am. Chem. Soc., 2007, 129, 6066; c) R. Giri, J. K. Lam and J.-Q. Yu, J. Am. Chem. Soc., 
2010, 132, 686; d) Y. Wu, B. Li, F. Mao, X. Li and F. Y. Kwong, Org. Lett., 2011, 13, 3258; e) Y. Wu, P. Y. Choy, F. 
Mao and F. Y. Kwong, Chem. Commun., 2013, 49, 689. 
105
 C. Arroniz, J. G. Denis, A. Ironmonger, G. Rassias and I. Larrosa, Chem. Sci., 2014, 5, 3509. 
106
 C. Seong, C. M. Park, S. Kim, W. Park and N. Park, United States Patent Application Publication. US 
2009/0258876 A1 
107
 D. Wensbo, T. Stefanac, J. Arora, L. Edwards, M. Isaac and A. Slassi, World Intellectual Property 
Organization. WO 2004/014902 A2 
 
 
202 
 
                                                                                                                                                                     
108
 a) A. O. Adeniji, B. M. Twenter, M. C. Byrns, Y. Jin, M. Chen, J. D. Winkler and T. M. Penning, J. Med. Chem., 
2012, 55, 2311; b) A. S. Guram, R. A. Rennels and S. L. Buchwald, Angew. Chem Int. Ed., 1995, 34, 1348. c) M. S. 
Driver and J. F. Hartwig, J. Am. Chem. Soc., 1997, 119, 8232. 
109
 a) C. Y. HO, United States Patent Application Publication. US 2009/0105288 A1; b) N. Miyaura and A. Suzuki, 
Chem. Rev., 1995, 95, 2457. 
110
 P. Y. Yeung, C. M. So, C. P. Lau and F. Y. Kwong, Angew. Chem. Int. Ed., 2010, 49, 8918. 
111
 F. Wilson, A. Reid, V.  Reader, R. J. Harrison, M. Sunose, R. Hernandez-Perni, J. Mayor, C. Boussard, K. Smelt, 
J. Taylor, A. Le Formal, A. Cansfield and S. Burckhardt, (Cellzome UK Ltd.) European Patent Appl. EP1849762A1, 
2007. 
112
 N. Jalalian, E. E. Ishikawa, L. F. Silva and B. Olofsson, Org. lett., 2011, 13, 1552. 
113
 T. Hama, S. G and J. F. Hartwig, J. Org. Chem., 2013, 78, 8250. 
114
 G.-J. Wu, J. Guan, F.-S. Han and Y.-L Zhao, ChemCatChem 2014, 6, 1589. 
115
 T. Satoh, T. Itaya, M. Miura and M. Nomura, Chem. Lett., 1996, 9, 823. 
116
 a) N. Gürbüz, I. Ö zdemira and B. Çetinkaya, Tetrahedron Lett., 2005, 46, 2273; b) Ö. Doğan, N. Gürbüz, I. 
Ö zdemira and B. Çetinkaya, J. Heterocyclic Chem., 2009, 46, 186. For selected examples of the use of aldehydes 
as directing groups for other C–H functionalisation processes see: c) K. Padala and M. Jeganmohan, Org. Lett., 
2012, 14, 1134; d) V. Lanke and K. R. Prabhu, Org. Lett., 2013, 15, 6262; e) X. Liu, G. Li, F. Song and J. You, 
Nature Commun., 2014, 5, 5030. 
117
 A. Modak, A. Deb, T. Patra, S. Rana, S. Maity and D. Maiti, Chem. Commun., 2012, 48, 4253. 
118
 C. Arroniz, J. G. Denis, A. Ironmonger, G. Rassias and I. Larrosa, Chem. Sci., 2014, 5, 3509. 
119
 J. Tsuji, Palladium Reagents and Catalysts, 1st Edn 2004, Wiley, 29-35. 
120
 a) M. P. Doyle and D. C. Forbes, Chem. Rev., 1998, 98, 911; b) H. M. L. Davies and R. E. J. Beckwith, Chem. 
Rev., 2003, 103, 2861; c) H. M. L. Davies and J. R. Manning, Nature 2008, 451, 417; d) M. P. Doyle, R. Duffy, M. 
Ratnikov and L. Zhou, Chem. Rev., 2010, 110, 704; e) D. Gillingham and N. Fei, Chem. Soc. Rev., 2013, 42, 4918. 
121
 M. Kennedy, M. A. Mckervey, A. R. Maguire and G. H. P. Roos, J. Chem. Soc., Chem. Commun., 1990, 361. 
122
 a) S. Hashimoto, N. Watanabe and S. Ikegami, Tetrahedron Lett., 1990, 31, 5173; b) S. Hashimoto, N. 
Watanabe, T. Sato, M. Shiro and S. Ikegami, Tetrahedron Lett., 1993, 34, 5109; c) M. A. Mckervey and T. Ye, J. 
Chem. Soc., Chem. Commun., 1992, 823; d) M. P. Doyle and D. C. Forbes, Chem. Rev., 1998, 98, 911; d) M. P. 
Doyle, J. Org. Chem., 2006, 71, 9253; e) M. P. Doyle, A. Vanoeveren, L. J. Westrum, M. N. Protopopova and T. 
W. Clayton, J. Am. Chem. Soc., 1991, 113, 8982; f) M. P. Doyle and A. V. Kalinin, Synlett, 1995, 1075; g) J. W. 
Bode, M. P. Doyle, M. N. Protopopova and Q. L. Zhou, J. Org. Chem., 1996, 61, 9146; h) M. P. Doyle and W. H. 
Hu, Chirality, 2002, 14, 169; i) M. P. Doyle, W. H. Hu and M. V. Valenzuela, J. Org. Chem., 2002, 67, 2954. 
123
 a) H. M. L. Davies, M. V. A. Grazini and E. Aouad, Org. Lett., 2001, 3, 1475; b) H. M. L. Davies, T. Hansen and 
M. R. Churchill, J. Am. Chem. Soc., 2000, 122, 3063. 
124
 a) R. Breslow and S. H. Gellman, J. Am. Chem. Soc., 1983, 105, 6728; b) R. Breslow and S. H. Gellman, J. 
Chem. Soc., Chem. Commun., 1982, 1400; c) J. P. Mahy, G. Bedi, P. Battioni and D. Mansuy, Tetrahedron Lett., 
1988, 29, 1927. 
 
 
203 
 
                                                                                                                                                                     
125
 N. Watanabe, Y. Ohtake, S. Hashimoto, M. Shiro and S. Ikegami, Tetrahedron Lett., 1995, 36, 1491. 
126
 M. C. Pirrung and J. Zhang, Tetrahedron Lett., 1992, 33, 5987. 
127
 M. Yamawaki, H. Tsutsui, S. Kitagaki, M. Anada and S. Hashimoto, Tetrahedron Lett., 2002, 43, 9561. 
128
 R. P. Reddy and H. M. L. Davies, Org. Lett., 2006, 8, 5013. 
129
 B.-F. Shi, N. Maugel, Y.-H. Zhang and J.-Q. Yu, Angew. Chem. Int. Ed., 2008, 47, 4882. 
130
 B.-F. Shi, Y.-H. Zhang, J. K. Lam, D.-H. Wang and J.-Q. Yu, J. Am. Chem. Soc., 2010, 132, 460. 
131
 D. G. Musaev, A. Kaledin, B.-F. Shi and J.-Q. Yu, J. Am. Chem. Soc., 2012, 134, 1690. 
132
 D.-W. Gao, Y.-C. Shi, Q. Gu, Z.-L. Zhao and S.-L. You, J. Am. Chem. Soc., 2013, 135, 86. 
133
 C. Pi, Y. Li, X. Cui, H. Zhang, Y. Han and Y. Wu, Chem. Sci., 2013, 4, 2675. 
134
 K. Yamaguchi, H. Kondo, J. Yamaguchi and K. Itami, Chem. Sci., 2013, 4, 3753. 
135
 a) M. Wasa, K. M. Engle, D. W. Lin, E. J. Yoo and J.-Q. Yu, J. Am. Chem. Soc., 2011, 133, 19598; Similiar work 
see: K.-J. Xiao, D. W. Lin, M. Miura, R.-Y. Zhu, W. Gong, M. Wasa and J.-Q. Yu, J. Am. Chem. Soc., 2014, 136, 
8138. 
136
 M. R. Albicher and N. Cramer, Angew. Chem. Int. Ed., 2009, 48, 9139. 
137
 a) T. Saget and N. Cramer, Angew. Chem. Int. Ed., 2013, 52, 7865. Similar work see b) R. Shintani, H. Otomo, 
K. Ota and T. Hayashi, J. Am. Chem. Soc., 2012, 134, 7305. 
138
 R. Deng, Y. Huang, X. Ma, G. Li, R. Zhu, B. Wang, Y.-B. Kang and Z. Gu, J. Am. Chem. Soc., 2014, 136, 4472. 
139
 D.-W. Gao, Q. Yin, Q. Gu and S.-L. You, J. Am. Chem. Soc., 2014, 136, 4841. 
140
 a) D. L. Boger, C. W. Boyce, R. M. Garbaccio and J. A. Goldberg, Chem. Rev., 1997, 97, 787; b) D. A. Horton, 
G. T. Bourne and M. L. Smythe, Chem. Rev., 2003, 103, 893; c) J. M. Ontoria, S. Di Marco, I. Conte, M. E. Di 
Francesco, C. Gardelli, U. Koch, V. G. Matassa, M. Poma, C. Steinkuhler, C. Volpari and S. Harper, J. Med. 
Chem., 2004, 47, 6443. 
141
 M. Nakanishi, D. Katayev, C. Besnard and E. P. Kundig, Angew. Chem. Int. Ed., 2011, 50, 7438. 
142
 D. Katayev, M. Nakanishi, T. Burgi and E. P. Kundig, Chem. Sci., 2012, 3, 1422. 
143
  S. Anas, A. Cordi and H. B. Kagan, Chem. Commun., 2011, 47, 11483. 
144
  a) T. Saget, S. J. Lemouzy and N. Cramer, Angew. Chem. Int. Ed., 2012, 51, 2238. b) P. A. Donets, T. Saget 
and N. Cramer, Organometallics 2012, 31, 8040. 
145
 X.-F. Cheng, Y. Li, Y.-M. Su, F. Yin, J.-Y. Wang, J. Sheng, H. U. Vora, X.-S. Wang and J.-Q. Yu, J. Am. Chem. Soc., 
2013, 135, 1236. 
146
 L. Chu, X.-C. Wang, C. E. Moore, A. L. Rheingold and J.-Q. Yu, J. Am. Chem. Soc., 2013, 135, 16344. 
147
 L. Chu, K.-J. Xiao and J.-Q. Yu, Science 2014, 346, 451. 
148
 K. S. L. Chan, H.-Y. Fu and J.-Q. Yu, J. Am. Chem. Soc., 2015, 137, 2042. 
149
 D. Shabashov and O. Daugulis, J. Am. Chem. Soc., 2010, 132, 3965. 
150
 B.-F. Shi, N. Maugel, Y.-H. Zhang and J.-Q. Yu, Angew. Chem. Int. Ed., 2008, 47, 4882. 
151
 a) Ferrocenes; T. Hayashi and A. Togni, Eds.; VCH: Weinheim, Germany, 1995; b) Metallocenes; A. Togni and 
R. L. Haltermann, Eds.; VCH: Weinheim, Germany, 1998. c) Chiral Ferrocenes in Asymmetric Catalysis; L.-X. Dai 
and X.-L. Hou, Eds.; Wiley-VCH: Weinheim, Germany, 2010. 
 
 
204 
 
                                                                                                                                                                     
152
 a) M. F. Semmelhack, in Comprehensive Organometallic Chemistry II, vol. 12, eds. E. W. Abel, F. G. A. Stone 
and G. Wilkinson, Pergamon, New York 1995, p. 979; b) L. S. Hegedus, Transition Metals in the Synthesis of 
Complex Organic; c) M. Rosillo, G. Dominguez and J. Perez-Castells, Chem. Soc. Rev., 2007, 36, 1589. 
153
 M. Uemura, in Stereochemistry of Organometallic and Inorganic Compounds, vol. 5, ed. P. Zanello, Elsevier, 
Amsterdam 1994, p. 507. 
154
 a) Y. Hayashi, H. Sakai, N. Kaneta and M. J. Uemura, Organomet. Chem., 1995, 503, 143; b) A. Ariffin, A. J. 
Blake, W.-S. Li and N. S. Simpkins, Synlett 1997, 1453; c) J. W. Han, H.-Y. Jang and Y. K. Chung, Tetrahedron: 
Asymmetry 1999, 10, 2853; d) S. G. Nelson and M. A. Hilfiker, Org. Lett. 1999, 1, 1379; e) U. Englert, R. Haerter, 
D. Vasen and A. Salzer, Organometallics 1999, 18, 4390; f) D. Vasen, A. Salzer, F. Gerhards, H.-J. Gals, R. 
Stürmer, N. H. Bieler and A. Togni, Organometallics 2000, 19, 539; g) I. Weber and G. B. Jones, Tetrahedron 
Lett., 2001, 42, 6983.  
155
 Y.-L. Tan, A. J. P. White, D. A. Widdowson, R. Wilhelm and D. J. Williams, J. Chem. Soc., Perkin Trans. 1, 2001, 
3269. 
156
 P. Ricci, K. Krӓmer, X. C. Cambeiro and I. Larrosa, J. Am. Chem. Soc., 2013, 135, 13258. 
157
 P. Ricci, K. Krӓmer and I. Larrosa, J. Am. Chem. Soc., 2014, 136, 18082. 
158
 a) Z. Zhang, H. Qian, J. Longmire and X. J. Zhang, J. Org. Chem. 2000, 65, 6223; b) T. Saito, T. Yokozawa, T. 
Ishizaki, T. Moroi, N. Sayo,N. T. Miura and H. Kumobayashi, Adv. Synth. Catal. 2001, 343, 264; c) H. Shimizu, I. 
Nagasaki, K. Matsumura, N. Sayo and T. Saito, Acc. Chem. Res. 2007, 40, 1385. 
159
 X. Zhang, K. Mashima, K. Koyano, N. Sayo, H. Kumobayashi, S. Akutagawa and H. Takaya, Tetrahedron Lett., 
1991, 32, 7283. 
160
 J.-P. Genet, T. Ayad and V. Ratovelomanana-Vidal, Chem. Rev. 2014, 114, 2824. 
161
 Y.-H. Zhang and J.-Q. Yu, J. Am. Chem. Soc., 2009, 131, 14654. 
162
 J. Ling, G. P. Horsman, S.-X. Huang, Y. Luo, S. Lin and B. Shen, J. Am. Chem. Soc., 2010, 132, 12534. 
163
 Takeda Chemical Industries, Ltd., 2004, EP 1424336A1. 
164
 C. Seong, C. M. Park, S. Kim, W. Park and N. Park, United States Patent Application Publication. US 
2009/0258876 A1. 
165
 D. Wensbo, T. Stefanac, J. Arora, L. Edwards, M. Isaac and A. Slassi, World Intellectual Property Organization. 
WO 2004/014902 A2. 
166
 L. J. Goossen, N. Rodríguez and C. Linder, J. Am. Chem. Soc., 2008, 130, 15248. 
167
 A. O. Adeniji, B. M. Twenter, M. C. Byrns, Y. Jin, M. Chen, J. D. Winkler and T. M. Penning, J. Med. Chem., 
2012, 55, 2311. 
168
 C. Y. HO, United States Patent Application Publication. US 2009/0105288 A1. 
169
 P. Y. Yeung, C. M. So, C. P. Lau and F. Y. Kwong, Angew. Chem. Int. Ed., 2010, 49, 8918. 
170
 Z. Huang , Z. Liu and J. (S.) Zhou, J. Am. Chem. Soc., 2011, 133, 15882. 
171
 J. Hu, H. Hirao, Y. Li and J. (S.) Zhou, Angew. Chem. Int. Ed., 2013, 52, 8676. 
172
 Y. Uozumi, N. Suzuki, A. Ogiwara and T. Hayashi, Tetrahedron 1994, 50, 4293. 
173
 Y. Uozumi, A. Tanahashi, S.-Y. Lee and T. Hayashi, J. Org. Chem. 1993, 58, 1945. 
